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ABSTRACT OF THESIS
Cytochrome P45C>s the terminal oxidase for the side chain
cleavage of cholesterol to pregnenolone in bovine adrenal cortex
mitochondria, was partially purified to a specific content of 10.2
nmoles cytochrome P450/mg protein with a recovery of 14%. The
method involves iso-octane extraction of lyophilised mitochondria,
ammonium sulphate fractionation in the presence of sodium cholate,
butanol-acetone extraction, phosphate buffer extraction; a second
ammonium sulphate fractionation, calcium phosphate gel adsorption
and elution.
The cytochrome P450gcc preparation has no detectable activity
for the 11g-hydroxylation of deoxycorticosterone. Cholesterol:
cytochrome P450 molar ratios are reduced to 1:100 and the
see
cytochrome has been isolated as a low spin haemoprotein. Adrenodoxin
contamination in the preparation has been reduced to less than 1%
on a molar basis to cytochrome P450 and NADPH adrenodoxin reductase
see
activity reduced to 4% of that in mitochondria. Sodium cholate,
initially added to effect solubilisation, was reduced in the final
preparation to a 3:1 molar ratio to cytochrome P450gcc. The molecular
weight of cytochrome P450 , determined by gel filtration, was 200,000.sec
The main bands of peroxidase activity observed using isoelectric focusing
were at pH 5.3 and 5.4.
Further purification of cytochrome was limited by
degradation of the cytochrome P450. A degradation product of
cytochrome 1*450 with a Soret absorption maximum at 412 nm
which failed to bind carbon monoxide was observed. Ligands to
cytochrome P450 , in particular 4-phenylimidazole and aminoglutethimide,
see
were found to inhibit the degradation process.
The absorption maxima of low spin cholesterol depleted
cytochrome P450 are 416, 535 and 568 ran; addition of cholesterol
see
results in the formation of a high spin cytochrome P450s -
cholesterol complex and a decrease in absorbance at 416 and 568 nm,
an increase in absorbance at 392 and 648 nm with isosbestic points
at 406, 457, 533 and 588 nm.
The affinity of cholesterol binding to cytochrome P450 ^as
been determined from the spectral dissociation constant Ks. The
spectral dissociation constant is related to the concentration of
cytochrome ^50 ; the equilibrium constant for cholesterol
association is K .. = 0.43 ± 0.03 x 10^ M ^ in 10 mM potassium
equil
phosphate buffer pH 7.4 at 20°C. Potassium chloride appears
inhibitory to cholesterol induced low to high spin state change of
cytochrome P450
see
The first order rate constant of cholesterol association with
-4-1 o
cytochrome P450 is k = 7.5 x 10 sec at 20 C and is
see
decreased by the presence of potassium chloride and increased by
calcium chloride. The activation energy for the first order rates
of cholesterol association to cytochrome P450 is 88 kJ mole
see
The first order rate constants of association of side chain
monohydroxylated sterols (24-, 25- and 26-hydroxycholesterol) to
cytochrome P450 are similar to one another but differ from that
see
of cholesterol, or the nuclear monohydroxylated sterols, 7a and 7g-
hydroxycholesterol and 19-hydroxycholesterol. The maximal absorbance
change induced and the initial rate of association however is
dependent on minor variations in the position of the hydroxyl group
within the sterol and to the optical isomers at the same site.
Cytochrome PASO^^-cholesterol is a one electron acceptor on
titration with NADPH. Cytochrome P450 -cholesterol can beJ see
anaerobically reduced to the ferrous state which on oxygenation
forms an oxygenated cytochrome P450scc~cholesterol complex.
This oxygenated complex autoxidises, in the absence of adrenodoxin,
to ferric cytochrome P450 -cholesterol without oxidation of
see
cholesterol. The decay of the oxygenated complex is first order,
k = 9.3 x 10 ^ sec ^ at 4°C. The rate of autoxidation is influenced
by pH, ionic strength and the nature of bound sterol. The activation
energy of autoxidation is 75 kJ mole Investigations into the
fate of the electron equivalence as oxygenated cytochrome
cholesterol complex autoxidises to the ferric haemoprotein were
initiated and attempts were made to monitor hydrogen peroxide and
superoxide anion generation.
Addition of equimolar amounts of adrenodoxin to cytochrome P450 -^ J see
cholesterol, followed by stoicheiometric reduction under anaerobic
conditions and then oxygenation allows single catalytic turnover cycles
of cytochrome P450 to be studied. This has allowed detection of
see
intermediates in the conversion of cholesterol to pregnenolone and a
precursor-product sequence of cholesterol-22-hydroxycholesterol-20,22-
dihydroxycholesterol-pregnenolone to be established. Addition of
oxidised adrenodoxin to oxygenated cytochrome P450scc~cholesterol
results in formation of 22-hydroxycholesterol; in the absence of added
adrenodoxin no oxygenated product of cholesterol is formed. Multiple
turnover cycles with deoxycorticosterone as substrate for cholesterol
depleted cytochrome ^50^^ failed to show deoxycorticosterone conversion to
corticosterone. Multiple turnover cycles with 7a-hydroxycholesterol
as substrate for cholesterol depleted cytochrome P450 confirmed
S GC
that the side chain of this nuclear monohydroxylated cholesterol is






















Steroids are numbered and rings lettered as in formula (1) IUPAC-IUB
1967 Revised Tentative Rules for Steroid Nomenclature (Eur. J. Biochem.
10, 1-19, 1969).
The configuration of substituents on sterols at and C^ used
in the text conforms to the IUPAC-IUB 1967 Revisted Tentative Rules
for Steroid Nomenclature (Eur. J. Biochem. 10, 1-19, 1969). (20S)-
20-hydroxycholesterol was previously known as 20a~hydroxycholesterol and
(20R,22R)-20,22-dihydroxycholesterol was known at 20a,22R-dihydroxy-
cholesterol.
ENZYMES
NADPH adrenodoxin reductase: NA)PH:ferredoxin oxidoreductase E.C.I.6.7.1.
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The function of the adrenal cortex is the production of steroid
hormones. The different classes of steroid hormone produced by
the gland, based on their main physiological effect are glucocorticoids,
mineralocorticoids and adrenal androgens and oestrogens.
In man, the principal glucocorticoid is Cortisol though some
corticosterone is also produced. This contrasts with the rat where
corticosterone is the primary glucocorticoid. The most important
metabolic effect of the glucocorticoid is that on protein and carbo¬
hydrate metabolism causing the breakdown of peripheral protein in muscle,
skin and connective tissue and a stimulation of gluconeogenic pathways
in liver with increased synthesis of glycogen. The glucocorticoids
have important effects on the regulation of fluid and electrolyte
balance, however the more important effect is to increase glomerular
filtration rate rather than facilitate sodium - potassium exchange on
the distal nephron. Administration of Cortisol leads to lymphopenia
and atrophy of the spleen, thymus and lymph nodes. Cortisol also
causes a reduction in the level of circulating eosinophils. Gluco¬
corticoids have widespread effects on connective tissue with an inhibition
of the formation and action of fibroblasts. Administration of gluco¬
corticoids can prevent the manifestations of the inflammatory reaction
perhaps by protecting the integrity of cellular and lysosomal membranes
and preventing the release of substances responsible for the chain of
events referred to as the inflammatory response.
The main mineralocorticoid is aldosterone and its principal
physiological action is the stimulation of the active reabsorption of
sodium by the distal nephron and facilitating the exchange of sodium
for potassium or hydrogen ion at this site.
2.
A major function of the foetal adrenal cortex is the secretion
of dehydroepiandrosterone essential as a placental substrate for
conversion to oestrogens. The deficiency states within the broad
term congenital adrenal hyperplasia emphasises the critical role of
balanced androgen and oestrogen secretion by the foetal adrenal in
the normal development of female and male genitalia.
The corticoids have a 21 carbon structure based on 4-pregnene-
3,20 dione with additional hydroxyl functions at 11(3- and 21-positions
in the case of corticosterone and at 11(3-, 17a- and 21 in the case
of Cortisol.
In the 1950's, a pathway of steroid biosynthesis was established by
Hayano et al. (1956) in which Cortisol was shown to be synthesised
solely by a route involving progesterone (Fig. 1.1). Following the
discovery that dehydroepiandrosterone was a major end product of
adrenal steroid biosynthesis, it was recognised that 17a-hydroxy-
pregnenolone was an intermediate in its biosynthesis. This realisation
was followed by proposals that 17a-hydroxypregnenolone was an intermediate
in Cortisol biosynthesis (Weliky and Engel (1961); Mulrow and Cohn
(1961)). Another proposed intermediate is 17a,21-dihydroxypregnenolone,
t

























Fig. 1.1 ALTERNATIVE PATHWAYS OF ADRENAL STEROID BIOSYNTHESIS
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The enzyme systems responsible for cholesterol side chain
cleavage, steroid llg-hydroxylation and steroid 18-hydroxylation
are localised in the mitochondrial fraction of homogenates of adrenal
cortex whereas the steroid 17a-hydroxylase and steroid 21-hydroxylase
are present in the microsomal fraction. The steroid 38-ol dehydrogenase
has been considered to be an enzyme located exclusively in the endo¬
plasmic reticulum but there is now evidence in adrenal and other
steroid producing tissues that this enzyme has a bimodal distribution
with activity present in the microsomal and mitochondrial fractions
(Simpson and Mason (1976)).
Adrenal steroids can be synthesised from both acetate and
cholesterol (Hechter and Pincus (1954)). However the role of
cholesterol as an obligatory intermediate has been controversial.
Hechter et al. (1953) perfused adrenal glands with radioactive cholesterol
and acetate and after perfusion with acetate the specific radioactivity
of cholesterol was much lower than that of the corticosteroid hormones.
This suggested that either an alternative pathway from acetate to the
steroid hormones existed or heterogeneity of the cholesterol pool was
present. Werbin and Chaikoff (1961) observed that the specific radio¬
activities of urinary Cortisol and adrenal cholesterol were equal after
14
long term feeding of (4- C) cholesterol to guinea pigs. These results
suggest that differences in specific activities of cholesterol and
steroid hormones in short term experiments were due to differences in
the rate of equilibration of different pools of cholesterol within the
adrenal cortex.
The administration of ACTH causes a fall in the adrenal cholesterol
concentration (Sayers et al. (1946)). The cholesterol in the mitochondria
and microsomes is in the free form. However the bulk of the cholesterol
in the gland is esterified and occurs in the lipid droplets which are
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found in large numbers in the cytoplasm, Garren et al. (1971).
The principal lipids in these droplets are cholesterol ester and
phospholipid; the cholesterol appears to be selectively esterified
to unsaturated fatty acids (Boyd and Trzeciak (1973); Goodman (1965)).
Cholesterol ester hydrolase activity is increased by ACTH administration
to rats with an increase in the pool size of free cholesterol available
for the cholesterol side chain cleavage reaction (Boyd and Trzeciak
(1973); Beckett and Boyd (1977)).
In most steroid hydroxylation reactions one atom of an oxygen
molecule is inserted into the hydroxyl group of the product and the
other oxygen atom is reduced to water. Mason (1957) gave the name
'mixed function oxidase' to such reactions which have the stoicheiometry:
NADPH + H+ + R-H + C>2 NADP + R-OH + H20. The requirement for
molecular oxygen was demonstrated by Hayano et al. (1955) who showed
18
the incorporation of C>2 during llg-hydroxylation of deoxycorticosterone.
The stoicheiometry of the equation was established by Cooper et al. (1963)
for the 21-hydroxylation of 17a-hydroxyprogesterone by enzymes present
in bovine adrenal microsomes.
Ryan and Engel (1957) showed that the 21-hydroxylation of 17a-
hydroxyprogesterone was inhibited by carbon monoxide and the inhibition
was reversed by light. Estabrook et al. (1963) on treating bovine
adrenal cortex mitochondria with NADPH and carbon monoxide observed
a pigment absorbing at 450 nm similar to that reported in liver micro¬
somes by Klingenberg (1958) and Garfinkel (1958) . This pigment was
later shown to be a protoporphyrin haemoprotein of the b-type and
named cytochrome P450 by Omura and Sato (1964) . Estabrook (1963)
demonstrated, by means of the photochemical action spectrum technique
of Warburg (1949) that cytochrome P450 is the terminal oxidase for the
steroid 21-hydroxylase. The presence of cytochrome P450 in adrenal
cortex mitochondria was shown by Harding et al. (1964). Wilson et al.
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(1965) demonstrated that carbon monoxide inhibited 118~hydroxylation
of deoxycorticosterone and Rosenthal and Cooper (1967) obtained the
photochemical action spectrum. Similar results have been obtained
for the cholesterol side chain cleavage reaction (Simpson and Boyd
(1966); Wilson and Harding (1970)) and for the steroid 18-hydroxylase
(Greengard et al. (1967)) in adrenal cortex mitochondria.
Omura et al. (1966) resolved the steroid llB-hydroxylase system
into three fractions, cytochrome P450, an FAD flavoprotein and an iron
sulphur protein - adrenodoxin (Suzuki and Kimura (1965)); the steroid
HB-hydroxylase activity could be reconstituted when these three
proteins were recombined. The cholesterol side chain cleavage system
has been resolved into similar components (Simpson and Boyd (1967) ;
Bryson and Sweat (1968)) as has the steroid 18-hydroxylase (Nakamura
et al. (1969)). NADPH adrenodoxin reductase and adrenodoxin have
been purified, crystallised and extensively characterised (Kimura et al.
(1973)); Sugiyama et al. (1975)). These components appear to lack
specificity as reconstituted with cytochrome P450 will support 118"
hydroxylation of deoxycorticosterone or the side chain cleavage of
cholesterol. The concept of individual cytochrome P450 haemoproteins
supporting the reactions of cholesterol side chain cleavage and 118-
hydroxylation of deoxycorticosterone has developed (Jefcoate et al.
(1970); Ramseyer and Harding (1973); Shikita and Hall (1973)). The
notations cytochrome P450 and cytochrome P450 118 have been
SCO
extensively used to distinguish the haemoprotein which acts as the
terminal oxidase for cholesterol side chain cleavage from that associated




NADPH -y Adrenodoxin Reductase -> Adrenodoxin
^Cytochrome P450 118
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Cytochrome P450(^M is the terminal oxidase in Pseudomonas putida
for the conversion of camphor to exo-5-hydroxycamphor (Katagiri et al.
(1968)). This soluble cytochrome P450 has been purified and crystall¬
ised (Yu et al. (1974)) and has been used as a mechanistic model and
guide for the purification of mammalian cytochrome P450.
Various steps of cyclic reductiop and oxidation have been
established for cytochrome as it functions in oxygen activation
and substrate hydroxylation (Estabrook et al. (1972); Gunsalus et al.
(1972)). These reactions (Fig. 1, 2) may be summarised as follows:
a) The interaction of the low spin form of ferric cytochrome P450
with a substrate resulting in a characteristic optical change
concomitant with the formation of a high spin state characteristic
3+
of the ferric cytochrome P450-substrate complex (Fe -S).
b) The one electron reduction of the ferric cytochrome P450-
substrate complex to ferrous cytochrome P450-substrate complex
2+(FeZ -S).
c) The interaction of molecular oxygen with the ferrous cytochrome
P450-substrate complex to form a ternary complex termed the
oxygenated ferrous cytochrome P450-substrate complex.
d) The oxygenated form of the cytochrome P450-substrate complex
undergoes a second one electron reduction to form an intermediate
which as yet is ill defined. The mechanism of transfer of one
atom of oxygen present in this complex to substrate with the
resultant formation of water from the remaining atom of oxygen
remains to be elucidated.
e) The formation of a complex of hydroxylated product with the
cytochrome and the dissociation of this product to regenerate
the low spin substrate depleted form of cytochrome P450, thus
allowing for its participation in another reaction cycle.
S - OH
Fig. 1.2. THE CATALYTIC CYCLE OF CYTOCHROME P450„.„ AS ESTABLISHEDCAM
BY ESTABROOK et al. (1972) AND GUNSALUS et al. (1972) SHOWING THE
STEPS OF CYCLIC REDUCTION AND OXIDATION OF IRON IN THE HAEMOPROTEIN
AS IT FUNCTIONS IN OXYGEN ACTIVATION AND SUBSTRATE HYDROXYLATION.
The oxygenated complexes are shown in only one of the possible
resonance forms. Abbreviations:. S: substrate; S-OH:
hydroxylated product; e: electron; Fe ++-S: ferric-substrate
++ ++J*2
complex; Fe -S: ferrous substrate complex; Fe : oxygenated
b
^ o2-
ferrous-substrate complex and Fe+H^ c : postulated complex formedb
on one electron reduction of the oxygenated ferrous-substrate form.
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This cycle of enzymatic events has been established for
cytochrome and a similar reaction cycle has been
assumed, but not established, for cytochrome P45C>scc.
However certain features of cytochrome P450scc distinguish
it from cytochrome P450„.w. The conversion of cholesterol toCAM
pregnenolone is more complex than the single hydroxylation reaction
catalysed by cytochrome anc* may involve stable oxygenated
derivatives of cholesterol. Suggested intermediates are (20S)-20-
hydroxycholesterol (Shimizi et al. (1962); (22R)-22-hydroxycholesterol
and (20R22R)-20,22-dihydroxycholesterol (Burstein et al. (1975);
cholesterol-(20S)-20-hydroperoxide (Van Lier and Smith (1970)) and
20,22-epoxycholesterol (Kraaipoel et al. (1975).
The rate limiting step in steroidogenesis appears to lie between
cholesterol and pregnenolone (Stone and Hechter (1954), current
evidence suggests thatthe availability of cholesterol to the desmolase
system is rate limiting (Mason et al. (1978b)). This is in contrast
to cytochrome P450„.., where electron donation at the second reductionCAM
step is rate limiting to the overall reaction and not the availability
or the binding of substrate (Gunsalus et al. (1972)).
Cytochrome unlike cytochrome behaves as an
integral protein of mitochondria (Singer and Nicholson (1972)) within
the inner membrane (Yago and Ichii (1969)). The resolution of
cytochrome P450 from other membrane components, particularly thesee
substrate cholesterol, is fundamental to the further understanding
of this enzyme. The solubilisation and purification of cytochrome
P450 from bovine adrenal mitochondria has been attempted by a
see
number of investigators (Ramseyer and Harding (1973); Shikita and
Hall (1973); Horie and Watanabe (1975); Takemori et al. (1975) and
Wang and Kimura (1976)). These preparations are of low specific
8.
content in terms of nmoles cytochrome P450scc/mg protein and are
significantly contaminated by both cholesterol and detergent.
The topography of adrenal cortex mitochondria and the spatial
relationships of cytochrome adrenodoxin and adrenodoxin
reductase within the mitochondrial membrane have only recently
become a focus of interest. At present no unified concept of
structural relationships can be made and fundamental differences
exist between authors in this area of research. However it is
agreed that cytochrome ^50
^ behaves as a protein buried within
the mitochondrial membrane and that its principal interactions
within the membrane are hydrophobic in character (Churchill et_ al.
(1978); Seybert et al. (1979)) requiring detergent action for
solubilisation from the mitochondrial membrane. Reconstitution of
cytochrome *"450^^ into phospholipid bilayers again suggests
hydrophobic interactions rather than ionic and a dependence on the
fatty acid composition of the phospholipid (Seybert eh al^. (1979)).
Adrenodoxin forms a binary complex with cytochrome P45C>scc (Kido and
Kimura (1979)) and this association requires cholesterol and
a detergent or phospholipid. It is agreed that adrenodoxin acts as
a peripheral protein in the membrane and that the association with
cytochrome is partially ionic in character (Kido and Kimura
(1979); Seybert et al. (1979)). Ternary complexes of cytochrome
P450 , adrenodoxin and adrenodoxin reductase can be formed
see
(Kimura et al. (1976)). The adrenodoxin-adrenodoxin reductase
binary complex formation is dependent on ionic strength but is
independent of cholesterol concentration (Kido and Kimura (1979)).
Cytochrome P450 and adrenodoxin reductase show no interaction
see
and a binary complex of these two proteins has not been demonstrated
(Kido and Kimura (1979)). These observations suggest that the
9.
proteins of the cholesterol side chain cleavage system are located
on the matrix surface of the inner mitochondrial membrane
(Churchill a^. (1978)); that cytochrome P450 , adrenodoxin
sec
and adrenodoxin reductase are arranged linearly within the membrane
and in the presence of high membrane cholesterol content the
adrenodoxin-adrenodoxin reductase complex associates with
cytochrome P450s (Kido and Kimura (1979)). This scheme proposes
a linearly mobile cytochrome within the membrane structure
in contrast to the proposals of Seybert et at. (1979) where
adrenodoxin provides a mobile shuttle between adrenodoxin reductase
and cytochrome -^450 ^. These schemes are not mutually exclusive
and further research into the spatial relationships of the hydroxylase
system within the mitochondrial membrane will be fundamental to the
understanding of the control of steroid hydroxylation reactions.
The aims of this study were to gain a fuller knowledge of
cytochrome P450 from bovine adrenal cortex mitochondria and
see
can be summarised:
a) the purification of cytochrome ^450 from bovine adrenal
cortex mitochondria;
b) to establish a sequence of cyclic reduction and oxidation for
cytochrome P450gcc, and
c) to identify intermediates in the conversion of cholesterol






4-Phenylimidazole was supplied by Aldrich Chemical Co.,
(Gillingham). Ketamine hydrochloride was supplied by Parke, Davis
and Co. (Pontypool). Sodium cholate, NADPH (tetrasodium salt,
Type III), bovine serum albumin (Type F) and Antifoam A concentrate
were obtained from Sigma Chemical Co., St. Louis. Aminoglutethimide
was a gift from Ciba Laboratories (Horsham).
Potassium superoxide was supplied by Lancaster Synthesis Ltd.
(Lancaster). Dicyclohexyl-18-crown-6 was kindly donated by
Professor J.I.G. Cadogan. Potassium superoxide 50 mM was dissolved
in a solution of 100 mM dicyclohexyl-18-crown-6 in dry dimethyl-
sulphoxide, Valentine and Curtis (1975) .
(20S)-20-hydroxycholesterol was synthesised by the method of
Petrow and Stuart-Webb (1956). 24-hydroxycholesterol, 25-hydroxy-
cholesterol and 26-hydroxycholesterol were synthesised by Dr. S.A.M.
Ali (1968). (22R)-22-hydroxycholesterol was kindly given by Dr. Marcel
Gut. (20R22R)-20,22-dihydroxycholesterol was a gift from Dr. J.I.
Mason. 7a-hydroxycholesterol and 76~hydroxycholesterol were synthesised
by the photoxygenation of cholesterol, Schenck et al. (1959). 7a-
hydroxypregnenolone was given by Professor Kirk, Medical Research Council
Steroid Reference Collection. 19-hydroxycholesterol was available
in this laboratory, previously synthesised in connection with other
studies. Deoxycorticosterone was supplied by Sigma Chemical Co.,
St. Louis.
Calcium phosphate gel was purchased from British Drug Houses Ltd.
Sephadex G-100 and Sepharose 4B were supplied by Pharmacia Fine Chemicals
(Uppsala). DEAE-cellulose was supplied by Whatman, England.
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(4- C) cholesterol 55 Ci/M and deoxy (la2a(n)- H) corticosterone
42 Ci/mM were purchased from the Radiochemical Centre (Amersham).
All other chemicals were of Analar grade and supplied by
British Drug House Ltd., (Poole) or Koch-Light (Colnbrook).
Organic solvents were redistilled prior to use.
Enzymes
Horseradish peroxidase (Type II) and catalase (C-30) were
purchased from Sigma Chemical Co., St. Louis. Glucose-6-phosphate
dehydrogenase (Grade II) was obtained from Boehringer Mannheim GmbH,
Mannheim.
Preparation of Adrenal Cortex Mitochondria
Bovine adrenal glands were obtained within 1 hr of slaughter
and placed on ice. All subsequent operations were carried out
between 0° and 5°C. The glands were trimmed of fat, cut in half
about their longitudinal axis and the medulla removed by dissection.
The cortex was scraped from the gland capsule and homogenised in 10
volumes of 10 mM potassium phosphate buffer pH 7.4 containing 0.25 M
sucrose and 1 mM EDTA using a teflon pestle in a glass homogeniser.
The homogenate was centrifuged at 650 g for 10 min producing pellet
and supernatant fractions. The supernatant was centrifuged again at
650 g for 10 min to remove debris carried over during the first
decantation and the pellet was rehomogenised and recentrifuged as
above. The combined supernatants were centrifuged at 8,500 g for
20 min and the mitochondrial pellet formed resuspended by a single
stroke of a loose fitting teflon-glass homogeniser in 20 volumes of
0.154 M potassium chloride containing 1 mM EDTA and centrifuged at
10,000 g for 20 min. The washed mitochondrial pellet was resuspended
in a minimum volume of distilled water and lyophilised. Lyophilisation
resulted in minimal loss of specific content of cytochrome P450 but
with the advantage that the organelle structure was disrupted such
that on subsequent extraction with phosphate buffer, soluble proteins
particularly adrenodoxin and NADPH adrenodoxin reductase were recovered
in the supernatant fraction on centrifugation.
Preparation of Adrendoxin
The method used for preparation of adrenodoxin is a modification
of the technique described by Orme-Johnson and Beinert (1969) .
Adrenal glands were trimmed of fat, cut in half about the longitudenal
axis; the medulla removed by dissection and the cortices frozen at
-20°C one layer deep in aluminium foil. The cortices were stored
frozen for at least 2 weeks and then 150 gms thawed by placing in a
litre of 0.25 M sucrose, 10 mM Tris hydrochloride pH 7.4 with 1 mM
EDTA at 4°C. The tissue was stirred for 4 hrs and then the sucrose
replaced with 0.15 M potassium chloride, 10 mM Tris hydrochloride
pH 7.4 with 1 mM EDTA. The cortices were left to wash overnight
and then removed and rinsed quickly with distilled water to remove
as much lipid and blood as possible. The washed tissue was then
homogenised in a Waring blender for 4 mins at maximal speed in a
litre of 0.5 M potassium chloride, 10 mM Tris hydrochloride pH 7.4
and 1 mM EDTA. Homogenisation was effected for 30 sec periods with
30 sec intervals when the blender was place in ice. The homogenate
was filtered through six layers of cheese-cloth to remove larger
particles and the filtrate sonicated by an Ultrasonics Rapidis 150
with the specifications: amperage 3, frequency 20 kc on maximal
settings. The homogenate was sonicated for 30 sec periods with 30
sec intervals for 10 mins. The homogenate was filtered again through
six layers of cheese-cloth to remove collected lipid and the entire
volume was sonicated again. The homogenate was centrifuged at 105,000 g
for 90 mins and the floating lipid layer and the pellet discarded.
To the infranatant was added about 150 mis of a thick slurry of DEAE-
cellulose, equilibrated with 10 mM potassium phosphate buffer pH 7.4.
The mixture was allowed to stir overnight and then centrifuged at
5,000 for 20 mins. The pellet of DEAE-cellulose was collected in
as small a volume as possible and stored frozen at -20°C. When
required, the DEAE-cellulose was defrosted and washed twice with one
litre aliquots of 10 mM potassium phosphate buffer pH 7.4 containing
0.1 M potassium chloride. The DEAE-cellulose was recovered by
centrifugation at 5,000 g for 20 mins and the supernatant discarded.
The washed DEAE-cellulose was stirred for 1 hr with 100 mis of 10 mM
potassium phosphate pH 7.4 containing 0.5 M potassium chloride and
the supernatant on centrifugation retained. This process was
repeated twice. The combined supernatants were diluted five fold
with 10 mM potassium phosphate buffer pH 7.4 and centrifuged at 20,000 g
for 30 mins to remove turbidity. The supernatant was passed onto a
DEAE-cellulose column 2.5 cms by 15 cms pre-equilibrated with 10 mM
potassium phosphate buffer pH 7.4. The adrenodoxin adsorbed as a
narrow band at the top of the column which was then washed with 500 mis
of 10 mM potassium phosphate buffer pH 7.4 containing 0.17 M potassium
chloride. Adrenodoxin was eluted with a minimal volume of 10 mM
potassium phosphate pH 7.4 containing 0.33 M potassium chloride and
the eluate chromatographed on a column of Sephadex G-100, 60 cms by
2.5 cms, equilibrated with 5 mM Tris hydrochloride pH 8.0 and containing
0.1 M potassium chloride. The spectral properties of adrenodoxin,
showing absorbance maxima at 415 nm and 455 nm were used for identification
of this protein in the eluate. Fractions containing adrenodoxin with
ratios of absorbance 415 nm/absorbance 280 nm greater than 0.6 were
pooled and transferred to a small DEAE-cellulose column 5 cms by 2 cms
equilibrated with 10 mM potassium phosphate buffer pH 7.4. The
adrenodoxin was eluted with 10 mM potassium phosphate buffer pH 7.4
containing 0.5 M potassium chloride. Selected fractions were dialysed
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against 10 mM potassium phosphate buffer pH 7.4 before storage in
small aliquots at -20°C.
Preparation of 7a-Hydroxypregnenolone
The 7a-hydroxypregnenolone was prepared by the photoxygenation
method of Schenck et al. (1959). Oxygen was bubbled through a
solution of 100 mgs pregnenolone, 5 mgs haematoporphyrin in 10 mis
chloroform and irradiated with a fluorescent light source for 12 hrs.
The pregnenolone hydroperoxides formed were reduced to the corresponding
hydroxypregnenolones by the addition of 500 mgs potassium iodide in
four drops of 10% acetic acid in ether:ethanol::1:5 by volume and by
gently warming for 45 mins. Excess iodine was removed with sodium
thiosulphite. The organic solvent was evaporated and the residue
chromatographed on preparative thin layer silica gel plates developed
in the solvent system benzene:ethyl acetate::7:13 by volume. The 7a-
hydroxycholesterol Rf 0.3 was eluted from the silica gel with chloro-
form:methanol::2:1 by volume and crystallised from methanol with a
yield of 15 mgs. The synthesised 7a-hydroxypregnenolone behaved on
thin layer chromatography and had a mass spectrum identical to .
authentic 7a-hydroxypregnenolone from the Medical Research Council
Steroid Reference Collection.
14
Preparation of (4- C) 7a-Hydroxycholesterol
The (4-^C) cholesterol, specific activity 55 yCi/mole, was
purified immediately before use by thin layer chromatography on silica
gel developed in diisopropyl ether:petroleum spirit:acetic acid:::70:
30:2 by volume. The region corresponding to standard cholesterol
was eluted from the thin layer plate using redistilled acetone.
14
The (4- C) cholesterol, 1.0 yCi in 50 yl acetone, was added to
an incubation medium of 7 mis containing 100 mM potassium phosphate
buffer pH 7.4, 10 mM S~mercaptoethylamine, 5 ymole NADP, 50 ymole glucose-
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6-phosphate, 1 unit glucose-6-phosphate dehydrogenase and approxi¬
mately 10 mgs liver microsomal protein equivalent to 1 gm wet weight
rat liver (Mitton et al. (1971)). After incubation at 37°C for
60 mins the reaction was stopped with 10 mis methanol and a lipid
extraction performed with 15 mis chloroform followed by 10 mis
boiling ethyl acetate. The sterols in the combined extracts were
separated by thin layer chromatography using silica gel H in the
solvent system benzene: ethyl acetate::7:13 by volume. The area
of radioactivity corresponding to standard 7a-hydroxycholesterol was
eluted from the thin layer plate using redistilled acetone.
The 7oc-hydroxycholesterol concentrations were determined as
14
free sterols by gas liquid chromatography and the (4- C) 7a-hydroxy-
cholesterol chromatographed as a single peak. The specific activity
of the prepared (4-^C) 7a-hydroxycholesterol was 0.42 yCi/mole.
14
The mass spectrum of (4- C) 7a-hydroxycholesterol was identical to
that prepared by photoxygenation of cholesterol and reduction.
Cytochrome P450 Assay
Cytochrome P450 concentrations were determined from the reduced
carbon monoxide difference spectrum (Omura and Sato (1964)) and
extinction coefficient of 95 mM '"cm ^ (Gunsalus et al. (1972) for
the 446 minus 490 nm absorption difference. An extinction coefficient
of 106 mM '"cm ^ was used for absolute spectra of the reduced carbon
monoxide complex of cytochrome at 446 nm (Gunsalus et al. (1972).
Spectral dissociation constants and type of spectral change on
ligand binding as defined by Schenkman et al. (1967). An extinction
coefficient of 110 mM ''"cm ^ was used for difference spectra of
substrate induced low to high spin state changes and an extinction
coefficient 51 mM '"cm ^ for the decrease in absorbance in the absolute
spectrum of the low spin species (Peterson (1971)).
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Adrenodoxin Assay
Electron paramagnetic resonance spectra were recorded using a
Varian E4 operated at -172°C. Adrenodoxin was quantitated from the
height of the signal at g = 1.94 by comparison with a purified
preparation (Estabrook et al. (1973)). The generic name iron sulphur
protein is used where there is EPR evidence of iron sulphur protein
of respiratory chain origin contaminating the adrenodoxin EPR spectrum.
NADPH Adrenodoxin Reductase Assay
The method was based on that of Omura et al. (1966) and results
expressed in nmoles 2,6-dichlorophenolindophenol reduced/min/nmole
cytochrome P450.
Protein Determination
Protein was assayed according to the method of Lowry et al. (1951)
using bovine serum albumin as standard.
Cholate Determinations
Cholate levels were determined by radioimmunoassay (Beckett et al.
(1978)).
Catalase Assay
Catalase activity was determined spectroscopically and activity
expressed in international units (Aebi (1974)).
Phospholipid Determinations
Phosphorus was determined by the method of McClare (1971) .
Phospholipids and protein in aqueous solution were precipitated by
addition of a 10% solution of trichloracetic acid and incubated at 4°C
for 30 mins. The precipitate was extracted with chloroform:methanol::
2:1 by volume, the solvent extract was taken to dryness by a stream of
nitrogen and the phosphorus liberated from the resultant film by 0.5 ml
perchloric acid. The colorimetrie reagent contained 8% perchloric acid,
1% ammonium molybdate and 0.2% ascorbic acid, 9.5 mis of this reagent
17.
was added to each tube and incubated at 50°C for 40 mins. The
absorbance at 825 nm was recorded against a reagent blank and
triphenyl phosphine was used as phosphorus standard. The absorbance
change was linear in the range 1-7 yg phosphorus. The mass of
phosphorus was multiplied by 25 to convert it to the mass of phospho¬
lipid. The average molecular weight of a phospholipid molecule was
taken as 760.
Cholesterol Determinations
Cholesterol concentrations, as the free sterol, were determined
by gas liquid chromatography on a 180 cm x 0.6 cm column of 0.5%
SE30 on Gas-Chrom Q support using a Pye series 104 gas chromatograph,
2
The conditions were: column temperature 240 C; attenuation 10 x 10 ;
nitrogen flow rate 30 ml/min; hydrogen flow rate 30 ml/min and air
flow 10 ml/min. The retention time of cholesterol was 10 min,
pregnenolone acetate was used as an internal standard.
Cholesterol was extracted from cytochrome P450 with methanol:J
see
chloroform:water:::1:2:3 by volume and the organic and aqueous phases
separated by centrifugation. The aqueous phase was discarded and
the organic phase carefully decanted into a boiling tube leaving the
protein which had formed an interface with the organic and aqueous
phases. The protein was re-extracted in a stoppered tube with 20 ml
of hot ethyl acetate and the protein removed by centrifugation. The
ethyl acetate was decanted and the protein re-extracted with the same
solvent. The combined organic solvent extracts were taken to dryness
in a warm bath and evaporated by a stream of air. Each residue was
dissolved in 0.2 ml of chloroform.
The residue dissolved in chloroform was transferred to a thin
layer plate (28 cm x 6.5 cm) coated with Silica gel H (Merck) and
the thin layer plates developed in the solvent system; diisopropyl
ether:petroleum spirit:acetic acid:::70:30:2 by volume. The area cf
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silica gel corresponding to cholesterol was extracted with an excess
volume of chloroformrmethanol::2:1 by volume which was reduced to
dryness with nitrogen gas and made up to a standard volume in acetone.
The efficiency of extraction of cholesterol was monitored by
. . .14
addition of 0.1 yCi (4- C ) cholesterol to cytochrome P450 and
its recovery after extraction and chromatography determined. The
recoveries were in the range 95-98% of radioactivity added.
Estimation of Hydrogen Peroxide Determinations
The estimation of hydrogen peroxide was based on a method
devised by Andreae (1955) in which the extent of loss of the fluorescence
of a peroxidase substrate scopoletin (6-methyl-7-hydroxy-l:2 benzo-
pyrone) is proportional to hydrogen peroxide concentration with a
stoicheiometry of one mole of hydrogen peroxide required for the
oxidation of one mole of scopoletin. This method was further refined
by Perschke and Broda (1961) and detection of hydrogen peroxide in the
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range 10 M was observed. Further modification was made by Hildebrandt
and Roots (1975) to allow detection of hydrogen peroxide based on
scopoletin horseradish peroxidase added directly to a mitochondrial
incubation and following the fluorescence decay with time.
A calibration of the decrease in the fluorescence of scopoletin
in the presence of known amounts of hydrogen peroxide was established.
Scopoletin (Sigma), stock solution 2.5 mM in 10 mM potassium phosphate
buffer pH 7.4 was added to a concentration of 2.5 yM in a cuvette
containing 10 mM potassium phosphate buffer pH 7.4, 1 mM EDTA. Horse¬
radish peroxidase (Sigma type II), stock solution 20 mgs/ml in a 10 mM
potassium phosphate buffer pH 7.4, was added to the cuvette to give a
final concentration of 40 yg/ml. Hydrogen peroxide solutions were
prepared by diluting Perhydrol with oxygen free 10 mM potassium phosphate
buffer pH 7.4. The hydrogen peroxide concentration was standardised
0
Fig. 2.1. THE RELATIONSHIP BETWEEN DECREASE IN RELATIVE.FLUORESCENT
UNITS OF SCQPOLETIN VERSUS HYDROGEN PEROXIDE CONCENTRATION
Scopoletin was added at a concentration of 2.5 pM in a cuvette
containing 10 mM potassium phosphate buffer, 1 mM EDTA. Horseradish
peroxidase Was added to the cuvette and the decrease in fluorescence
after each addition noted, showing a stoicheiometry of one mole of
hydrogen peroxide required for the oxidation of one mole of scopoletin
(Fig. A). However when the experiment was repeated under the same
conditions with cytochrome P45>C)scc added to 15 pM, some quenching of
fluorescence was noted and the molar ratio of hydrogen peroxide added
to scopoletin oxidation was 2.8:1 (Fig. B).
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spectrophotometrically at 240 nm, by using a molar extinction
coefficient of 43.6 M ^cm ^ and further dilution to give a stock
solution of 7.6 mM in oxygen free 10 mM potassium phosphate buffer pH
7.4. Fluorescence measurements were made on a Perkin Elmer spectro-
fluorimeter Model MPF2A with excitation wavelength 350 nm; emission
wavelength 450 nm; reference sensitivity on direct and sample sensi¬
tivity setting 2. The decrease in fluorescence of scopoletin on
addition of hydrogen peroxide is shown in Fig. 2.1. The experiment
was repeated under the same conditions with cytochrome P^5()scc added
to 15 pM.
Gas Liquid Chromatography of Sterols
Concentrations of cholesterol, 20a hydroxycholesterol and 22R-
hydroxycholesterol were determined as the free sterols by gas liquid
chromatography on a 180 cm x 0.6 cm column of 0.5% SE30 on Gas-Chrom
Q support using a Pye series 104 gas chromatograph. The conditions
were: column temperature 240°C; heater mark 2; nitrogen flow rate
30 ml/min; hydrogen flow rate 30 ml/min and air flow 10 ml/min.
The retention times of cholesterol, 20a hydroxycholesterol and 22R-
hydroxycholesterol were 10, 12.5 and 18.5 min respectively. Cholesterol
was used as internal standard for 22R-hydroxycholesterol determinations
and pregnenolone acetate as internal standard for cholesterol and 20a
hydroxycholesterol. The calibration curves for cholesterol and 22-
hydroxycholesterol are given in Figs. 2.2 and 2.3.
Concentrations of 7a-hydroxycholesterol were determined by gas
liquid chromatography with the above conditions, (Craig (1978)). The
retention time was 6 mins and pregnenolone acetate was used as internal
standard.
Sterols were recovered from biological material by solvent and thin
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Fig. 2.2. CALIBRATION CURVE OF MASS OF CHOLESTEROL VERSUS PEAK
HEIGHT OF DEFLECTION DETERMINED BY GAS LIQUID CHROMATOGRAPHY
Peak height is given in arbitrary units and at this attenuation,
fullscale deflection is 10 units. The column was 180 cms x 0.6 cms
of 0.5% SE30 on Gas-Chrom Q support and using a Pye 104 series
chromatograph. The conditions were: column temperature 240°C,
2
heater mark 2, attenuation 50 x 10 , nitrogen flow rate 30 ml/min,
hydrogen flow rate 30 ml/min and air flow 10 ml/min. The stock
solution of cholesterol was 0.2 mgs/ml dissolved in redistilled
acetone.
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Fig. 2.3. CALIBRATION CURVE OF MASS OF 22R-HYDROXYCHOLESTEROL
VERSUS PEAK HEIGHT OF DEFLECTION DETERMINED BY GAS LIQUID CHROMATOGRAPHY
Peak height is given in arbitrary units and at this attenuation,
full scale deflection is 10 units. The column was 180 x 0.6 cm
of 0.5% SE30 on Gas-Chrom Q support and using a Pye 104 series
chromatograph. The conditions were: column temperature 240°C,
2
heater mark 2, attenuation 10 x 10 , nitrogen flow 30 ml/min,
hydrogen flow rate 30 ml/min and air flow 10 ml/min. The stock
solution of 22R-hydroxycholesterol was 0.2 mgs/ml dissolved in
redistilled acetone.
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gel corresponding to a sterol standard were extracted with chloroform:
methanol, 2:1 by vol, reduced to dryness in a vial with nitrogen gas
and made up to a standard volume in acetone. The efficiency of
/ 14
extraction of sterols was monitored by addition of 0.1 pCi Q- C)
cholesterol to the biological material and recovery after extraction
and chromatography determined. Recoveries were in the range 94-98%.
Gas-Chromatography Mass Spectroscopy
Trimethylsilyl derivatives of sterols were prepared in glass
tubes 75 mm x 2 mm and sealed prior to heating. The 7a-, 20- and
22-hydroxycholesterols as well as 7a-hydroxypregnenolone were
converted to the trimethylsilyl ethers by dissolving in bis(trimethyl¬
silyl) tr if luoroacetamide and heating at 60°C for 60 mins. The 20,22-
dihydroxycholesterol was dissolved in a mixture of pyridine, bis(tri¬
methylsilyl) acetamide and trimethylchlorosilane (molar ratio 5:5:1)
and heated at 120°C for 60 mins to obtain the tri(trimethylsilyl)
ether. The trimethylsilyl derivatised sterols were chromatographed
using a Hewlett Packard 402 gas chromatograph on a column 150 cms x
0.6 cms) containing 1% Desisil 300 on Chromasorb G with a column
temperature of 300°C and a helium flow of 40 ml/min. The gas chromato¬
graph was coupled through a Watson-Bieman separator, maintained at 300°C,
to an A.E.I. MS12 mass spectrometer. Spectra were recorded at 20 eV
with a block temperature of 280°C and scan speed of 16 seconds/decade.
The data was acquired and processed by an A.E.I. DS30 data system.
Isoelectric Focusing
Analytical isoelectric focusing was performed on Ampholine PAG
plates pH range 3.5-9.5, prepared thin layer polyacrylamide gels, in
an LKB 2117 Multiphor electrophoresis unit using an LKB 2103 power
supply. The pH gradient was established by a one hour pre-run at
settings: 30W, 1500 V and 200 mA prior to the application of the
max max
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protein solutions to areas of gel corresponding to neutral pH.
The protein samples were run for a further hour at the same settings.
The pH gradient was determined by cutting gel pieces and homogenising
in de-aerated distilled water. Gels were stained with Coomassie
Brilliant Blue R-250 (Vesterberg (1972). Benzidine staining was by
the method of Welton and Aust (1974).
Preparative flat bed electrofocusing in granulated Sephadex G75,
was performed according to the method of Winters et al. (1975) using
the LKB 2117-501 Ampholine Electrofocusing Kit. Typical instrument




Absorption spectra were recorded on a Pye Unicam SP800 spectro¬
photometer fitted with a temperature regulated cell holder.
Anaerobic spectroscopy was performed in a 2.5 ml quartz cuvette
with a tapered ground glass joint size CIO. A jointed glass extension
attachment, length 5 cm x 1 cm diameter was used above the cuvette
and sealed with a size 17 Suba-seal. The joint between the cuvette
and attachment was sealed at its widest diameter with a thin film of
silicon grease. Anaerobiosis was obtained by equilibration of the
cuvette contents with oxygen free nitrogen. Nitrogen of 'white spot'
quality (British Oxygen Company) was passed through a pyrogallol
solution and then through 1 M potassium phosphate buffer pH 7.4 to
trap any alkali carried over. The pyrogallol solution was prepared
by dissolving 15 gm of pyrogallol in 50 gm% w/v sodium hydroxide in
distilled water pre-equilibrated with nitrogen. Nitrogen from these
solutions was passed by means of thin teflon tubing and a long 18 gauge
needle through the Suba-seal to the bottom of the cuvette. The cuvette
contents were bubbled with nitrogen for 30 min and excessive frothing
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was prevented by coating the tip of the needle with a thin film of
Antifoam A Concentrate. Small vials with Suba-seal or rubber
stoppers of a diaphragm type were used for stock solutions of NADPH
or sodium dithionite and anaerobiosis obtained in the same manner
as that for the cuvette.
The stock solutions of NADPH were 10 mM in 0.5% w/v sodium
bicarbonate and that for sodium dithionite 10 mM in distilled water.
Transfer of solutions from vials to cuvette was made with an air
tight 10 yl syringe.
For experiments requiring carbon monoxide saturation of solutions,
anaerobiosis of cuvettes and vials was attained as above and then
bubbled with carbon monoxide for 15 min. The carbon monoxide was
passed through the pyrogallol and phosphate buffer solutions prior to
use.
Single and Multiple Turnover Cycles of Cytochrome P450_^c
14
(4- C) cholesterol in acetone was evaporated onto the bottom of
a vial with nitrogen gas. Cholesterol, stock solution 2 mM in propylene
glycol, was added to the vial and stirred for 2 hr. The recovery of
14 . ...
(4- C) cholesterol in the propylene glycol was 96-98% of initially
14
added radioactivity. The (4- C) cholesterol was purified immediately
before use by thin layer chromatography on silica gel H (developing
solvent; di-isopropyl ether - petroleum spirit - acetic acid, 70:30:
2, by volume). The region corresponding to a standard cholesterol
sample was eluted from the thin layer chromatography plate using re¬
distilled acetone.
3
Deoxy la2a(n)- H corticosterone was pre-equilibrated with
deoxycorticosterone, 2 mM in propylene glycol, in the same manner.
3
Deoxy la2a(n)- H corticosterone was purified immediately before use
by thin layer chromatography on silica gel H (developing solvent
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chloroform:ethyl acetate, 8:2 by volume). The region corresponding
to a standard deoxycorticosterone sample was eluted from the thin
layer chromatography plate using redistilled acetone.
14 ...
(4- C )7a-hydroxycholesterol was pre-equilibrated with 7a-
hydroxycholesterol, final concentration 2 mM in propylene glycol.
14
(4- C) 7a-hydroxycholesterol was purified prior to use by thin
layer chromatography on silica gel H (developing solvents; benzene:
ethyl acetate::7:13 by volume).
Cholesterol or deoxycorticosterone, prepared as above and of
known specific radioactivity, was added to low spin substrate
depleted cytochrome *-n 10 potassium phosphate buffer pH 7.4,
1 mM EDTA and allowed to incubate 15 hr at 20°C. The substrate was
added to a two fold molar excess to cytochrome P450 and the radioactivity
prior adjusted such that 0.1 yCi was added to 2 ml cytochrome ^50
c
solution.
Adrenodoxin was added to a 1:1 molar ratio with cytochrome P450
see
substrate complex. A typical reaction solution was 2.2 ml cytochrome
P450gcc substrate complex (stock solution 17 nmoles cytochrome P450/ml)
and 0.23 ml adrenodoxin (153 nmoles adrenodoxin/ml). The reaction
temperature was 37°C and incubations performed in a 2.5 ml spectrophotometer
cuvette.
Solvent Extraction of Incubations
The contents of a cuvette were poured into a 'Quickfit' joined test
tube and the cuvette rinsed with a total volume of 10 ml methanol; the
methanol rinses were added to the contents of the tube. Chloroform 20 ml
was added to the tube followed by 30 ml water and the organic and aqueous
phases partitioned by centrifugation. The aqueous phase was discarded
and the organic phase carefully decanted into a boiling tube leaving the
protein, which had formed an interface with organic and aqueous phases.
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The protein was re-extracted in a stoppered tube with 20 ml hot
ethyl acetate and the protein removed by centrifugation. The ethyl
acetate was decanted and the protein re-extracted with the same
solvent. The combined organic solvent extracts were taken to dryness
in a warm water bath and evaporated by a stream of air. Each residue
was dissolved in 0.2 ml of chloroform.
Thin Layer Chromatography
The residue dissolved in chloroform was transferred to a thin
layer plate (28 cm x 6.5 cm) coated with silica gel H. This process
was repeated three times for each residue resulting in 95-98% of the
extracted radioactivity being transferred to the plate. Standard
non-radioactive steroids were also applied at the origin. The thin
layer plates were developed to the full length of the plate in the
solvent system; diisopropyl ether:petroleum spiritracetic acid,
70:30:2 by volume. This solvent system (Simpson and Boyd (1966)
has the property of separating the postulated mono- and dihydroxylated
intermediates of side chain cleavage of cholesterol from cholesterol
and from the C21 steroids.
Deoxycorticosterone and corticosterone were separated by thin
layer chromatography on silica gel H (developing solvents; chloroform:
ethyl acetate::8:2 by volume).
7a-hydroxycholesterol and 7a-hydroxypregnenolone were separated
by thin layer chromatography on silica gel H (developing solvents;
benzene:ethyl acetate::7:13 by volume).
Determination of Radioactivity
Thin layer plates were scanned in a Panax RTLS 1A thin layer
radioactive scanner. Silica gel was scraped from the plates into vials
and 5 ml of scintillant added. The scintillation fluid was prepared by
adding 20 gm 2,5 diphenyloxazole and 150 gm 1,4-Di 2-(5-phenyloxazolyl)
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benzene dissolved in 250 ml methanol to 4750 ml of toluene. Radio¬
activity was then quantitatively determined in a Packard Tri-Carb
liquid scintillation spectrometer. The efficiency of counting
14 3
C disintegrations was 81% and H 30%.
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CHAPTER 3
PARTIAL PURIFICATION AND PROPERTIES OF CYTOCHROME P45QRf.r
INTRODUCTION
Cytochrome P450 behaves as an integral protein of adrenal cortex
mitochondria according to the classification of Singer and Nicolson
(1972). Osmotic disruption and sub-mitochondrial fractionation by
Satre et al. (1969) and Sottocasa and Sandri (1970) suggested that
cytochrome P450 and 118-hydroxylase activity of bovine adrenal
mitochondria occurred in the inner membrane fraction. Similar
conclusions were reached by Yago and Ichii (1969) for the cholesterol
side chain cleavage system. The ready release of other components
of the mitochondrial hydroxylase system in soluble form, namely adreno-
doxin and adrenodoxin reductase, by ultrasonic disruption of mitochondria
suggests that these proteins are present in the soluble matrix or
loosely associated with the mitochondrial membrane (Kimura et al.(1976).
The use of optical difference spectroscopy to study ligand inter¬
actions with cytochrome P450 developed in the main from investigations
into the nature of this haemoprotein in liver microsomes. Liver microsomes
contain a variety of distinct cytochrome P450s with individual catalytic
specificities (van der Hoeven et al. (1974)), cytochrome b^ and are
invariably contaminated by haemoglobin; absolute spectral changes may
be difficult to appreciate in this mixture of haemoproteins. Optical
difference spectra of cytochrome P450 can be classified into three groups:
a) Type I spectral change characterised by a peak of absorbance at
around 385 nm and an absorbance trough at 420 nm.
b) An inverse Type I spectral change which is the mirror of the Type
I spectral change (X max 420 nm, Xmin 385 nm) .
c) Type II spectral change characterised by a broad trough between
390 and 410 nm and an absorbance peak varying between 425 nm and
435 nm. Amines interact with cytochrome P450 and optical
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difference spectra vary between two extremes termed Type Ila
(X max 425 nm, X min 390 nm) and Type lib (X max 432 nm,
X min 410 nm)(Schenkman et al. (1967); Calabrese et al. (1968)).
Electron paramagnetic and magnetic susceptibility studies of
cytochrome P450cam (Tsai et al. (1970)) have established that cytochrome
P450 can exist as a high spin cytochrome (Fe+++ haem, S = 5/2), as a
low spin cytochrome (Fe+++ haem, S = 1/2) or more frequently in a
mixed spin state where the electron paramagnetic spectra show distinct
high and low spin components. Absolute optical spectra of purified
cytochrome have been similarly resolved into spectra of a high
spin cytochrome (X max 392, 540 and 645 nm) and a low spin cytochrome
(X max 416, 535 and 565 nm). Mixed spin states are more commonly
observed in which the spectra are derived additively from the individual
spectral components, Peterson (1971). The basis of the four categories
of optical difference spectra has become evident from electron para¬
magnetic studies of ligand interactions with cytochrome P450 (Stern et
al. (1973); Grasdalen et al. (1975)). In summary, a Type I spectral
change reflects an increase in the high spin character of the
haemoprotein upon binding of the ligand whereas an inverse Type I
change reflects the opposite. A Type Ila difference spectrum reflects
a change from a high spin complex to that of a low spin complex of
the cytochrome in which the haem bonding is perturbed. The Type lib
difference spectrum reflects a change from the spectrum of a low spin
cytochrome P450 to the spectrum of a perturbed low spin state of the
cytochrome (Jefcoate (1978)).
The concept of separate forms of cytochrome P450 in adrenal cortex
mitochondria has developed, as a consequence of various observations.
Cytochrome P450 has the property of binding steroids to give character¬
istic optical and EPR spectra. For example a Type I optical difference
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(max 385 ran, min 420 and 570 nm) characterises the change from low
spin substrate depleted enzyme to the high spin enzyme-substrate
complex (Schenkman et al. (1967)), and can be obtained by addition
of 11-deoxycorticosterone, a substrate for the 118-hydroxylase
v
enzyme,to adrenal cortex mitochondria. A spectral change, the
mirror image of the above, is produced by addition of pregnenolone
or (20S)-20-hydroxycholesterol. These spectral changes are non-
additive and Whysner et al. (1969) suggested that they can be
interpreted as involving distinct cytochrome P450 binding sites.
Thus it appears that the Type I optical change produced by 11-deoxy-
corticosterone is due to the formation of a haemoprotein-substrate
complex with a form of cytochrome P450 involved in llB~hydroxylation,
which in the absence of added substrate was largely in the free form.
However in the case ofthe haemoprotein concerned with cholesterol side
chain cleavage the inverted Type I spectrum produced by pregnenolone
is due to the displacement of endogenous substrate, cholesterol, from
this cytochrome P450. The cholesterol side chain cleavage cytochrome
P450 occurs at least in bovine adrenal cortex mitochondria largely in
a substrate bound form. Cheng and Harding (1973) showed that when
cholesterol was removed from their preparation, (20S)-20-hydroxycholesterol
no longer produced an inverted Type I spectrum and only did so when
cholesterol was added to the preparation. The substrate cholesterol
produced a characteristic Type I spectrum when added to the preparation.
The EPR spectrum of bovine adrenal mitochondria shows both low spin
ferric and high spin ferric forms to be present. Addition of (20S)-20-
hydroxycholesterol causes a decrease in the g = 8.05 signal due to a
decrease in the high spin cytochrome P450 and an increase in the low
spin form. When deoxycorticosterone is added in the presence of
(20S)-20-hydroxycholesterol, another high spin species is formed with a
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g value of 7.9 (Jefcoate et al. (1973)). The conclusion that
the two species of cytochrome P450 which catalyse cholesterol
side chain cleavage and llg-hydroxylation are distinct entities
was proved by the demonstration of their physical separation
(Jefcoate et al. (1970)). The separation of the specific cytochrome
P450 (cytochrome P450gcc) associated with the side chain cleavage
of cholesterol from that associated with the llg-hydroxylation of
deoxycorticosterone (cytochrome P450 116) has been confirmed by
Ramseyer and Harding (1973) and Shikita and Hall (1973).
The solubilisation and purification of cytochrome P450gcc from
bovine adrenal mitochondria has been attempted by a number of
investigators (Ramseyer and Harding (1973); Shikita and Hall (1973);
Horie and Watanabe (1975); Takemori et al. (1975) and Wang and
Kimura (1976)). These preparations are of low specific content in
terms of nmoles cytochrome P450/mg protein and have significant
contamination by both cholesterol and detergent. The resolution
of cytochrome P450gcc from other membrane components particularly
the substrate cholesterol is fundamental to the further understanding
of the enzyme. The primary objectives for purification of
cytochrome may be summarised as follows:
a) separation of cytochrome P450 from cytochrome P450 116;
see
b) the development of techniques for removal of lipid and in
particular substrate cholesterol from cytochrome P450gcc;
c) to obtain cytochrome P450 free from adrenodoxin and
s cc
adrenodoxin reductase;
d) to render cytochrome P450gcc soluble in an aqueous media free
from detergents;
e) to stabilise cytochrome P450gcc during purification by the use
of ligands, and
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f) the development of chromatographic procedures for purification
of cytochrome P450scc to a high specific content.
RESULTS AND DISCUSSION
Isooctane Extraction of Lyophilised Adrenal Cortex Mitochondria
Lyophilised adrenal cortex mitochondria were suspended by homo-
genisation, 20 mg/ml protein, in 100 mM potassium phosphate buffer
pH 7.4 containing 1 mM EDTA and 1 mM 4-phenylimadazole (Fig. 3.1).
The homogenate was centrifuged at 105,000 g for 60 min and the
supernatant discarded; the pellet was resuspended by homogenisation
in the same volume of buffer and centrifugation repeated, again
discarding the supernatant. The use of 100 mM potassium phosphate
buffer pH 7.4 was found to give optimal extraction of soluble
proteins with minimal losses of cytochrome P450. The specific content
of cytochrome P450 increased to 1.75 nmoles/mg protein (Table 3.1).
Many methods are available to dissociate integral proteins from
membranes and include the use of detergents, proteases, lipases,
organic solvents and protein denaturants. The use of iso-octane
extraction to partially remove lipid from mitochondrial membrane
containing cytochrome P450 was developed for use with this haemoprotein.
The method allows removal of the organic solvent by phase partition
and recoveries of cytochrome P450 are acceptable. Mild sonication
was included to facilitate the development of an emulsion and increase
the effectiveness of extraction. This method allows removal of
ubiquinones, carotenoids, approximately 30% of the phospholipid and
about 45% of the cholesterol. Although the specific content of
cytochrome P450 is not increased by iso-octane extraction this step
is required to allow separation of cytochrome P450 with cholesterol
side chain cleavage activity from cytochrome P450 with llg-hydroxylase
activity during the subsequent ammonium sulphate fractionation in the
TABLE 3.1. Recoveries of protein and cytochrome P450 during
partial purification of cytochrome P450gcc
The specific content of cytochrome P450gcc is expressed in nmoles
cytochrome P450/mg protein. Protein and cytochrome P450 concentrations
























































presence of sodium cholate (Jefcoate et al. (1970)). The 105,000 g
pellet was resuspended by homogenisation in the above buffer at 20 mg
protein/ml and stirred vigorously with a magnetic stirrer. An equal
volume of iso-octane was added dropwise over 10 min into the vortex
of the suspension. This emulsion was sonicated using an Ultrasonic
Rapidis 150 sonicator with the specifications: frequency 20kc,
amperage 3, using a 9 millimetre probe at setting 9 for a total of
2.5 min. Sonication was performed in an ice cooled 250 ml beaker
for 30 sec periods with intervals of 30 sec. The sonicated
emulsion was gently stirred for 30 min then centrifuged at 30,000 g
for 20 min. The centrifuged emulsion separated into three phases;
a yellow upper phase of iso-octane; a lower aqueous phase and a
middle dark brown band between the upper and lower phases and containing
the bulk of the protein. The iso-octane phase was discarded and
the middle and lower phases re-homogenised together. This extraction
process was repeated and after centrifugation the upper and lower
phases were discarded. The middle phase, which will be referred to
as the iso-octane interlayer, containing the bulk of cytochrome P450
and other proteins was rehomogenised in a minimum volume of distilled
water and lyophilised (Fig. 3.1). The lyophilised powder was stored
at -20°C in the flask used for lyophilisation.
Ammonium Sulphate Fractionation of Lyophilised Iso-Octane Interlayer
The lyophilised iso-octane interlayer was suspended by homogenisation,
20 mg protein/ml, in 100 mM potassium phosphate buffer pH 7.4 containing
1 mM EDTA and 1 mM 4-phenylimidazole. Sodium cholate, stock solution
100 mg/ml in the above buffer, was added dropwise over 10 min to the
stirred iso-octane interlayer suspension (Fig. 3.1). The final con¬
centration of sodium cholate was 0.5 mg/mg protein and after addition
of this detergent the suspension was gently stirred for 30 min. The
concentration of sodium cholate used was optimal for the solubilisation
of cytochrome P450 from mitochondrial membrane and similar to the values
used by Mitani and Horie (1969). Ammonium sulphate, stock solution
80% saturated in 100 mM potassium phosphate buffer pH 8.0 containing
1 mM EDTA, was then added over 30 min by means of a peristaltic pump
to produce a solution which was 35% saturated with respect to ammonium
sulphate. This solution was centrifuged at 30,000 g for 30 min.
The pellet was discarded and to the supernatant, ammonium sulphate
solution was added over 30 min to produce a solution which was 50%
saturated with respect to ammonium sulphate. This solution was centri¬
fuged at 30,000 g for 20 min. The pellet from this centrifugation
was resuspended in a minimum volume of 10 mM potassium phosphate buffer
pH 7.4 containing 1 mM EDTA and 1 mM 4-phenylimadazole and dialysed
against 3 litres of 10 mM potassium phosphate buffer pH 7.4 for 15 hr,
followed by dialysis against 3 litres of distilled water for 3 hr
(Fig. 3.1). The dialysate was lyophilised and will be referred to as
the 35-50% ammonium sulphate fraction. This fraction was stored at
-20°C in the flask used for lyophilisation. The ammonium sulphate
fraction which precipitated between 25-35% saturation showed high 116-
hydroxylase and low cholesterol side chain cleavage activity. Conversely
the fraction which precipitated between 35-50% ammonium sulphate saturation
showed the reverse pattern. The 25-35% ammonium sulphate fraction was
predominantly a low spin haemoprotein showing maximal binding with 11-
deoxycorticosterone whereas the 35-50% fraction was predominantly a
high spin haemoprotein and bound pregnenolone in an inverse Type I
manner (Jefcoate et al. (1970)). This preparation of cytochrome P450gcc
gave useful information relating to spectral and EPR changes (Simpson
et al. (1971); Jefcoate et al. (1973)). However the preparation was
of low specific content, 1.8 nmoles/mg protein (Table 3.1) and on
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dialysis to remove ammonium sulphate the preparation became turbid
and approximately 50% of the cytochrome precipitated on centrifugation
at 105,000 g for 60 min. The turbidity could be reversed by readdition
of sodium cholate suggesting that solubility of the preparation was
dependent on the detergent present. Similarly on titration of the
preparation with pregnenolone, biphasic, inverse Type I binding plots
were obtained, whereas uniphasic binding was observed in intact
mitochondria. On centrifugation of this solution at 105,000 g x 60 min,
the pellet and supernatant gave uniphasic spectral binding plots with
pregnenolone but exhibited different spectral dissociation constants.
The cytochrome P450 isolated was predominantly a high spin substrates cc
bound form with a cholesterol content of 8-10 fold molar excess
(Table 3.2) and was unsuitable for kinetic studies of substrate binding.
Butanol-Acetone Extraction of the Lyophilised 35-50% Ammonium
Sulphate Fraction
The lyophilised 35-50% ammonium sulphate fraction was stored at
-20°C and without warming, 1 ml of butanol at -20°C was added for
each 4 mg protein. The butanol-protein suspension was homogenised
with an all glass homogeniser and centrifuged at 20,000 g for 5 min.
in a rotor and centrifuge pre-cooled to -20°C. The supernatant was
discarded and the pellet resuspended by homogenisation in acetone at
-20°C. The acetone-protein suspension was rapidly filtered on a
Buchner funnel and washed with three volumes of acetone. The butanol-
acetone extracted powder retained on filtration was immediately dried
for 1 hr in a vacuum desiccator under continuous suction. The butanol-
acetone extracted powder was used immediately after drying (Fig. 3.1).
The solvent n-butanol has been used extensively for removal of lipid
particularly phospholipid from protein (Morton (1955)) and combined
with acetone extraction at sub-zero temperature has proved particularly
useful for the further resolution of cytochrome P450gcc. The
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recovery of cytochrome P450 after this procedure is approximatelysee
80% and the specific content increases (Table 3.1). The phospho¬
lipid, cholesterol and cholate contents are all reduced.
Associated with the reduction of the cholesterol content the cytochrome
is now in a predominantly low spin state (Fig. 3.2).
Potassium Phosphate Buffer Extraction of a Butanol-Acetone Extracted
Powder
The butanol-acetone extracted powder was suspended by homogenisation
in 100 mM potassium phosphate buffer pH 7.4 containing 5 mM D,L-
dithiothreitol. The homogenate was centrifuged at 105,000 g for 60 min;
the supernatant carefully collected and the pellet discarded (Fig. 3.1).
The protein concentration of the homogenate was varied from 4 to 12 mg/ml
depending on the concentration of cytochrome P450 required in the
105,000 g supernatant.
The 105,000 g x 60 min supernatant of a butanol-acetone powder
shows an increase in specific content of cytochrome compared to the
pellet and the original powder (Table 3.1). No deoxycorticosterone
binding can be detected in this supernatant and no llg-hydroxylase
activity demonstrated.
Cytochrome P450 is now substrate depleted with a.cholesterol:J
see r
cytochrome P450 molar ratio 0.01:1 (Table 3.2) and further
see
purification of this cholesterol depleted cytochrome P^50scc was
associated with marked loss of this haemoprotein. Addition of
cholesterol or pregnenolone, the product of the cholesterol side chain
cleavage reaction, stabilised the cytochrome P45C>scc to further
purification (Table 3.5) and this protective effect was observed with
ligands to the haemoprotein other than substrate or product (Table 3.5).
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Fig. 3.2. ABSOLUTE SPECTRA OF CYTOCHROME P450 BEFORE AND AFTER& sCC
BUTANOL-ACETONE EXTRACTION
Cytochrome P450 is predominantly in a high spin state prior
S OQ
to butanol-acetone extraction with absorption maxima at 392 and 648 nm.
The cholesterol to cytochrome P450 molar ratio is 8:1. After
see
extraction the absorption maxima are 416, 535 and 568 nm with a
cholesterol to cytochrome *"^50^^ molar ratio of 0.01:1. Cytochrome
P450 concentration was adjusted, in both cases, to 17.2 nmoles/ml
see
on the basis of the carbon monoxide difference spectrum. The spectra
were recorded at 20°C and the cytochrome was suspended in 10 mM
potassium phosphate buffer pH 7.4.
cytochrome P450 spectrum prior to butanol-acetone extraction.
cytochrome P450 spectrum after butanol-acetone extraction.
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Ammonium Sulphate Fractionation of the 105,000 g Supernatant of a
Butanol-Acetone Extracted Powder
The two ligands most commonly employed were aminoglutethimide
and 4-phenylimidazole at 0.5 mM and 1 mM concentrations respectively.
The stock solution of aminoglutethimide was 10 mM in propylene glycol
and that of 4-phenylimidazole was 45 mM in propylene glycol. To
the stirred 105,000 g supernatant extract, ammonium sulphate was
added dropwise over 45 min to a saturation of 35% and centrifuged at
30,000 g for 20 min. The stock solution of ammonium sulphate was
80% saturated in 100 mM potassium phosphate buffer pH 8.0, 1 mM EDTA.
The small pellet formed on centrifugation was discarded. Ammonium
sulphate solution was added to the supernatant over 45 min to a
saturation of 50% and centrifuged at 30,000 g for 20 min. The pellet
formed was resuspended in a minimum volume of 10 mM potassium phosphate
buffer pH 7.4 with 1 mM EDTA and containing either 0.5 mM aminoglutethimide
or 1 mM 4-phenylimidazole (Fig. 3.1). The resuspended pellet was
dialysed for 3 hr against 3 litres of 10 mM potassium phosphate buffer
pH 7.4. The specific content of cytochrome P450gcc increased with
minimal loss of cytochrome (Table 3.1).
Calcium Phosphate Gel Fractionation
Calcium phosphate gel was washed initially with distilled water
and then resuspended in a thin slurry with 10 mM potassium phosphate
buffer pH 7.4. The 35-50% ammonium sulphate fraction of the 105,000 g
supernatant of a butanol-acetone powder was resuspended in 10 mM phosphate
buffer pH 7.4, stirred and a minimal volume of calcium phosphate gel
added (Fig. 3.1). When concentrated, cytochrome P450 is dark brown in
colour and thus the calcium phosphate gel was titrated into the cytochrome
solution until all the coloured protein was adsorbed on a minimal amount
of gel. The gel was then centrifuged at 3,000 g for 5 min and the
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supernatant decanted. The pellet was gently stirred with a higher
molarity phosphate buffer for 20 min and the centrifugation repeated.
During the initial experiments with this technique, increments were
of 20 mM potassium phosphate buffer. However when the elution pattern
of protein and cytochrome P450 was realised the gel was washed with
100 mM potassium phosphate buffer after the initial wash with 10 mM
potassium phosphate buffer and cytochrome P450 subsequently eluted
with 200 mM buffer. The cytochrome P450 eluted was dialysed against
3 litres of 10 mM potassium phosphate buffer pH 7.4 to give a preparation
of cytochrome ^50^^ with a specific content of 8-10 nmoles/mg protein
(Table 3.1).
The elution pattern changes with the ligand employed to stabilise
the cytochrome P450. In the example shown (Fig. 3.3), cytochrome
P450gcc- aminoglutethimide elutes maximally within the range 100-200 mM
potassium phosphate buffer whereas cytochrome P450-cholesterol complex
elutes maximally in the range 150-250 mM potassium phosphate.
Overall yields and specific contents of cytochrome P450gcc for the last
two stages of purification are marginally greater for the cytochrome
stabilised with aminoglutethimide than stabilised with cholesterol.
Cholesterol
The cholesterol content of the preparation is reduced as the
purification of cytochrome P450 proceeds (Table 3.2). The stages
see
associated with the most marked cholesterol reductions are the iso-
octane extraction of lyophilised mitochondria, the ammonium sulphate
fractionation of iso-octane interlayer in the presence of sodium cholate
and the butanol-acetone extraction of 35-50% ammonium sulphate fraction.
Associated with the changes in cholesterol content cytochrome P450scc
is predominantly high spin until the butanol-acetone extraction when
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The results are also expressed in terms of specific content,
nmoles cytochrome P450scc/mg protein.
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addition of cholesterol to this low spin haemoprotein restores the
haemoprotein to the high spin states.
Sodium Cholate
The concentration of sodium cholate, added to solubilise
cytochrome P450 from the lyophilised iso-octane interlayer, was
reduced as the preparation proceeded (Table 3.3). The purification
steps associated with the most marked reduction in sodium cholate
were the dialysis of the 35-50% ammonium sulphate fraction and the
butanol-acetone extraction. The concentration of sodium cholate
in the 105,000 g supernatant fraction of a butanol-acetone powder
extract was in three fold molar excess to cytochrome P450
see
Similar reductions in cholate concentration have been reported by
Autor et al. (1973) from cholate solubilised liver microsomal
cytochrome P450.
Cytochrome P450gcc behaves as an integral protein of mitochondrial
membrane (Singer and Nicolson (1972)) and as a rule such proteins are
not very soluble in aqueous solutions. Cytochrome after
butanol-acetone treatment, is phospholipid and detergent depleted
but is retained in the 105,000 g x 60 min supernatant of a phosphate
buffer extract. The cytochrome P450gcc from this supernatant behaves
as an aggregate of apparent molecular weight 200,000 and one possible
explanation of this solubility could be that by mutually covering
hydrophobic domains, individual proteins form a complex with sufficient
polar surface to remain soluble in water (Helenius and Simons (1975)).
Detergents both ionic and non-ionic can act as denaturants to
cytochrome P450 (Mason et al. (1965)). Cytochrome P45C>scc is exposed
to a concentration of sodium cholate well above the critical micellar
concentration (Carey and Small (1970)) during the solubilisation of
the iso-octane interlayer. However when cytochrome P450scc is
TABLE 3.2 NADPH adrenodoxin reductase activities and cholesterol:
cytochrome P450 molar ratios during purification of
cytochrome P450
see
Determination of cytochrome P450 and cholesterol concentrations
were as described in Methods. NADPH adrenodoxin reductase activity
was determined by the method of Omura et al. (1966) and is
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TABLE 3.3 Sodium cholate:cytochrome P450 molar ratios during
purification of cytochrome P450 . Cholate andv J
see
cytochrome P450 concentrations were determined as
in Methods
Molar ratio sodium cholate:
cytochrome P450J see
Iso-octane interlayer -
(0.5 mg cholate/mg protein) 655:1
Dialysed 35-50% (NH.) SO,
fraction 24:1
105,000 g supernatant of
butanol-acetone powder 3:1
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depleted of this added cholate it retains enzymatic and spectral
properties similar to those of cytochrome P450 in intact mitochondria.
NADPH Adrenodoxin Reductase
The most substantial decrease in NADPH-adrenodoxin reductase
activity was noted on washing lyophilised mitochondria. Residual
activity in the 105,000 g supernatant of a butanol-acetone powder
represents a twenty-five fold decrease in activity compared to
lyophilised mitochondria (Table 3.2).
Adrenodoxin
Adrenodoxin is usually determined by examination of the character¬
istic electron paramagnetic resonance (EPR) spectrum of the reduced
protein at liquid nitrogen temperature. Under these conditions
adrenodoxin has signals in the first derivative spectrum with g values
at 1.94 and 2.03 (Fig. 3.4). The adrenodoxin in adrenocortical
mitochondria can be quantitated from the height of the signal of the
EPR spectrum at g 1.94 by comparison with a highly purified adrenodoxin
preparation (Estabrook et al. (1973)). The EPR spectra of the
'adrenodoxin like' iron sulphur proteins are perturbed, however, if
the preparations contain large amounts of the respiratory chain iron
sulphur proteins, since these proteins also exhibit EPR signal in the
same region of the spectrum. Signals in the 1.86-1.92 region are
indicative of such respiratory chain iron sulphur proteins (Orme-
Johnson (1973)). This overlap in signal position makes quantitative
determination of adrenodoxin difficult when levels are low and the
predominant signal appears to be that of the iron sulphur protein of
respiratory chain origin. Similar problems of iron sulphur protein
quantitation have been observed in the determination of testodoxin
levels in testis mitochondria (Mason et al. (1973)).
TABLE 3.4 The molar ratios of iron sulphur protein:cytochrome




The contamination of cytochrome P450 by iron sulphur protein was
S CO
reduced to minimal amounts by adequate washing of the lyophilised
mitochondria with 100 mM potassium phosphate buffer pH 7.4 and by
the inclusion of a 50% ammonium sulphate precipitation on a sodium
cholate solubilised iso-octane interlayer. The individual experiments
show variation in (1) concentration, protein/ml, of resuspended
lyophilised mitochondria; (2) number of times a resuspension was
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Fig. 3.4. THE ELECTRON PARAMAGNETIC RESONANCE SPECTRA OF IRON SULPHUR
PROTEINS DURING PURIFICATION OF CYTOCHROME P450
see
Samples were suspended in 200 mM Tris-chloride buffer pH 7.4
and reduced with sodium dithionite. Sample A upper trace, a 105,000 g
supernatant fraction extracted from butanol-acetone powder (expt. A,
Table 3.4) containing 6.3 nmoles cytochrome P450/ml. Sample B
lower trace, a butanol-acetone powder (expt. B, Table 3.4) containing
34.2 nmoles cytochrome P450/ml cytochrome P450 . The instrument
S CO
settings were temperature -172°C, modulation amplitude 12.59,
microwave power 50 mW, modulation frequency 100 kHz and microwave
frequency 9.14 GhZ. Sample A represents the EPR signal where the
iron sulphur protein is in the main adrenodoxin and sample B represents
significant contamination of the adrenodoxin with iron sulphur protein
of respiratory chain origin.
39.
Adrenodoxin is relatively loosely bound in adrenocortical
mitochondria and can be released into a supernatant fraction on
centrifugation by prior sonication or lyophilisation leaving most
of the cytochrome P450 bound to membrane in the pellet. The data
presented in Table 3.4 emphasises the importance of homogenisation
and centrifugation of lyophilised mitochondria in excess phosphate
buffer and the effect of the 50% saturated ammonium sulphate
fractionation step, as necessary to further reduce adrenodoxin levels
at a later stage in the preparation. These procedures reduce
contamination of cytochrome P450gCC by iron sulphur proteins to
less than 1% on a molar basis. Adrenodoxin is relatively more
soluble than the respiratory chain iron sulphur proteins as can be
observed in expt. A, Table 3.4, when adrenodoxin is the main con¬
taminant and the molar ratio of iron sulphur proteins cytochrome
P450gcc changes from 1:1 in a butanol-acetone powder to 1:0.58
in the 105,000 g supernatant fraction of a butanol-acetone powder
extract. In expt. B, Table 3.4, by contrast when the respiratory chain
iron sulphur proteins are a predominant contaminant the molar ratio of
iron sulphur protein:cytochrome changes from 1:12.5 in a
butanol-acetone powder to 1:20 in the 105,000 g supernatant fraction
of a butanol-acetone powder extract.
Protective Ligands
Cytochrome P450 in the ferric, substrate depleted form has a
Soret absorption band at 416 nm. Upon reduction the Soret band of
the ferrous form moves to 411 nm. Upon addition of carbon monoxide
to this reduced cytochrome P450 preparation the Soret band shifts
to 446 nm. An enzymatically inactive derivative of the cytochrome
forms on treatment of cytochrome P450 with mercurial compounds, acetone,
sodium deoxycholate or urea (Mason et al. (1965)). This derived
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cytochrome has a ferrous carbon monoxide Soret absorption at 420 nm..
In general, all these biologically inactive forms are termed
cytochrome P420. However such cytochrome P420s were not observed
as a major degradation product during the purification of cytochrome
P450
see
Another cytochrome P450 derivative has been observed with the
appearance of a Soret absorption band at 412 nm and ferrous absorption
band at 422 nm but failing to bind carbon monoxide (Fig. 3.5) when
cytochrome P450 is treated by a wide variety of agents, high salt
concentration, potassium superoxide, organic solvent, prolonged
exposure to gel filtration or ionic exchange chromatography. This
product cannot be re-converted to cytochrome P450 or cytochrome P420
by sulphydryl groups such as 10 mM dithiothreitol or cysteine or
using 20% glycerol or a combination of thiols and glycerol.
This degraded form of cytochrome P450 was observed initially as
a result of ammonium sulphate fractionation of the 105,000 g super¬
natant fraction of a butanol-acetone powder extract. Addition of
cholesterol to such a preparation prior to ammonium sulphate fractionation
prevents the production of such a haemoprotein and this is interpreted
as a protective effect.
Aminoglutathimide is an inhibitor of the cholesterol side chain
cleavage reaction (Kahnt and Neher (1966)) and forms a distinct spectral
complex with cytochrome P45C>scc (Jefcoate et al. (1973) . Mahaffee et al.
(1974)) have shown the inhibitory effect of aminoglutethimide on the
cholesterol side chain cleavage reaction can be reversed by washing
mitochondria prepared from rats pre-treated with aminoglutethimide.
Addition of aminoglutethimide to cholesterol depleted cytochrome P450gcc,
Soret absorption maximum 416 nm, results in the formation of a
cytochrome P45C>scc-aminoglutethimide complex, Soret absorption maximum





Fig. 3.5. DEGRADATION DF CYTOCHROME P450 -CHOLESTEROL COMPLEX
see
BY POTASSIUM SUPEROXIDE
A 5 yl solution of potassium superoxide, stock solution 50 mM
in dimethylsulphoxide, was added to a 2.5 ml solution of cytochrome
P450 -cholesterol with the immediate formation of a haemoprotein
see r
having a Soret absorption at 412 nm. This degradation product was
reduced by sodium dithionite but failed to bind carbon monoxide.
The cytochrome ^^^<-)scc concentration was 12.25 nmoles/ml with
cholesterol 100 nmoles/ml and suspended in 10 mM potassium phosphate
buffer pH 7.4.
curve 1 - ferric cytochrome P450scc~cholesterol complex;
curve 2 - reduced carbon monoxide absolute spectrum of cytochrome ^450g ;
curve 3 - haemoprotein generated by addition of potassium superoxide to
cytochrome P450gcc-cholesterol complex.
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glutethimide complex returned the Soret absorption maximum to 416 nm
and this is interpreted as indicative of removal of the aminoglutethimide
ligand to the haemoprotein (Fig. 3.6).
4-Phenylimidazole forms a distinct spectral complex with cytochrome
.P45C>ca^ (Gunsalus et al. (1972)) and in a similar manner to amino¬
glutethimide, dialysis or gel filtration of the cytochrome P450 -4-S CO
phenylimidazole complex results in reformation of the 416 nm Soret
absorption band characteristic of the low spin substrate depleted
cytochrome P450
see
Imidazole induced a spectral change in cytochrome P450gcc similar
to that of 4-phenylimidazole but with a lower affinity as measured by
the spectral dissociation constant (Table 3.5).
Ketamine and pregnenolone induce inverse Type I spectral changes
with 105,000 g supernatant fraction of a butanol-acetone powder extract.
The inverse Type I spectral change is small, less than 10% of the total
cytochrome P450 based on an extinction coefficient of 110 mM ^cm
(Peterson (1971)) for this spectral change and interpreted as ligand
binding to that fraction of cytochrome P450gcc in a high spin state.
The inverse Type I spectral change induced by ketamine can be reversed
by dialysis unlike that induced by pregnenolone. The recovery of
cytochrome P450 (Table 3.5) after ammonium sulphate fractionation
SCO
in the presence of ketamine or pregnenolone suggests that the extent of
binding may be greater than that observed by the inverse Type I spectral
change. These ligands could be binding to low spin cytochrome P45C>scc
without optical perturbation. In view of these doubts on the extent
and nature of binding and subsequent reversibility, ketamine was not
used as a protective ligand.
Aminoglutethimide and 4-phenylimidazole were the 'protective ligands'
routinely used in view of their high affinity for cytochrome P450gcc as
THE STRUCTURE OF PROTECTIVE LIGANDS USED DURING THE PURIFICATION OF
CYTOCHROME P450
see
A: cholesterol; B: pregnenolone; C: ketamine; D: amino-
glutethimide and E: 4-phenylimidazole.
TABLE 3.5 Properties of ligands and stabilisation of cytochrome
P450 during ammonium sulphate fractionation of the
s cc
105,000 g supernatant of a butanol-acetone powder
The spectral dissociation constants were determined at the concentrations
of cytochrome P450 shown, on a low spin cytochrome P450 preparation
s c c see
in 100 mM potassium phosphate buffer pH 7.4; specific content 4.4-6.1
nmoles cytochrome P450/mg protein. The inverse Type I spectral change
induced by pregnenolone and ketamine were small; the spectral change
induced represents less than 10% of the total cytochrome P450. The
spectral changes induced by the ligands are as defined by Schenkman
et al. (1967). The ligand concentration refers to the concentration
added to cytochrome P450 prior to ammonium sulphate fractionation.
SCO
The reversibility of ligand binding is based on spectral shifts consequent
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Fig. 3.6A. ABSOLUTE SPECTRA OF LIGAND INTERACTIONS WITH CYTOCHROME P450
Cytochrome P450 , as isolated from the 105,000 g supernatant of
see
a butanol-acetone powder, is a low spin cholesterol depleted haemoprotein
with a Soret absorption maximum at 417 nm. Addition of amino-
glutethimide 500 yM results in the formation of a cytochrome
aminoglutethimide complex with a Soret absorption maximum at
422 nm; dialysis of this complex results in reformation of a spectral
species with a Soret maximum of 417 nm. The addition of cholesterol
100 ym to low spin substrate depleted cytochrome ^450^^ results in the
formation of a cytochrome P450 -cholesterol complex -with a Soret
see
maximum at 392 nm; dialysis of this complex does not result in reversal
of the spectral change. The cytochrome P450 concentration was 4.6 nmoles/
ml in 10 mM potassium phosphate buffer pH 7.4.
B. THE REDUCED CARBON MONOXIDE DIFFERENCE SPECTRUM of low spin
substrate depleted cytochrome P^50gcc with a Soret absorption maximum at
446 nm and a shoulder at 420 nm.
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measured by the spectral dissociation constants, their reversibility
of binding and the degree of protection afforded to the haemoprotein
(Table 3.5).
The properties of ligands and recoveries of cytochrome P450
SCO
after ammonium sulphate fractionation of the 105,000 g supernatant
of a butanol acetone powder are given in Table 3.5. The results
show that in the presence of exogenously added ligand the recovery of
cytochrome increased markedly compared to that of control
without added ligand. The recovery of cytochrome P450gcc is greater
in the presence of 4-phenylimidazole or aminoglutethimide than in the
presence of cholesterol or pregnenolone. However these groups of
ligands cannot be directly compared as the molar ratios of ligand
to cytochrome P450 related to the apparent spectral dissociation
see
constant of a ligand differ. For example the pregnenolone concentration
given in Table 3.5 is fifty fold greater than the apparent spectral
dissociation constant at that concentration of cytochrome P450
see
whereas the similar ratio for aminoglutethimide is one hundred fold.
The importance of defining the spectral dissociation constant in
terms of cytochrome P450 concentration will be discussed in
see
Chapter 4 in relation to cholesterol binding. The effect of exogenously
added ligands on cytochrome P450 can be rationalised on the basis
s cc
of knowledge of the endogenous axial ligands.
The first clue to the nature of the axial ligands of ferric
cytochrome P450 was derived from EPR experiments. Miyake et al. (1968)
demonstrated that ferric cytochrome P450 was predominantly a low spin
(S = |) haemoprotein while Jefcoate and Gaylor (1969) and Blumberg et
al. (1971) subsequently showed that the EPR spectra of low spin
cytochrome P450 and cytochrome P420 (Stern et al. (1973)) were similar
to those derived from the addition of mercaptoethanol or other alkyl
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mercaptides to ferric haemoglobin or ferric myoglobin. These
findings and various model studies with haemin thiol complexes
(Bayer et al. (1969)) suggested that a necessary axial ligand for the
iron in ferric cytochrome P450 is a thiol presumably a cysteine residue.
Although one may infer the nature of the obligate axial ligands in
the ferric protein from EPR data this is not possible for the ferrous
state and synthetic models must be used.
A model compound was prepared by Stern and Peisach (1974) from
haemin with the same optical properties in the Soret region as the
carbon monoxide complex of the ferrous cytochrome P450. Obligate
for the formation of this spectral species absorbing at 450 nm (EmM 93)
and 555 nm (EmM 23) in a dimethylsulphoxide ethanol solvent was the
presence of ferrous haem, carbon monoxide, thiol and a strong base.
Decreasing the dielectric constant of the solvent which would be
equivalent to increasing the hydrophobicity of the haem environment
caused a small shift in the Soret absorption to the blue with no
change in the extinction coefficient. The absence of thiol or strong
base resulted in formation of a typical haem carbon monoxide complex
with absorption at 413 nm (EmM 150), 535 (EmM 25), and 566 nm (EmM 30).
Nitrous oxide binds to cytochrome P450 producing optical spectra
very different from nitrosyl haemoglobin or myoglobin (Ebel et al. (1975)).
The optical spectra of nitrosyl cytochrome P450 can be duplicated by a
model compound consisting of ferrous haem, sodium methyl mercaptide
and nitrous oxide (Stern and Peisach (1976)) once more suggesting
that thiolate anion is a ligand to the haem.
One physical study which set about to elucidate the chemical
nature of ftie ligand counter to the sulphur in cytochrome P450 was that
of Griffin et al. (1975). On the basis of proton nuclear magnetic
resonance these authors suggested that water is the ligand trans to
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the sulphur. However ligands other than water with exchangeable
protons such as imidazole can relax water protons (Peisach (1973)).
Further the electron paramagnetic resonance spectrum for low spin
haem thiol complexes prepared in the absence of nitrogenous base
has crystal field parameters sufficiently removed from those of
cytochrome P450 to make it unlikely the possible participation of
water as a haem ligand in the protein (Chevion et al. (1977)).
Analysis of a large number of model compounds and derivatives
of haemoglobin, myoglobin as well as cytochrome P450
suggest that an imidazole is trans to the sulphur (Chevion et al. (1977)).
From a comparison of crystal field parameters of haem thiol compounds
it is suggested that exogenous ligands can exchange with endogenous
haem ligands in the ferric cytochrome that is trans to the sulphur.
The ferrous protein model compound studies indicate that the
haem ligand trans to the sulphur is displaced by either carbon monoxide
(Stern and Peisach (1974)) or by nitrous oxide (Ebel et al. (1975))
as the optical spectrum of the carbon monoxide or nitrous oxide
ligated forms could only be duplicated when an alkyl mercaptide was
present.
Model reactions of exogenously added ligands to cytochrome P450gcc
have been proposed to account for the changes observed in spin state
of the cytochrome (Griffin and Peterson (1972); Griffin et al. (1975)
and Chevion et al. (1977)), and may be summarised as follows. In
the low spin state, in the absence of exogenous ligands, the iron is
six co-ordinated with sulphydryl and imidazole nitrogen groups from
amino acid residues of the protein occupying the fifth and sixth ligand
positions. In general substrates for cytochrome P450 dependent
reactions are hydrophobic in character with few or only weakly ionisable
functional groupings on the molecule. The ability to induce fundamental
4 5.
changes in the spin state of cytochrome P450 by a substrate which
does not directly interact with the iron of the haem has been
rationalised in terms of indirect effects upon the protein moiety
of cytochrome P450. Chevion et al. (1977) suggest that substrate
interacts at a site proximal to the iron-porphyrin complex and
perhaps by hydrophobic interaction with amino acid residues at this
site causes a perturbation in protein structure which disrupts the
iron-imidazole bond with a movement of the iron out of the plane of
the porphyrin ring giving rise to the high spin state of the cytochrome
and associated Type I optical spectral change.
Ligands which induce an inverse Type I spectral change are
effecting a reversal of this process and strengthen the iron-imidazole
bond forming a low spin state. The ligands with a nitrogenous
functional grouping such as aminoglutethimide or 4-phenylimidazole
are thought to directly ligand to the iron displacing the endogenous
imidazole ligand and inducing a perturbed low spin state with a Type
II optical spectral change.
The ligands used during the purification of cytochrome P450
. s cc
apparently must interact with the haem or protein components in
different manners but having the same common property of maintaining
the integrity of the haemoprotein. The hydrophobic nature of these
protective ligands and their interaction with the protein component
may be important in maintaining the structure of the haemoprotein.
Molecular Weight of Cytochrome
The molecular weight of partially purified cytochrome P450gcc was
determined by gel filtration on Sepharose 4B. The column was calibrated
with proteins of known molecular weight and the results plotted as the
ratio of elution volume:void volume against the logarithm of molecular
weight (Fig. 3.7). Cytochrome ^50^^, specific content 9.1 nmoles/mg
6.0 r
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Eig. 3.7. DETERMINATION OF THE NATIVE MOLECULAR WEIGHT OF PARTIALLY
PURIFIED CYTOCHROME P450 BY GEL FILTRATION CHROMATOGRAPHY
scc
Cytochrome specific content 9.1 nmoles/mg protein, and
concentrated by ammonium sulphate precipitation was applied to a
column of Sepharose 4B dimensions 45 x 1.5 cm pre~equilibrated with
10 mM potassium phosphate buffer pH 7.4 containing 1 mM EDTA, 100 mM
potassium chloride and 500 yM aminoglutethimide and eluted with the
same buffer at a flow rate of 20 ml/hr. Protein and cytochrome P450
eluted as a single peak. The results are plotted as the ratio of
elution volume of cytochrome P450/void volume Ve/Vo against logarithm
molecular weight. The column was calibrated with proteins of known




protein, was chromatographed on Sepharose 4B in the presence of
500 yM aminoglutethimide; protein and cytochrome eluted as
a single peak with a molecular weight of 200,000.
The molecular weight of other partially purified preparations
of cytochrome P450 range from 60,000 (Horie and Watanabe (1975))
s c c
to 850,000 (Shikita and Hall (1973)). Within certain preparations
of cytochrome P450scc there may be a single molecular cytochrome
P450 species (Takemori et al. (1975)) or multiple molecular forms of
this haemoprotein (Shikita and Hall (1973); Horie and Watanabe (1975)).
Minimal molecular weight determinations of cytochrome P450gcc give values
of 46,000 (Takemori et al. (1975)), 53,000 (Shikita and Hall (1973)) and
60,000 (Wang and Kimura (1976)). These results suggest cytochrome
P450 aggregates during purification procedures,
s c. c
Isoelectric Focusing of Cytochrome P^50_^
Analytical isoelectric focusing of cytochrome P450gcc from the
105,000 g supernatant fraction of a butanol-acetone extract allows
separation of multiple minor bands associated with peroxidase activity
in the range pH 5.1-6.2 with the main bands at pH 5.3 and 5.4 (Fig. 3.8).
Multiple bands with peroxidase activity reflect fundamentally different
cytochrome P450s or simply charge variation dependent on degree of
aggregation, bound cholate, trace phospholipid or the presence of
degradation products with peroxidase activity such as cytochrome P420.
The pi values previously determined for cytochrome P450 show a wide
variation. Tilley et al. (1976) report a haem containing subunit
of cytochrome P450gcc with a pi of 7.0. The cytochrome pi
values are 4.55 (low spin) and 4.67 (high spin (Dus et al. (1970))
whereas a liver microsomal cytochrome P450 fraction LM2, homogeneous
by polyacrylamide gel electrophoresis,gave four bands in the range
pH 7-9 (Ingelman-Sundberg and Gustaffson (1977)). This range of pi
Fig. 3.8. ISOELECTRIC FOCUSSING ON POLYACRYLAMIDE GEL
Cytochrome P450 , specific content 5.1 nmoles/mg protein, was
s cc
applied at neutral pH to a gel with a pre-established pH gradient
and electrofocussing performed as described in Methods. A: represents
protein bands observed after staining with Coomassie Blue; B: bands
of peroxidative activity and C: the established pH gradient at the
termination of the electrophoresis run.
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values may simply represent variation in the methods employed,
fundamental differences in the cytochrome P450s or the need for
further purification to homogeneity and high specific content of
the mammalian cytochrome.
Preparative isoelectric focusing in granulated gel using Ampholine
range pH 4-6 resulted in precipitation of cytochrome at the
zone of application with no migration of the cytochrome P450.
Addition of 2% glycine or 1% Nonidet to the gel did not improve
cytochrome P450 migration.
Further Purification of Cytochrome P450i gCC
Cytochrome is th6 terminal oxidase in Pseudomonas putida
for the conversion of camphor to exo-5-hydroxycamphor (Katagiri et al.
(1968)). This soluble cytochrome P450 has been purified and
crystallised (Yu et al. (1974)) and has been used as a mechanistic
model and guide for the purification of mammalian cytochrome P450.
The resolution of membrane bound cytochrome P450 from mammalian sources
and purification to high specific content with reasonable recovery
has been less successful. Van der Hoeven et al. (1974) have purified
liver microsomal cytochrome P450 to a high specific content, almost
comparable to that of cytochrome but yields are of the order
of a few percent and the later kinetic experiments of these authors
have been conducted with less pure cytochrome P450 (Peterson et al.
(1977)). The situation is similar with the purification of cytochrome
P450 from adrenal cortex mitochondria. The preparations of Shikita
see
and Hall (1973) and Wang and Kimura (1976) are of low specific content
and have a low overall yield of cytochrome P450. The purification
procedures of Takemori et al. (1975) and Horie and Watanabe (1975)
give preparations with higher specific content, around 12 nmoles/mg
protein but again with relatively low recovery. The need exists for
48.
a preparation of mammalian cytochrome P450 of high specific content
with a reasonable degree of recovery.
Further purification of cytochrome P^5C>scc to a higher specific
content has been attempted. The use of the chromatographic method
ofgel filtration has been investigated. The cytochrome P450
SCO
fraction eluted from calcium phosphate gel as previously described was
concentrated by ammonium sulphate precipitation to a final saturation
of 50% and applied to a column of Biogel A 0.5 M, 50 2.5 cms, previously
equilibrated with 10 mM potassium phosphate buffer containing 1 mM
EDTA, 1 mM dithiothreitol and 0.5 mM aminoglutethimide and eluted with
the same buffer solution at a rate of 25 mls/hr. The cytochrome
eluted as a single peak with a Ve/Vo ratio of 1:1. The recoveries and
specific content of cytochrome P450 eluted are given in Table 3.6.
s c c
The results indicate a loss of total cytochrome P450 without con-
scc
comitant formation of cytochrome P420 or the degradative product
previously described. This loss of total cytochrome P450 was
SCO
associated with a decrease in specific content and coupled with the
observation that rapid decolourisation of the cytochrome P450 bandr
see
occurred during the elution process has led to the conclusion that a
degradative process resulting in a haemoprotein dissociation is probably
involved. Exclusion of EDTA or dithiothreitol from the eluant made
no significant difference to recovery of cytochrome P450gcc. Similarly
increasing the dithiothreitol concentration to 10 mM or inclusion of
glycerol to a 20% solution or a combination of both did not significantly
increase recovery of cytochrome P450gcc. These agents have been useful
in the partial reconversion of cytochrome P420 to cytochrome P450 but
do not appear to reduce the extent of this haem-protein dissociation.
Variation in ionic strength (0.01-0.1 y ); pH (6.8-7.8); temperature
(4 and 20°C); nature of eluting buffer (potassium phosphate or Tris
TABLE 3.6 Recovery of cytochrome P450 after column chromatography
SCO
Cytochrome P450 was applied to a column of Biogel A0.5M, 50 x 2.5 cms
see
previously equilibrated with 10 mM potassium phosphate buffer pH 7.2
containing 1 mM EDTA, 1 mM dithiothreitol and 0.5 mM aminoglutethimide
and eluted with the same buffer solution at a rate of 25 mls/hr.
The cytochrome P450 eluted as a single peak with a Ve/Vo ratio of 1:1.
see
Cytochrome P450 was applied in 10 mM potassium phosphate buffer pH 7.2
see
containing 1 mM EDTA, 1 mM dithiothreitol and 0.5 mM aminoglutethimide
to a column of DEAE-cellulose 5x2 cms and then eluted with 100 mM
potassium phosphate buffer pH 7.2 containing the same additives.
The total nmoles and nmoles/mg protein refer in the table to nmoles
cytochrome P450 and nmoles cytochrome P450 /mg protein respectively,
s ee see
Cytochrome P450 Cytochrome P450
Applied Recovered
Total nmoles/mg Total nmoles/mg
nmoles protein nmoles protein
Biogel A0.5M 48 10.1 29 8.5
DEAE-cellulose 62 9.8 31 6.5
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hydrochloride) or the inclusion of n-propyl gallate (1 mM); the use
of double glass distilled deionised water for buffer solutions;
the use of argon saturated buffers; the exclusion of light during
chromatography or the use of siliconised glassware or polypropylene
columns did not reduce the extent of this degradation. The time of
exposure of cytochrome P450 to a chromatographic gel appears to be
scc
an important consideration and short column lengths with high flow
rates within the limits of resolution of the gel results in less
cytochrome loss. This was also observed on chromatographic gels
where the cytochrome P450 was retained longer for the same flow
characteristics such as Sepharose 4B or Biogel A1.5 M.
The use of ion exchange chromatography for further purification
of cytochrome P^50scc resulted in losses of the total cytochrome
P450gcc applied and also a decrease in specific content. In the
example shown (Table 3.6) cytochrome P450gcc was applied in 10 mM
potassium phosphate buffer pH 7.2 containing 1 mM EDTA, 1 mM dithio-
threitol and 0.5 mM aminoglutethimide to a column of DEAE-cellulose
(5 cms x 2 cms) and then eluted with 100 mM potassium phosphate buffer
pH 7.2 containing the same additives.
Hydrophobic interactions between cytochrome P450 and aliphaticsee
or aromatic substituents linked to Sepharose 4B have been used
successfully by Takemori et al. (1975) as a method of purification of
cytochrome P450gcc. In initial experiments using m-aminohexyl- and
w-aminooctyl-Sepharose 4B no significant elution of cytochrome P450
see
was obtained by simply increasing ionic strength and high concentrations
of sodium cholate were required to elute cytochrome P450 . Hydrophobicsec
interaction chromatography was not further explored at this time as it
appeared counterproductive to aim for and attain a cholate depleted
cytochrome P450scc preparation and then use detergent to elute from a
50.
substituted Sepharose column.
The apparent loss of haem during the purification of mammalian
cytochrome P450 has been a significant problem (Shikita and Hall
(1973); Wang and Kimura (1976); Watanabe and Horie (1975); van der
Hoeven et al. (1974)). However no detailed study has been made into
the nature of this haem-protein dissociation observed particularly
during chromatographic procedures. The degradation of cytochrome
P450 during column chromatography may be an oxidative process.SCO
The oxidative process could be indirect through peroxidation of
associated lipid contaminants although inclusion of metal chelators
or antioxidants did not reduce the extent of this degradation.
Another possible oxidative attack could be a direct process through
generation of an active oxygen species at the iron-porphyrin centre.
The generation of a superoxy or a peroxy species would necessitate
the initial reduction of the ferric iron prior to oxygen activation
and one would have to postulate an internal reduction perhaps through
an adjacent thiol residue. A more rigorous approach to the exclusion
of molecular oxygen during column chromatography or the use of carbon
monoxide as a protective ligand might be productive.
Summary
Cytochrome P450 , the terminal oxidase for the side chain cleavage
s c c
of cholesterol to pregnenolone in bovine adrenal cortex mitochondria,
was partially purified to a specific content of 10.2 nmoles cytochrome
P450/mg protein with a recovery of 14%. The method involves iso-octane
extraction of lyophilised mitochondria; ammonium sulphate fractionation
in the presence of sodium cholate, butanol-acetone extraction, phosphate
buffer extraction; a second ammonium sulphate fractionation, calcim
phosphate gel adsorption and elution.
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The cytochrome P450 preparation has no detectable activitySCO
for the llg-hydroxylation of deoxycorticosterone. Cholesterol:
cytochrome P450 molar ratios are reduced to 1:100 and the cytochrome
see
has been isolated as a low spin haemoprotein. Adrenodoxin contamination
in the preparation has been reduced to less than 1% on a molar basis
to cytochrome P450 and NADPH adrenodoxin reductase activity reduced
see
to 4% of that in mitochondria. Sodium cholate, initially added to
effect solubilisation, was reduced in the final preparation to a 3:1
molar ratio to cytochrome P450 . The molecular weight of cytochrome
see
P450 , determined by gel filtration, was 200,000. The main bands
see
of peroxidase activity observed using isoelectric focusing were at
pH 5.3 and 5.4.
Further purification of cytochrome P450 was limited by degradation
sec
of the cytochrome P450. A degradation product of cytochrome P450see
with a Soret absorption maximum at 412 nm which failed to bind carbon
monoxide was observed. Ligands to cytochrome P450gcc, in particular




SPECTRAL INTERACTIONS OF CHOLESTEROL AND CYTOCHROME P450„__ FROM
—D L.L.
BOVINE ADRENAL CORTEX MITOCHONDRIA
INTRODUCTION
Cytochrome P450 has been partially purified from bovine adrenal
sco
cortex mitochondria and isolated as a cholesterol depleted, low spin
haemoprotein. This chapter describes the re-association of cholesterol
with this partially purified preparation of cytochrome P450gcc and
factors which influence this reaction.
Limited amounts of cholesterol are available within adrenal
mitochondria for use as substrate in the sterol side chain cleavage
reaction (Simpson et al. (1971)). Elevation of the plasma ACTH
increases the proportions of cholesterol in these mitochondria
bound to cytochrome P450 (Jefcoate et al. (1973)). Cycloheximide
see
administration to rats tends to block the effects of subsequent ACTH
administration and decreases pregnenolone production by adrenal cortex
mitochondria but does not prevent the mitochondrial accumulation of
cholesterol (Mahaffee et al. (1974); Arthur et al. (1976)).
Jefcoate et al. (1974) implied that the cycloheximide sensitive process
was dependent on the nature of the sterol substrate since the adrenal
metabolism of 25-hydroxycholesterol was insensitive to the action of
cycloheximide. Mason et al. (1978a) showed that analogues of
cholesterol with non-polar alkyl side chains like cholesterol were
sensitive to the cycloheximide pretreatment whereas the metabolism of
cholesterol derivatives with polar side chains was insensitive. This
implies that the cycloheximide sensitive factor or labile protein
factor (Garren et al. (1965)) appears to be related to the transfer of
non-polar sterols wlthin the mitochondria to the oxygenase enzymes.
TABLE 4.1 Properties of cytochrome P450 preparation
see
NADPH adrenodoxin reductase a
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Cytochrome P450 was partially purified from adrenal cortexSCO
mitochondria as previously described. The specific content of
cytochrome P450gcc used was 6.3-7.8 nmoles cytochrome P450/mg protein.
Cytochrome P^50gcc, as prepared, is a low spin substrate depleted
haemoprotein with a cholesterol content less than 1% on a molar basis
to cytochrome P450. The properties of the cytochrome P450gcc
preparation are shown in Table 4.1.
The absorption maxima of low spin cholesterol depleted cytochrome
P450 are 416, 535 and 568 nm. Addition of cholesterol to low spin
see
substrate depleted cytochrome P450 results in a decrease in
see
absorbance at 416 and 568 nm and an increase in absorbance at 392 and
648 nm with isosbestic points at 406, 457, 533 and 588 nm (Fig. 4.1)
to produce a spectral species which is identical to that prior to
butanol-acetone extraction. The molar ratio cholesterol:cytochrome
P450 prior to butanol-acetone extraction is about 9:1 with cytochrome
see
P450 in a predominantly high spin state and after butanol-acetone
see
extraction the ratio is 0.01:1 with cytochrome predominantly
in a low spin form.
Spectral Dissociation Constants
Addition of non-saturating amounts of cholesterol to low spin,
substrate depleted cytochrome P450gcc results, at equilibrium, in an
increasing proportion of cytochrome P450 in a high spin state as the
see
cholesterol concentration increases to saturation (Fig. 4.1). If
these optical changes are monitored as difference spectra, a Type I
optical change (Schenkman et al. (1967)) is observed with absorbance
maximum at 385 nm and minima at 420 and 570 nm (Fig. 4.2). A plot
of absorbance change (absorbance 385 nm minus absorbance 420 nm)
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Fig. 4.1. ABSOLUTE SPECTRAL CHANGES AT EQUILIBRIUM ON ADDITION OF
CHOLESTEROL TO LOW SPIN CYTOCHROME P450
-see
Cholesterol, stock solution 2 mM in propylene glycol, was added
to a 1 ml spectrophotometer cuvette containing low spin cytochrome
P450 . The cytochrome P450 concentration was 17.2 nmoles/ml
see see
in 10 mM potassium phosphate buffer pH 7.4. 1 mM EDTA and spectra
were recorded after incubation for 15 hrs at 20°C. The concentrations
of added cholesterol were 1, zero; 2, 5 yM; 3, 13.8 yM; 4, 17 yM
and 5, 50 yM.
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Fig. 4.2. DIFFERENCE SPECTRA OBSERVED ON ADDITION OF CHOLESTEROL
TO LOW SPIN CYTOCHROME P450
Cholesterol, stock solution 2 mM in propylene glycol, was added
to a 1 ml spectrophotometer cuvette containing low spin cytochrome
P450 . The cytochrome P450 concentration was 0.75 nmoles/ml
see see
in 10 mM potassium phosphate buffer pH 7.4 with 1 mM EDTA and after
cholesterol addition the samples were incubated for 15 hrs at 20°C
prior to spectral observation. The difference spectra of samples
were recorded against a control containing low spin cytochrome P^5C)scc
with no added cholesterol but with addition of an appropriate
concentration of propylene glycol. The added cholesterol concentrations
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Fig. 4.3. RELATIONSHIP OF ABSORBANCE -CHANGE (385-420 run) OF
CYTOCHROME P450 TO CHOLESTEROL CONCENTRATION ADDED
scc
Cholesterol, stock solution 2 mM in propylene glycol, was
added to a low spin cytochrome P450 preparation containing 3.6 nmoles
SCC
cytochrome P450/ml in 10 mM potassium phosphate pH 7.4, and allowed
to incubate at 20°C for 15 hrs prior to spectral measurements. The
samples containing cholesterol were read against a control containing
no added cholesterol and the absorbance difference 385 minus 420 mn
plotted against cholesterol concentration.
1
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Fig. 4.4. DOUBLE RECIPROCAL PLOT OF ABSORBANCE CHANGS AGAINST
CHOLESTEROL CONCENTRATION
The data is taken from Fig. 4.3 and allows calculation of
the spectral dissociation constant Ks and the maximal absorbance
change induced by the ligand."
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against cholesterol concentration (Fig. 4.3) shows an increase in
absorbance change with increase in cholesterol concentration towards
saturation. A plot of the reciprocal of absorbance change against
the reciprocal of the cholesterol concentration allows calculation of
the spectral dissociation constant Ks and the maximal absorbance
change induced by the ligand (Fig. 4.4).
Equilibrium Constant
A plot of the spectral dissociation constant Ks of cholesterol
against concentration of cytochrome P450gcc is shown in Fig. 4.5 at
two different potassium phosphate buffer concentrations. The spectral
dissociation constant varies with the enzyme concentration and these
results are expected if the concentration of free cholesterol during
the titration is not much greater than the concentration of bound
cholesterol. The observed changes in the absorption spectrum of
cytochrome P450 on addition of cholesterol can be used to calculate
see
the equilibrium constant of the reaction:
E + cholesterol ^ Hi E-cholesterol
using the method developed by Peterson (1971) for camphor binding to
cytochrome P450 . The assumptions made for the calculations are:J
cam r
a) the concentration of free cytochrome P450gcc (E) is equal to the
total concentration of cytochrome P450gcc (Et) minus the concentration
of the cholesterol complex of cytochrome (E-cholesterol);
b) the concentration of the cholesterol complex was calculated from
the absorbance of the Type I change using an extinction coefficient
of 110 mM ^"crn ^ (Peterson (1971));
c) the concentration of free cholesterol is equal to the total concen¬
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Fig. 4.5. THE RELATIONSHIP BETWEEN THE SPECTRAL DISSOCIATION
CONSTANT Ks OF CHOLESTEROL AND CYTOCHROME P450 CONCENTRATION
see -
The specrral dissociation constants were determined from a
reciprocal plot of absorbance change (385-420 nm) against
cholesterol concentration for a particular cytochrome P450 concen¬
tration. The lower and upper curves represent spectral
dissociation constants determined in 10 mM and 100 mM potassium
phosphate buffer pH 7.4 at 20°C respectively.
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The equilibrium constant
K . = (E-cholesterol) = 0.43 ± 0.03 x 106M_1
eC*U1 (E). (Cholesterol)
This value is valid for cytochrome P450 in 10 mM potassium phosphate
SCO
buffer pH 7.4, 1 mM EDTA at 20°C.
Effect of Potassium Chloride on Spin States at Equilibrium
The effect of potassium chloride concentration on the Type I
spectral change induced with a non-saturating (lower curve) and
saturating (upper curve) amount of cholesterol is shown in Fig. 4.6.
Potassium chloride was added to 1 ml aliquots of low spin cytochrome
P450gcc, concentration 2.75 nmoles/ml, in 20 mM Tris hydrochloride
buffer at 20°C. Cholesterol concentrations were 4 yM (lower curve)
and 100 yM (upper curve). The control sample of cytochrome P450gcc
on the lower curve with added cholesterol but no potassium chloride
has a K ... = 0.44 x 10^ M ^ and 47% of the cytochrome P450 wasequil J see
in a high spin state; with 100 mM potassium chloride added the K =
0.08 x 10^ M ^ and 21% of the cytochrome P450 was in a high spin
s c c
state. The control sample, the upper curve, was 85% high spin compared
to 60% high spin in the presence of 100 mM potassium chloride.
Concentrations of potassium chloride greater than 100 mM resulted in
formation of cytochrome P420 and an increase in turbidity as measured
by the absorbance at 457 nm.
The data from Fig. 4.6 was plotted as absorbance change (absorbance
385 nm minus absorbance 420 nm) potassium chloride concentration against
absorbance change (Fig. 4.7). A biphasic plot was obtained on data
from the lower curve (non-saturating cholesterol) with values for
potassium chloride of 5 mM and 77 mM, calculated from the slope of
the plots - =■. A linear plot was obtained from the upper curveK.
(saturating cholesterol) with a K^. = 104 mM. These results suggest
that potassium chloride appears tohave two effects on inhibition and
POTASSIUM CHLORIDE CONCENTRATION mM
Fig. 4.6. THE EFFECT OF POTASSIUM CHLORIDE ON THE CHOLESTEROL INDUCED
LOW TO HIGH SPIN STATE TRANSITIONS OF CYTOCHROME P450 AT EQUILIBRIUM
— see
Potassium chloride was added to 1 ml aliquots of low spin cytochrome
P450gcc concentration 2.75 nmoles cytochrome P450/ml, in 20 mM Tris
hydrochloride buffer pH 7.4 at 20°C. Cholesterol, stock solution 2 mM
in propylene glycol, was added to each aliquot to a concentration of 4 yM
(lower curve) and to 100 yM (upper curve). The samples were incubated
at 20°C for 15 hrs and the Type 1 absorbance changes recorded against a
control with no cholesterol or potassium chloride added.
)
Fig. 4.7. A PLOT OF ABSORBANCE CHANGE (385-420 nm) POTASSIUM
CHLORIDE CONCENTRATION AGAINST ABSORBANCE CHANGE (385~420 nm)
The data was taken from the lower curve (non-saturating
cholesterol concentration) Fig. 4.6 and plotted as above gives
slopes = - rpp and maximal absorbance changes from extrapolationKJ.
to the x axis. The biphasic plot has K Inhibitory (KI) values for
potassium chloride of 5 mM and 77 mM on cholesterol induced low to
high spin state transition of cytochrome P450 at equilibrium.
see
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the inhibitory effect with the lower value is antagonised by
choles terol.
Rate of Cholesterol Induced Low to High Spin State Transition of
Cytochrome P450
— see
The addition of a saturating amount of cholesterol at time zero
to low spin substrate depleted cytochrome P450 followed by
see
observations on the absorbance change (absorbance 385 nm minus
absorbance 420 nm) with time results in a plot as shown in Fig. 4.8.
The results were subsequently plotted as a first order reaction with
respect to (Af-At); the difference between the final absorbance change
Af and that at time t, At (Fig. 4.9). The results were plotted as a
first order reaction since under these conditions not all of the
cytochrome P450 is converted to the enzyme-cholesterol complex;
see
(Af-At) is not directly proportional to the total unbound cytochrome
P450 at time t but only that part which remains to be bound to
cholesterol at equilibrium. The first order rate constant was calculated
• • • • k •
from Fig. 4.9 using the relationship slope = ^ 3Q3 with a value for
k = 7.5 x 10 ^ sec valid for binding of cholesterol to low spin
cytochrome P450gcc in 10 mM potassium phosphate buffer pH 7.4 at 20°C.
Effect of Potassium Chloride on the Rate of Cholesterol Binding to
Cytochrome P450
— see
The Type I spectral change induced by the addition of saturating
amounts of cholesterol to low spin cytochrome P450 were observed
s cc
with time in the absence and presence of varying potassium chloride
concentrations. The first order rate constants were calculated and
the relationship to potassium chloride concentration shown in Fig. 4.10.
The effect of potassium chloride is to decrease the first order rate
constant of association of cholesterol with cytochrome P450 . TheSCO
inhibitory effect of monovalent ions contrasts markedly with the
0.2
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Fig. 4.8. A PLOT OF ABSORBANCE CHANGE (385-420 iim) ON ADDITION
OF CHOLESTEROL TO LOW SPIN CYTOCHROME P450 AGAINST TIME
—see
Cholesterol 100 yM, stock solution 2 mM in propylene glycol,
was added at time zero to low spin cytochrome ^50
c in a 1 ml
spectrophotometer cuvette. Cytochrome 1>^^®SCC concentration
was 1.7 nmoles/ml in 10 mM potassium phosphate buffer pH 7.4.
The reaction temperature was 20°C and the Type 1 spectral change
was followed with time.
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Fig. 4.9. A FIRST ORDER PLOT OF THE REACTION OF CHOLESTEROL
WITH LOW SPIN CYTOCHROME P450
sCC
The data is taken from Fig. 4.8 and plotted as a first order
reaction with respect to (Af-At); the difference between final
absorbance change Af and that at time t, At. From the relationship
1c •
slope — ; the first order rate constant was calculated
Z • JUJ
-4 -1
k = 7.5 x 10 sec . First order kinetics were observed for 85%
of the absorbance change.
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Fig. 4.10. THE EFFECT OF POTASSIUM CHLORIDE ON THE RATE OF
CHOLESTEROL INDUCED LOW TO HIGH SPIN STATE CHANGE OF CYTOCHROME P450
scc
Cholesterol (final concentration 100 pM), stock solution 2 mM in
propylene glycol, was added at time zero to a 1 ml spectrophotometer
cuvette containing low spin cytochrome P450gcc and the absorbance change
(385-420 nm) recorded with time. The cytochrome P450 concentrations oc
was 2.1 nmoles/ml in 50 mM Tris hydrochloride buffer pH 7.0 at the
reaction temperature of 20°C. Potassium chloride was added 5 mins
prior to the addition of cholesterol. The first order rate constants
were calculated and the constants plotted against potassium chloride
concentrations.
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stimulatory pattern of the divalent ion, calcium.
Effect of Calcium Chloride on the Rate of Cholesterol Binding to
Cytochrome P450—1L see
The Type I spectral changes induced by the addition of
saturating amounts of cholesterol to low spin cytochrome P450gcc
were observed with time in the presence and absence of calcium
chloride (Fig. 4.11). The first order rate constants were
calculated and the relationship to concentration of calcium chloride
shown in Fig. 4.12. Maximal increase in the first order rate constant
was noted at about 1 mM calcium chloride concentration. No increase
in the first order rate constant of the association of cholesterol
with low spin cytochrome P450 was noted in the presence of
SCO
magnesium or manganese chloride. A similar specificity for calcium
ions was noted by Mason et al. (1978b) for the stimulation of
pregnenolone production in intact mitochondria.
Effect of Temperature on the Rate of Cholesterol Binding to
Cytochrome P450
— see
First order rate constants of cholesterol induced low to high
spin state change were determined as previously described over the
range 4-37°C. The influence of temperature on the reaction velocity
_£ /RT
can be expressed in the form of the Arrhenius equation, k = Ae
—E /RT
where k is the reaction rate, e is the Boltzman factor, A is a
constant and E is the activation energy of the reaction. The logarithmic
E
form of the equation, log k - log A = „ oTTtp? requires a plot of log k
J— • Jlvl
against I/T to be linear with a gradient equal to E/2.303RT. A plot
of the logarithm of the first order rate constants against the reciprocal
of the absolute temperature is linear (Fig. 4.13) and the calculated
activation energy E = 88 kJ mole The activation energy of the low
to high spin state equilibrium of cytochrome in intact rat adrenal
MINS.
Fig. 4.11. THE EFFECT OF CALCIUM CHLORIDE ON THE RATE OF CHOLESTEROL
INDUCED LOW TO HIGH SPIN STATE TRANSITION OF CYTOCHROME P450
see
Cholesterol (final concentration 100 yM) stock solution 2 mM in
propylene glycol, was added at time zero to a 1 ml spectrophotometer
cuvette containing low spin cytochrome and the absorbance
change (385-420 nm) recorded with time. . The cytochrome P450gcc con¬
centration was 1.75 nmoles/ml in 50 mM Tris hydrochloride buffer
pH 7.0 containing 100 mM potassium chloride. The reaction temperature
was 20°C. Calcium chloride was added to a 1 mM concentration 5 mins
prior to the addition of cholesterol and the consequent spectral
changes with time represented by the upper curve. The control reaction
without calcium chloride is represented by the spectral changes
shown in the lower curve. The first order rate constants in the
presence of calcium chloride was 11.4 x 10 and in the absence of
calcium chloride 7.0 x 10
CALCIUM CHLORIDE CONCENTRATION mM
Fig. 4.12. THE EFFECT OF CALCIUM CHLORIDE CONCENTRATION ON THE
FIRST ORDER RATE CONSTANT OF CHOLESTEROL INDUCED LOW TO HIGH SPIN
STATE TRANSITION OF CYTOCHROME P450
see
Cholesterol (final concentration 100 yM), stock solution 2 mM
in propylene glycol, was added at time zero to a 1 ml spectrophotometer
cuvette containing low spin cytochrome P450 and the absorbanceSCO
change (385-420 nm) recorded with time. The cytochrome
concentration was 1.07 nmoles/ml in 20 mM Tris hydrochloride buffer
pH 7.0 at the reaction temperature 20°C. Calcium chloride, stock
solution 1 M in distilled water, was added 5 mins prior to the
addition of cholesterol. The first order rate constants were
calculated and plotted against calcium chloride concentration.
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Fig. 4.13. THE RELATIONSHIP OF THE LOGARITHM OF THE FIRST ORDER
RATE CONSTANT OF CHOLESTEROL INDUCED LOW TO HIGH SPIN STATE TRANSITION
OF CYTOCHROME P450 TO THE RECIPROCAL OF THE ABSOLUTE TEMPERATURE
sCC —— —
The concentration of low spin cytochrome P450scc was 1.7 nmoles/ml
in 10 mM potassium phosphate buffer pH 7.4 with 1 mM EDTA and
cholesterol was added at time zero. The temperature of reaction T
was varied over the range 4-37°C. The absorbance change (385-420 nm)
was recorded with time and the first order rate constant k calculated
for a particular temperature. The plot of log k against I/T is
linear with a gradient of E/2.303R. The activation energy calculated
from this plot was 88 kJ mole ^.
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mitochondria has been reported as 63 and 76 kJ mole ^ (Paul et al.
(1976); Jefcoate (1977)).
Monohydroxylated Cholesterol Analogues
Cholesterol analogues with single additional substituents at
various positions on the sterol molecule have been compared with
cholesterol with regard to their ability to induce a low to high spin
state change on substrate depleted cytochrome P450 . The mon-
SCO
hydroxylated sterols can be classified according to the position of
the hydroxyl substituent; side chain monohydroxylated sterols (26-,
25-, and 24-hydroxycholesterols); nuclear monohydroxylated sterols 7a,
76 and 19-hydroxycholesterols. Monohydroxylated cholesterols were
added in saturating equal amounts at time zero to a low spin substrate
depleted preparation of cytochrome P450 . The absorbance change
see
(absorbance 385 nm minus absorbance 420 nm) was plotted against time
(Fig. 4.14). Maximal absorbance changes were recorded for each
cytochrome P450gcc-sterol complex at equilibrium, 15 hrs at 20°C, and
the percentage low to high spin state change calculated using an extinction
coefficient 110 mM ^ (Peterson (1971), for the Type I spectral change.
First order rate constants were calculated for each sterol analogue
based on the maximal absorbance change induced by that sterol at equil¬
ibrium (Table 4.2). Initial rates of absorbance for each sterol were
calculated and expressed as absorbance change (absorbance 385 nm minus
-2 . -1
absorbance 420 nm) x 10 min
DISCUSSION
The interpretation of the association of sterols with partially
purified cytochrome P450 and the extrapolation of the data to
SCO
cytochrome P450 within the mitochondrial membrane must be made withJ
see
caution. However the study of partially purified preparations of










Fig. 4.14. A PLOT OF ABSORBANCE CHANGE (385-420 nm) ON ADDITION OF
STEROLS TO LOW SPIN CYTOCHROME P450 AGAINST TIME
see
Sterols (final concentration 100 yM) , stock solutions 2 mM in
propylene glycol, were added at time zero to low spin cytochrome
P450 in a spectrophotometer cuvette. Cytochrome P450 concen-
see sec
tration was 4.8 nmoles/ml in 50 mM potassium phosphate buffer pH 7.4.
The reaction temperature was 20°C and the absorbance change was
followed with time after the addition of a sterol. The examples
shown are cholesterol ■ a ; a monohydroxylated side chain sterol,
26-hydroxycholesterol 0 0 and a monohydroxylated nuclear sterol,
7a-hydroxycholesterol • • .
TABLE4.2Spectralpropertiesfthin e actionmonohydroxylatedholesterolanal guesw hl w spincytochromeP450 see Sterols(100yM)finalconcentration)w readdedtimz olcuv t eso t iningl w spinsubstratesdepletedcytochromeP450.4.8nmol /mladet rmin dyhc rbononoxi esee differencesp ctrum.Cytochro e^50wassuspendedmMpotas iumpho phateb ff rH7.4, 1mMEDTAandthereactiontemperaturew s20°C.Theabsorba cech ng(385-420m)w splott d againsttime.M ximalabsorbancechangforster l-cytochromeP450gccinter cti nw se orded atequilibrium,15hrst20°Candthepercentagelowoighsp ntatch ninducedbytst rol calculatedusingnextinctioncoeff cie tf110mM''" m(̂P t rs n971))f rtypchange. Firstorderratconstantswerealculatedu ingthmaximalb orba cech ginducbye chs ol. SterolFirstOrder RateCons ant Rx10~^sec~lAbsorbance (385minus420nm) atEquilibriumInitialRate
Absorbance
Changex10~^min~-*-





































bound cytochrome P450 may allow an examination of the effects of
s cc
other membrane components on this haemoprotein. This preparation
of partially purified cytochrome P450 retains features similar
scc
to those observed on cytochrome P450 within the mitochondrial
see
membrane.
The optical changes induced by cholesterol and cholesterol
analogues on substrate depleted cytochrome P450gcc are similar to
those observed on addition of camphor to cytochrome
(Gunsalus et al. (1972); Peterson (1971)), and are interpreted as
a low to high spin state transition of the haemoprotein (Tsai et al.
(1970). The association of substrate to ferric cytochrome P450 is
considered to be the initial event in the catalytic turnover of the
haemoprotein (Estabrook et al. (1972)).
The first order rate constant of cholesterol induced low to high
spin state transition of partially purified cytochrome
-4 -1
k = 7.5 x 10 sec , a similar value was obtained for cholesterol
association to cytochrome P45C>scc in intact mitochondria (Mason et al.
(1978a)). Cholesterol association with cytochrome P450gcc, in terms
of a low to high spin state change is slow both in intact mitochondria
and in this partially purified preparation when compared with the
first order rate constant of 7000 sec ^ for camphor binding to
cytochrome (Gunsalus et al. (1972)). The importance of
the cholesterol side chain cleavage reaction as a rate limiting event
in steroidogenesis has been emphasised by Stone and Hechter (1954) and
is directly or indirectly under the influence of ACTH which may act
indirectly on intramitochondrial movement or binding of cholesterol
to cytochrome P450 (Mason et al. (1978a); Simpson et al. (1978)).
see
Potassium chloride appears to inhibit the cholesterol induced low
to high spin state transition of cytochrome P450scc> The results
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suggest that at least two inhibitory processes are involved and that
the effect with the lower value is antagonised by cholesterol.
The effect of potassium chloride on camphor binding to cytochrome
P450 is to lower the spectral dissociation constant (Peterson (1971)).
Calcium ions were found to increase the rate of association of
cholesterol to partially purified cytochrome P450 as measured by
see
the low to high spin state change of the haemoprotein. Simpson et al.
(1974) observed, in rat adrenal mitochondria, an increase in the Type I
spectral change with substrates of cholesterol side chain cleavage in
the presence of calcium ions. Mason et al. (1978b) propose that calcium
ions and certain basic proteins and peptides alter the lipid phase
separation of mitochondrial membrane resulting in displacement of
cholesterol to a site nearer the cholesterol desmolase enzyme system.
A similar mechanism could operate in the calcium ion stimulation of
the rate of cholesterol association with partially purified cytochrome
P450 as the preparation has trace phospholipid as contaminant,
see
Mason et al. (1978a) propose that sterols with non-polar alkyl
side chains like cholesterol approach the active site of the sterol
desmolase in intact mitochondria in a different manner to sterols with
polar side chains. These observations have been extended to the
spectral interactions of side chain, nuclear and nuclear angular methyl
monohydroxylated cholesterol analogues with partially purified cytochrome
P450 . The first order rate constants of association of the side
see
chain monohydroxylated sterols (24-, 25-, and 26-hydroxycholesterol)
to cytochrome P450 are similar but differ from that of cholesterol
see
(Table 4.2), and the nuclear monohydroxylated sterols (7a, 78 and 19
hydroxycholesterols). This may indicate different patterns of association
of these groups of sterols with cytochrome P450gcc.
61.
The maximal absorbance change induced by a sterol on cytochrome
P45C>scc is sensitive to minor variation in the position of the hydroxyl
group within the molecule and to optical isomers of the hydroxyl
substituent at the same site. In the case of the side chain mono-
hydroxylated sterols, the maximal absorbance change is of the pattern
24- > 26- > 25-hydroxycholesterol. The configuration of the hydroxyl
group at C7 show that 7g-hydroxycholesterol induces a maximal absorbance
change greater than 7a-hydroxycholesterol.
The initial velocities of sterol induced absorbance changes with
cytochrome P450 are shown in Table 4.2 and the rates derived for
see
the side chain monohydroxylated sterols show an order 24- > 26- > 25-
hydroxycholesterol > cholesterol, a pattern which agrees with the rates
of enzymatic activity for these sterols (Mason et al. (1978a)).
However if this association between spectral changes and enzymatic
activity is retained at equilibrium, the pattern of activity predicted
from the spectral data would be cholesterol > 24- > 26- > 25-hydroxy¬
cholesterol. The further correlation of spectral perturbations
induced by sterols on cytochrome P450gcc and the enzymatic activity of
the cytochrome P450 -sterol complex is in progress.
SCO
SUMMARY
The absorption maximal of low spin, cholesterol depleted cytochrome
P450 are 416, 535 and 568 nm; addition of cholesterol results in
see
the formation of a high spin cytochrome P450 -cholesterol complex and
see
a decrease in absorbance at 416 and 568 nm, an increase in absorbance
at 392 and 648 nm with isosbestic points at 406, 457, 533 and 588 nm.
The affinity of cholesterol binding to cytochrome has
been determined from the spectral dissociation constant Ks. The
spectral dissociation constant is related to the concentration of cytochrome
P450 ; the equilibrium constant for cholesterol association is K .- =
see equil
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0.43 ± 0.03 x 10^ M ^ in 10 mM potassium phosphate buffer pH 7.4 at
20°C. Potassium chloride appears inhibitory to cholesterol induced
low to high spin state change of cytochrome P450
see
The first order rate constant of cholesterol association with
• ~~4 ""X o •
cytochrome P450 is k = 7.5 x 10 sec at 20 C and is decreased
. see
by the presence of potassium chloride and increased by calcium
chloride. The activation energy for the first order rates of chole¬
sterol association to cytochrome P450 is 88 kJ mole ^.
see
The first order rate constants of association of side chain
monohydroxylated sterols (24-, 25- and 26-hydroxycholesterol) to
cytochrome P450 are similar to one another but differ from that
see
of cholesterol, or the nuclear monohydroxylated sterols, 7a and 78 -
hydroxycholesterol and 19-hydroxycholesterol. The maximal absorbance
change induced and the initial rate of association however is dependent
on minor variations in the position of the hydroxyl group within the
sterol and to the optical isomers at the same site.
63.
CHAPTER 5
REDUCTION AND OXYGENATION OF THE CYTOCHROME P450 -CHOLESTEROL COMPLEX
gCC
INTRODUCTION
The reduction of oxidised cytochrome indicates that one
electron is accepted per haem group in this reaction whether the natural
electron donor (Gunsalus et al. (1972)) or an artificial donor is used
(Peterson (1971)). However determination of the stoicheiometry of
reduction of purified rat liver microsomal P450 fraction LM2 suggested
that two electrons per haem were accepted (Guengerich et al. (1975))
although potentiometric measurements by the same authors gave a value
of n = 1 (van der Hoeven et al. (1974)). Repetition of these experiments
using dithionite as reductant to rat liver microsomal cytochrome P450
fractions LM2 and LM4 and cytochrome showed that each of these
proteins accepted and donated one electron (Peterson et al. (1977)).
However the authors point out irreproducible values as high as n = 2
could still be obtained and that a lag phase occurred in the titration
curve with dithionite as reductant to purified rat liver microsomal
cytochrome P450 before stoicheiometric reduction was obtained. A more
recent report (Cooper et al. (1977)) titrating rat liver microsomes
with dithionite showed a stoicheiometry of n = 1 and no lag phase in
the reduction of cytochrome P450. In view of the above results and the
potentially higher electron equivalence for conversion of substrate to
product in the side chain cleavage of cholesterol to pregnenolone compared
to other cytochrome P450 dependent reactions; a study of the stoicheiometry
of reduction of oxidised cytochrome P450 was undertaken.
see
Gunsalus et al. (1972) and Estabrook et al. (1972) described a
spectral complex of molecular oxygen and ferrous cytochrome ^450^^ and
in the same year Estabrook et al. (1972) observed a spectral intermediate
in liver microsomes during the catalytic cycle which was ascribed to the
64.
oxygenated form of reduced cytochrome P450. The activation of molecular
oxygen by cytochrome P450 is crucial to our understanding of the chemical
nature of mixed function oxidation and in view of the potentially more
complex nature of the cholesterol side chain cleavage reaction, the
formation, autoxidation and hydroxylation reactions of oxygenated
cytochrome have been investigated.
RESULTS
Stoicheiometry of Reduction of Cytochrome P450
Cytochrome P450scc~cholesterol complex with catalytic amounts of
NADPH adrenodoxin reductase and adrenodoxin (Table 5.1), under an
atmosphere of carbon monoxide, was titrated with NADPH. The increase
in absorbance at 446 ran was followed as a function of time after each
addition of NADPH and the spectra recorded after no further change in
absorbance had occurred for a period of 15 min (Fig. 5.1). Under
these conditions reduction of cytochrome P450 -cholesterol complex
see
was slow taking 60 min to reach completion. These results plotted
as nmoles cytochrome P450gcc-cholesterol reduced against nmoles NADPH
added (Fig. 5.2) show the number of electrons accepted by cytochrome
P450 -cholesterol to be 1.02. Repetition with other preparations
see
of cytochrome P450 -cholesterol gives the number of electrons accepted,
see
standard deviation and number of experiments as 1.05 ± 0.04.
After complete reduction, the carbon monoxide complex of cytochrome
P450gcc-cholesterol has absorption maxima of 363, 446 and 550 nm and
isosbestic points to the ferric cytochrome P450scc~cholesterol form at
350, 425, 534 and 580 nm (Fig. 5.1).
The following observations were made during the reduction of low
spin, substrate depleted cytochrome P450gcc; the extent of reduction
was incomplete even at a ten-fold molar excess of NADPH; the rate of
reduction was slow and the titration curve showed no definite end point
(Fig. 5.3).
TABLE 5.1 Properties of cytochrome preparation
NADPH adrenodoxin reductase activity was measured by the method of
Omura et_ al_. (1966) and expressed as nmoles 2,6-dichlorophenolindophenol
reduced/min/nmole cytochrome P450.
















392 and 648 nm





less than 2% mitochondrial activity
200,000
cholesterol side chain cleavage
No llg hydroxylase activity detected.
TABLE 5.2 Comparison of the principal absorption bands in the
spectrum of oxygenated cytochrome P450scc~cholesterol
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Fig. 5.1. TITRATION OF CYTOCHROME P450 CHOLESTEROL COMPLEX WITH&
sCC
NADPH UNDER AN ATMOSPHERE OF CARBON MONOXIDE
Cytochrome P450 at a concentration of 12.25 nmoles/ml in
S GC
10 mM potassium phosphate buffer pH 7.4, 1 mM EDTA with cholesterol
added to 100 nmoles/ml was placed in an anaerobic spectrophotometer
cuvette, total volume 2.5 ml, and bubbled with oxygen free nitrogen
for 30 min; the cuvette was then bubbled with oxygen free carbon
monoxide for 15 min. The specific content of cytochrome P450 wasr
see
6.8 nmoles/mg protein. The sample was titrated with aliquots of an
anaerobic solution of NADPH and spectra recorded after each addition
when reduction was complete:
curve 1 - no addition of NADPH,
curve 2 - 2.14 nmoles/ml NADPH added,
curve 3 - 4.28 nmoles/ml NADPH added,
curve 4 - 6.62 nmoles/ml NADPH added,
curve 5 - 8.56 nmoles/ml NADPH added.
Fig. 5.2. RELATIONSHIP BETWEEN REDUCED CYTOCHROME P450 -CHOLESTEROL
——— sCC
COMPLEX AND AMOUNTS OF NADPH ADDED
The data was taken from Fig. 5.1 using the extinction coefficient
of 106 mM ^cm ^ (Gunsalus et^ al. (1972)) for the absolute spectrum
of the reduced carbon monoxide complex of cytochrome P450 at 446 nm.
16 -\
Fig. 5.3. RELATIONSHIP BETWEEN LOW SPIN SUBSTRATE DEPLETED CYTOCHROME
P450 AND AMOUNTS OF NADPH ADDED
sCC
The data were obtained by the method described in Fig. 5.2.
The cytochrome P450 concentration was 15.1 nmoles/ml and the data
emphasises the lack of definite end point of reduction and the molar
excesses of NADPH required to effect reduction.
65.
Oxygenated Cytochrome P450 -Cholesterol Complex
S CO
Cytochrome P450 -cholesterol was reduced, under anaerobic
see
conditions, with stoicheiometric amounts of sodium dithionite to
produce a ferrous form with absorption maxima at 411 and 545 nm.
Oxygenation of ferrous cytochrome P450 -cholesterol results in the
see
appearance of a spectral species with absorption maxima at 355, 418
and 555 nm. These spectral characteristics distinguish it from
other species of the enzyme with marked similarity to oxygenated
cytochrome (Gunsalus et al. (1972)) and other oxygenated
haemoproteins (Estabrook et al. (1972)) (Table 5.2).
Carbon Monoxide Interchange with Oxygen
The replacement of oxygen in the medium of the oxygenated
cytochrome P45C>scc-cholesterol complex by carbon monoxide is useful
to differentiate between a possible low spin ferric complex and that
of a ferrous-oxygenated species. In the former no development of
the characteristic red shift of the Soret band to 446 nm of the carbon
monoxide would replace oxygen as a ligand. The data in Fig. 5.4
confirms that carbon monoxide can replace oxygen from the oxygenated
complex.
Autoxidation of Oxygenated Cytochrome P450_t_c_-Cholesterol
In the absence of adrenodoxin, the oxygenated cytochrome P450scc~
cholesterol complex spontaneously oxidises to high spin ferric cyto¬
chrome P450gcc with isosbestic points at 409, 495, 535 and 596 nm
(Fig. 5.5). The autoxidation can be followed by the decrease in
absorbance at 418 nm (Fig. 5.6) and shows an exponential decay with
time. The decay of the oxygenated complex follows first order kinetics
in that a plot of the logarithm of absorbance at 418 nm, which corresponds
to the fraction remaining of the oxygenated complex, against time is
linear (Fig. 5.7). First order rate constants can be calculated from
350 400 450 500
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Fig. 5.4. REPLACEMENT OF OXYGEN FROM THE CYTOCHROME P450f see—
CHOLESTEROL-OXYGEN COMPLEX BY CARBON MONOXIDE.
Cytochrome P450scc concentration was 12.25 yM with 100 yM
cholesterol in 10 mM potassium phosphate buffer pH 7.4, 1 mM EDTA,
curve 1. The solution was reduced with a stoicheiometric amount
of dithionite, under anaerobic conditions, and when fully reduced
oxygenated with a bubble of oxygen to form the oxygenated complex
. The solution was then bubbled with 5 ml carbon monoxide
and the spectrum recorded, curve 2. Further addition of a grain
of sodium dithionite represents full development of the reduced
carbon monoxide complex, curve 3.
Fig. 5.5. THE AUTOXIDATION OF THE OXYGENATED COMPLEX OF CYTOCHROME
P450 -CHOLESTEROL COMPLEX
s cc
Cytochrome P450at a concentration of 12.5 yM with
100 yM cholesterol in 10 mM potassium phosphate buffer pH 7.4 was
reduced stoicheiometrically with sodium dithionite solution.
The solution was oxygenated with a bubble of oxygen and the spectrum
recorded (1) 5 sec after oxygenation. Repetitive scans were made
at (2) 15 sec; (3) 45 sec; (4) 75 sec; (5) 90 sec and (6) 30 min.
The spectrum at 30 min was identical to the original ferric enzyme.
The temperature of reaction was 4°C.
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Fig. 5.6. THE AUTOXIDATION OF OXYGENATED CYTOCHROME P450 WITH
-see
TIME AS FOLLOWED BY THE CHANGES IN ABSORBANCE AT 418 nm
A solution of 10 yM cytochrome P450 , with cholesterol added
S CO
to 100 yM, in 10 mM potassium phosphate buffer pH 7.4, 1 mM EDTA
was made anaerobic in a spectrophotometer cuvette as described in
Methods. The solution was reduced with a stoicheiometric amount
of sodium dithionite (stock solution 50 niM in anaerobic 10 mM
potassium phosphate buffer pH 7.4) and the extent of reduction was
observed by the decrease in absorbance at 390 nm until maximal and
constant with time. The absorbance of reduced cytochrome P450
see
at 418 nm was then monitored (curve A); the solution was then
oxygenated with a bubble of oxygen (point B); the absorbance
increased with the formation of the oxygenated complex (curve C)
and the subsequent exponential decay to the ferric form observed
with time (curve D) . The temperature of the reaction was 4°C.
0-" 1 1 I I
o 50 100 150 200
SECS.
Fig. 5.7. THE AUTOXIDATION OF OXYGENATED CYTOCHROME P450 AS A°
see—■
PLOT OF LOGARITHM ABSORBANCE AT 418 nm, WHICH CORRESPONDS TO THE
FRACTION REMAINING OF OXYGENATED COMPLEX, VERSUS TIME
The data is taken from the decay curve as shown in Fig. 5.6.
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this plot using the expression slope = ^ ■■ . The order of decay
is confirmed by the first order rate constants being independent of
the initial concentration of oxygenated cytochrome P450 -cholesterol
s oo
complex and that the initial rate of decay of the complex is proportional
to the concentrated of the complex (Fig. 5.8). The rate of decay is
constant between preparations with a first order constant, k = 9.3 x
10 ^ ± 0.26 x 10 ^ sec ^ at 4°C.
Factors Influencing Autoxidation of Oxygenated Cytochrome P450^cc
a) pH
The effect of pH, at constant ionic strength and temperature, observed
on the first order rate constant of autoxidation of oxygenated cytochrome
P450 -cholesterol complex is shown in Fig. 5.9. The influence of pH
S CO
in the range pH 8.0-7.0 is minimal but below pH 7.0 a marked effect of
pH on the first order rate of autoxidation of oxygenated cytochrome
P450 -cholesterol exists. The influence of pH below 6.0 was not
see
observed in view of increasing insolubility of cytochrome as
approaches its isoelectric point. Similar observations of pH dependence
of first order rate constants have been made on cytochrome
(Peterson et al. (1972); Lipscomb et al. (1976)).
b) Temperature
First order rate constants of autoxidation of oxygenated cytochrome
P450 -cholesterol were determined over the temperature range 4-25°C
see
in 10 mM potassium phosphate buffer pH 7.4 and the logarithm of k plotted
against the reciprocal of absolute temperature (Fig. 5.10). The
activation energy of autoxidation of cytochrome P450 -cholesterolsee
complex is 75 kJ mole ^. The hydroxylated sterols, 25- and 26-hydroxy-
cholesterol induce low to high spin state changes in cytochrome P450s cc
and on anaerobic reduction and subsequent oxygenation form stable
oxygenated complexes. The activation energies of autoxidation of the
o 4 8 12
CONCENTRATION CYTOCHROME P450 jiM
Fig. 5.8. RELATIONSHIP BETWEEN INITIAL VELOCITY OF AUTOXIDATION
AND CONCENTRATION OF OXYGENATED CYTOCHROME P450 -CHOLESTEROL COMPLEX
SCC ;
A stock solution of 15 yM cytochrome P450scc, with cholesterol
(100 yM), was diluted to appropriate concentrations with 10 mM
potassium phosphate buffer pH 7.4, 1 mM EDTA. The solutions were
made anaerobic in a spectrophotometer cuvette as described in
Methods and reduced with stoicheiometric amounts of NADPH; stock
solution 10 mM in 0.5% sodium bicarbonate. The extent of
reduction was observed by the decrease in absorbance at 392 nm and
followed until maximal and constant with time. The solutions were
oxygenated with a bubble of oxygen and the absorbance at 418 nm followed
with time. The initial velocity was calculated from the plot and
the initial concentration of oxygenated cytochrome P450scc~cholesterol
complex calculated from the absorbance 418 nm at time zero using an
-1 -1
extinction coefficient of 62 mM cm . The temperature of reaction
was 4°q
40
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Fig. 5.9. THE EFFECT OF pH, AT CONSTANT IONIC STRENGTH AND TEMPERATURE,
ON THE FIRST ORDER RATE CONSTANT OF AUTOXIDATION OF OXYGENATED
CYTOCHROME P450 -CHOLESTEROL COMPLEX
scc
First order rate constants were determined as in Figs. 6 and 7
on a 10 yM solution of cytochrome P450gcc, with cholesterol added
to 100 yM, at constant ionic strength 0.1 y and temperature 4°C
but variation in pH between 6.2 and 8.0.
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Fig. 5.10. A PLOT OF THE LOGARITHM OF THE FIRST ORDER RATE
CONSTANTS OF THE AUTOXIDATION OF THE OXYGENATED CYTOCHROME P450
scc
STEROL COMPLEX (log k 10~3) VERSUS THE RECIPROCAL OF ABSOLUTE
TEMPERATURE (I/T x 1Q3 "k"1).
First order rate constants were determined as in Figs. 5.6
and 5.7 on a 10 yM solution of cytochrome P450gcc, with sterol added
to 100 yM, in 10 mM potassium phosphate buffer pH 7.4 with 1 mM
EDTA. The temperature was varied over the range 4 to 20°C.
The plot of log k against I/T is linear with a gradient of E/2.303R.
The activation energy was calculated from this plot. The sterol
ligand to cytochrome P450 was varied: 10 yM cytochrome
SOC-
P450 with 100 yM cholesterol; 10 yM cytochrome P450
see scc
with 100 yM 25~hydroxycholesterol and 10 yM cytochrome
P450gcc with 100 yM 26-hydroxycholesterol.
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oxygenated complexes are not significantly different for 25-hydroxy-
cholesterol and 26-hydroxycholesterol at 76 and 75 kJ mole * respectively.
The first order rate constants for the autoxidation of oxygenated
-3 -1
cytochrome P450 -hydroxycholesterol complexes are 10 x 10 sec
see
_3 ^ ^
and 18 x 10 sec at 4 C for 25-hydroxycholesterol and 26-hydroxy¬
cholesterol respectively.
c) Ionic strength
Variation of ionic strength and the effect of ionic strength on
the first order rate constants of autoxidation was investigated at
constant pH and temperature. Potassium chloride was added to cyto¬
chrome P450scc~cholesterol complex in 10 mM potassium phosphate
buffer pH 7.4 and the first order rate constants of autoxidation of
the oxygenated complex determined over the range 0.012-0.6 p. The
autoxidation of oxygenated cytochrome P450scc~cholesterol shows
limited dependence on ionic strength (Fig. 5.11). Similar results
can be obtained by adding sodium chloride.
d) Hydrogen peroxide
Titration of ferric cytochrome P450 -cholesterol complex under
see
anaerobic conditions with hydrogen peroxide up to concentrations of
10 mM caused no spectral perturbation of the high spin state.
However addition of hydrogen peroxide in stoicheiometric amounts to
ferrous cytochrome P450 caused an immediate oxidation of the ferrous
see
to the ferric state. Addition of hydrogen peroxide accelerates the
autoxidation of the oxygenated cytochrome P450 -cholesterol complex.
see
Hydrogen peroxide added simultaneously with oxygen to ferrous cytochrome
P450 allowed calculation of first order rate constants of autoxidation
see
of oxygenated cytochrome P450scc"cholesterol complex (Fig. 5.12). In
the example shown with a concentration of 10 pM cytochrome P450 -see
cholesterol; hydrogen peroxide, a concentration of 225 pM, accelerated
IONIC STRENGTH /i
Fig. 5.11. VARIATION OF IONIC STRENGTH AND THE EFFECT ON FIRST
ORDER CONSTANTS OF AUTOXIDATION OF OXYGENATED CYTOCHROME P450
see
Ionic strength was varied by addition of aliquots of potassium
chloride as described in text and the first order constants determined
as in Figs. 6 and 7. The concentration of cytochrome P450 wassee
10.2 nmoles/ml in 10 mM potassium phosphate buffer with cholesterol
added to 100 nmoles/ml and the temperature of reaction was 4°C.
HYDROGEN PEROXIDE fiM
I
_ . _ _ 1 1
Fig. 5.12. EFFECT OF HYDROGEN PEROXIDE ON THE FIRST ORDER RATE




^ at 10.1 yM, with cholesterol added to 100 yM,
in 10 mM potassium phosphate buffer pH 7.4, 1 mM EDTA and under an
atmosphere Of nitrogen was reduced stoicheiometrically with NADPH.
The cytochrome was oxygenated with a bubble of oxygen and a solution
of hydrogen peroxide was simultaneously added; stock solution of
hydrogen peroxide 7.6 mM in oxygen free 10 mM potassium phosphate
buffer pH 7.4. First order rate constants of autoxidation were
determined as in Figs. 5.6 and 5.7 and plotted against concentration
of hydrogen peroxide added. The temperature of reaction was 4°C.
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the decay by a factor of two. The low reactivity of hydrogen
peroxide with the oxygenated cytochrome P450 -cholesterol complexsee
suggests a small rate constant for cytochrome P450 deoxygenation for
otherwise hydrogen peroxide which reacts rapidly with reduced cytochrome
P450 would accelerate markedly the conversion to the oxidised form,
e) Catalase
Inclusion of catalase during the reduction/oxygenation cycle of
cytochrome P450 -cholesterol complex prolongs the stability of thesee
oxygenated form. Relatively high catalase activity is required to
observe this effect and the maximal decrease in the autoxidation rate
plateaus at around 30% (Fig. 5.13). These results suggest that hydrogen
peroxide is produced during the autoxidation of oxygenated cytochrome
P450 and the peroxide oxidises in part the reduced cytochrome P450
see see
Detection of Hydrogen Peroxide During the Autoxidation of the Oxygenated
Complex of Cytochrome P450_^c-Cholesterol Complex
The method of Loschen et al. (1971) was used to continuously
monitor hydrogen peroxide production during the autoxidation of oxygenated
cytochrome P450 -cholesterol complex. Simultaneous parallel experiments
SCO
observing the absorbance decrease of the 418 nm band of the oxygenated
complex and the fluorescence emission of scopoletin were made. No free
hydrogen peroxide was detected.
Similarly the sampling method of Hildebrandt and Roots (1975)
taking aliquots of cytochrome P450gcc solution during the decay of the
oxygenated complex failed to detect free hydrogen peroxide.
Although no spectral complex was observed between hydrogen peroxide
and oxidised cytochrome P450 -cholesterol complex, the measurements of
see
catalase like activity in the preparation by the method of Aebi (1974)
showed an activity of 200-300 nmoles hydrogen peroxide consumed/nmole
cytochrome P450/min. This activity could explain the lack of free
10
Fig. 5.13. THE EFFECT OF CATALASE ON THE FIRST ORDER RATE CONSTANT
OF AUTOXIDATION OF OXYGENATED CYTOCHROME P450 -CHOLESTEROL COMPLEX
sCc
Cytochrome P450 concentration was 10.0 yM, with added cholesterol
100 yM, in 10 mM potassium phosphate buffer pH 7.4. A 2.5 ml solution
was reduced anaerobically, oxygenated and the first order rate constant
of autoxidation determined as previously described. The reaction
temperature was 4°C. Catalase activity per incubation is expressed
in international units.
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hydrogen peroxide during the decay of the oxygenated complex.
Detection of Superoxide Anion During the Autoxidation of the Oxygenated
Complex of Cytochrome P450J- see
The detection of superoxide anion as a decay product of the
oxygenated cytochrome P450scc~cholesterol complex was investigated.
Indirect methods were used, based on changes in absorption spectra
of radical scavenging chromophores and the inhibition of these changes
by superoxide dismutase. The ideal scavenger should not react
chemically with cytochrome P450, it should have a large extinction
difference on reaction and should have a maximal absorption change at
an isosbestic point of oxidised and oxygenated cytochrome P450.
Cytochrome c, the most commonly used agent (McCord and Fridowich
(1969)) is reduced by ferrous cytochrome P450 (Tyson et al. (1972)).
Adrenalin is converted to adrenochrome by superoxide anion (Misra and
Fridowich (1972)) and has a maximal absorption at 480 nm but a low
extinction coefficient at the isosbestic point of cytochrome P450 at
494 nm. Tetranitromethane is reduced to the nitroform anion by the
superoxide radical (Beauchamp and Fridowich (1971) and has a maximal
absorption at 350 nm. However tetranitromethane reacts with cytochrome
P450 to form an amide complex. Similar reactions were observed with
nitroblue tetrazolium used by Fridowich (1974) as an indicator of
superoxide anion production.
Determination of Cholesterol Oxidation Products During the Autoxidation
of Oxygenated Cytochrome
The experimental evidence for the absence of formation of oxidative
products of cholesterol during the autoxidation of oxygenated cytochrome
P450gcc will be presented in Chapter 6. It is sufficient at this stage
to discount cholesterol as a possible electron acceptor from the
oxygenated complex of cytochrome P450gcc.
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DISCUSSION
In the reduction of purified cytochrome P450 one electron is
vAn
accepted per haem (Gunsalus et al. (1972); Peterson (1971)). The
stoicheiometry of reduction of purified rat liver microsomal cytochrome
P450 suggested two electrons accepted per haem (van der Hoeven et al.
(1974)) repetition of the titrations (Peterson et al. (1977)) and results
from liver microsomal studies (Cooper et al. (1977)) give a value of
one. The evidence presented suggests that cytochrome P450gcc-
cholesterol is a one electron acceptor. The observations made on
reduction of low spin, substrate depleted cytochrome P450s^c may
indicate a change in redox potential on binding cholesterol similar to
that described for cytochrome P450 (Gunsalus et al. (1973)).
The absorption spectrum of cytochrome P^50gcc shows a similarity
to that described for the oxygenated complex of cytochrome
(Gunsalus et al. (1972)) and to other oxygenated haemoproteins
(Estabrook et al. (1972)). The oxygenated complexes of cytochrome
P450 and cytochrome P450 show similar patterns of stability to
LAM. SCC
pH changes (Peterson et al. (1972); Lipscomb et al. (1976)) variations
in ionic strength (Peterson et al. (1972)), changes in temperature
(Lipscomb et al. (1976)) and minor modifications in substrate structure
(Lipscomb et al. (1976)). However oxygenated cytochrome P450gcc is
more rapidly autoxidised than cytochrome (Peterson et al. (1972);
Lipscomb et al. (1976)). Interspecies variation of structure, as in
the case of oxyhaemoglobins with differing rates of autoxidation,
may be an intrinsic cause of this difference in rate. However the purity,
as expressed in nmoles cytochrome P450/mg protein, is less in the cytochrome
P450 preparation compared to that of cytochrome P450 as described
SCC LAT1
by Lipscomb et al. (1976) and Peterson et al. (1972). This leaves the
possibility of redox acceptors or modifiers unknown influencing the
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autoxidation rate as the non-haem iron contents of these different
cytochrome preparations are comparable. The rate of autoxidation
of oxygenated cytochrome P450 -camphor complex quoted by Lipscomb
-3 -1
et al. (1976) is 2.5 x 10 sec and that by Peterson et al.
*~4 ""1 o • • • • •
3.4 x 10 sec at 4 C. The reasons for this wide variation in
rate for a similar enzyme are unkown at this time.
The spectral correlations of the oxygenated form of reduced
cytochrome P450 from liver microsomes to other oxygenated proteins
in particular cytochrome P450 and P450 is less clear.
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Estabrook et al. (1972) described a spectral intermediate in the
catalytic cycle of cytochrome P450 which required oxygen, NADPH, and
a Type I hydroxylatable substrate with absorption maxima in the
difference spectrum of 440 and 590 nm, correcting for cytochrome b,.
absorption. Further evidence for the occurrence of an oxyferrous
complex in liver microsomes came from Rosen et al. (1973) who showed
by flash photolysis experiments that oxygen and carbon monoxide are
competitively bound to the cytochrome. Guengenich et al. (1976)
described, using purified liver microsomal cytochrome P450, that
during the steady state of enzymatic activity a spectral complex
was formed with difference maxima at 442, 560 and 588 nm similar to
that described by Estabrook et al. (1972). This spectral species
was named Complex II by the authors, was relatively stable with a
life of 5 mins before it decayed. The authors again described a
requirement for a Type I substrate whether benzphetamine, cyclohexane,
nitroanisole or hexobarbital; an NADPH source and molecular oxygen.
During rapid reaction studies with the same system the authors noted
another spectral complex with maxima in the difference spectra of 430
and 450 nm, Complex I in the terminology of Estabrook e_t aT. (1972)
which decayed rapidly in 10 msec to give Complex II. The Soret
maxima of the absolute spectra of purified liver microsomal
cytochrome P450 are useful for comparison to those of cytochrome
P450_,4Vf and P450 : P450 LM oxidised 418 nm; P450 LM reducedCAM see
414; P450 LM Complex I 423 nm and P450 LM Complex II 421 nm.
After complete reduction of cytochrome P450 by a slight excess
of NADPH under an atmosphere of carbon monoxide the spectrum shows
similarities to carbonmonoxy complexes of cytochrome P450 from
other sources, with absorption maxima at 368, 446, and 550 nm and
isosbestic points to the ferric high form at 350, 425, 471, 534 and
580 nm. The ratio of absorbance of the 446 nm Soret band to that
of the 550 nm band for the carbon monoxide complex of the reduced
form is 8.4 which corresponds well with a ratio of 8.2 for P450^^
(Gunsalus et al. (1972); 8.3 for the LM2 fraction of purified rat
liver microsomal P450 (Peterson et al. (1977) and values between 8
and 9 from previously published spectra of bovine adrenal mitochondrial
P450 (Takemori et al. (1975). Hanson and co-workers (1976) have
shown that the optical transition in the near U.V. region of the
carbon monoxy P450^^ spectrum at 363 nm has the same integrated
intensity as the Soret B (ir-ir*) band at 446nm. Using single crystal
spectroscopy they have shown that this U.V. band has the same
polarisation as the Soret band showing that this U.V. band has the
same symmetry. The total integrated intensity of the carbon monoxide
P450-,... bands at 446 and 363 nm is within 10% of the total integratedCAM
intensity observed within the same region for carbonmonoxyhaemoglobin.
However the near U.V. spectrum of this substance has only 40% of
the integrated absorption strength of the Soret band and is a N (it—it)
band. The authors conclude that these spectral observations are
consistent with P^O^,^ being classified as having a hyperporphyrin
structure according to the classification of Buchler (1975). A
73.
common spectral pattern exhibited by a number of hyperporphyrins is
two Soret bands one in the near U.V. 350-380 run region and a second
in the 440-480 nm region; a metal to porphyrin charge transfer
transition is responsible for the two Soret bands. The pattern of
two Soret bands is readily observable in cytochrome P450gcc carbon
monoxide complex (Fig. 5.1) however the near U.V. band is at slightly
longer wavelength, 368 nm, that that reported for cytochrome P^SO^^,
363 nm (Hanson et al. (1976).
During steady state observation of catalytic turnover of
cytochrome! P^O^^ the dominant spectral species was the oxygenated
complex (Gunsalus et al. (1972). First order rate constants of
individual reactions of the same enzyme cycle shows that the second
electron reduction is the slowest; this reaction may control the
balance between autoxidation and hydroxylation pathways of the
oxygenated complex. The nature of the products of autoxidation of
the oxygenated complex is therefore of interest from consideration
of the structure of the oxygenated complex.
Detailed information on the structure of oxygenated cytochrome
P450 is lacking and one must reason on the basis of information known
from other oxygenated cytochromes. The nature of the ligands to the
iron centre of cytochrome P450 have similarities to those of oxyhaemo-
globin and oxymyoglobin except that the distal histidine is replaced
by a mercaptide anion in cytochrome P450 (Chevion et al. (1977).
On the basis of 0-0 infra-red stretching frequency, oxygen-metal
ion adducts can be subdivided into two classes; class I with 0-0
frequency of 1100 cm ^ called superoxides and class II adducts with
0-0 frequency of 840 cm ^ and called peroxides (Valentine (1973) .
When the stoicheiometry of the adducts is 1:1 the geometry of the bond
must be bent-end on, Fe-0 or cyclic, Fe^JL . Oxyhaemoglobin infra-red
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stretching frequencies suggest the former structure (Caughey et al.
(1975) .
In the light of the initial observation that the optical spectra
of oxyhaemoglobin and oxymyoglobin bear strong resemblance to those
of their respective hydroxy complexes it was suggested that the best
electronic description for oxygenated-haem complex is that of low
spin ferric iron bound to superoxide anion (Weiss (1964)). This
has been supported by X-ray fluorescence (Koster (1972)), Raman
spectroscopy and infra-red spectra of oxyhaemoglobin (Caughey et al.
(1975) . This evidence does not provide a distinction between an
3 -
ionic Fe 0^, produced by an electron transfer from iron to dioxygen
and a covalent Fe-0-0 produced by interactions between iron and
oxygen. The degree of electron density transferred from iron to
dioxygen significantly determines the properties of the complex.
If the proposed electronic structure of the oxy-haem complex is
that of ferric haem bound to superoxide anion, then the superoxide
anion should be able to dissociate as has been demonstrated for shark
and mammalian oxyhaemoglobin (Misra and Fridowich (1972); Wever et al.
(1973)) as well as cytochrome P450_._, (Sligar et al. (1974)). ThisCAM
does not mean that the superoxide is bound ionically in the original
oxygenated haem complex or that the haem iron is tri-positively
charged. The structure consisting of superoxide anion bound to low
spin ferric haem is only a 'best fit' and clearly other resonance forms
must exist.
2+ ^ 3+
Consider the equation Fe—0-0^— Fe—0-0 as implying charge
transfer from iron to oxygen, then a mechanism is suggested by which
transfer of more electron density oxygen affinity should be increased and
with less transfer of electron density oxygen affinity should be decreased.
By substitution of unnatural iron porphyrins these principles have been
shown for myoglobin and haemoglobin (Rossi-Fanelli and Antonini (1957);
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(Sogita and Yoneyama (1971)). Peisach (1975) has suggested that
the ring nitrogen of the proximal imidazole that is not liganded
to iron in haemoglobin is in a hydrophobic environment surrounded
by three leucines. The hydrophobicity of the environment governs
the state of protonation of the imidazole and affects the electron
density at the haem iron. The hydrogen bonded will have low affinity
for oxygen and vice versa for the non-hydrogen bonded. This
suggestion could explain the Bohr effect and the role of allosteric
modifiers to indirectly alter hydrophobicity of the proximal imidazole
environment.
Haemoglobin involvement as a catalyst of hydroxylation of aniline
in the presence of reducing equivalents and oxygen has been well
established (Juchau and Symms (1972); Symms and Juchau (1974);
(Mieyal et al. (1976)). It has been suggested that aniline increases
the hydrophobic character of the active site causing a shift in
electron transfer in favour of oxygen and consequently altering the
reactivity (Hieyal and Blumer (1976)). Similar speculations could
be made for cytochrome P450 where substrate binding, usually highly
aromatic or aliphatic in character, stabilise the oxygenated complex
(Lipscomb et al. (1976)).
The possible routes of autoxidation of oxygenated cytochrome
P450scc-cholesterol complex to the ferric state are shown in Fig. 5.14.
The dissociation of molecular oxygen leaving the haem in a ferrous
state requires the subsequent donation of an electron to either an
acceptor group in the protein moiety of the cytochrome, as has been
postulated in methaemoglobin formation, or to an acceptor external to
the cytochrome. The possibility of formation of the ferric state from
the oxygenated cytochrome complex by donation of both electron equivalence
and oxygen to the substrate cholesterol must also be considered.
+++
Fig. 5.14. THE POSSIBLE ROUTES OF AUTOXIDATION OF OXYGENATED
CYTOCHROME P450 -CHOLESTEROL COMPLEX TO THE FERRIC STATE
see
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However this latter route can be discounted by the failure to detect
oxidation products of cholesterol following the autoxidation of the
oxygenated cytochrome P450scc~cholesterol complex.
If superoxide anion is a product of the autoxidation of
oxygenated cytochrome P450 then the subsequent formation of other
reactive oxygen species must be considered. It has been suggested
that superoxide anion spontaneously dismutates (Kahn (1970);
Mayeda and Bard (1974)) to singlet oxygen''^ as in reaction 1 (Fig. 5.15).
The enzyme superoxide dismutase (McCord and Fridowich (1969) catalyzes
the dismutation of CT leading to the formation of ground state oxygen
(Kahn (1970) rather than'o^, reaction (2) (Fig. 5.15). In either case,
the spontaneous or enzyme catalysed dismutation of 0. leads to
2
hydrogen peroxide . It has been postulated that molecular oxygen
CT may react with H^O^ to Pr°duce hydroxyl radicals OH*via Haber-Weiss
reaction (Haber and Weiss (1934)), reaction (3) (Fig. 5.15). There is,
however, controversy concerning the possibility of this reaction under
physiological conditions (Fee and Bergamini (1975); Halliwell (1976)).
Direct evidence for OH-generated from reaction 3 has not been demonstrated.
Frequently its postulation is based on the inhibiting effect of both
superoxide dismutase and catalase on a specific reaction. It has been
suggested that under certain conditions, 0^ may react with to
form 0^ and OH. (Kellogg and Fridowich (1975)). Arneson (1970) has
proposed that *0^ may be generated from a reaction between 0/ and the
hydroxyl radical, as in reaction (4) (Fig. 5.15). This reaction has
not been demonstrated under biological conditions. Superoxide
radicals are known to dismutase to form peroxide and oxygen in an
excited singlet state. Chemiluminescence from singlet oxygen has been
observed, the major pathway for de-excitation being a dimeric relaxation
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Fig. 5.15. THE POSSIBLE REACTIONS OF THE SUPEROXIDE ANION
0^ superoxide anion; ^"O^ singlet oxygen; OH. hydroxyl
radical and OH hydroxyl anion.
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630 ran (Khan and Kaska (1970)).
The established chemical methods used in detection of superoxide
anion production during autoxidation of oxygenated cytochrome P450gcc
were not without significant side reactions and were insufficiently sensitive
to allow unequivocal detection of the superoxide radical. Free hydrogen
peroxide arising from the dismutation of superoxide anion could not be
detected owing to the presence of a peroxidase-like activity in the
preparation. The effect of catalase prolonging the presence of
hydrogen peroxide decreasing the stability of the oxygenated complex
of cytochrome P450gcc can only be taken as tentative evidence for the
production of hydrogen peroxide during the decay of this complex to
the ferric state. These initial experiments may indicate that a more
indirect approach to the nature of the iron-oxygen ligand should be
made. One possible approach would be the detection of chemiluminescence
during the autoxidation of cytochrome P450 and suggest that 60% of
the electron equivalence can be ascribed to the formation of the
superoxide anion. The use of spectroscopic methods similar to those
used in the investigation of the structure of oxyhaemoglobin or oxy-




Cytochrome P450scc-cholesterol is a one electron acceptor on
titration with NADPH.
Cytochrome P450scc~cholesterol can be anaerobically reduced to
the ferrous state which on oxygenation forms an oxygenated cytochrome
P450scc~ cholesterol complex. This oxygenated complex autoxidises,
in the absence of adrenodoxin, to ferric cytochrome P450scc~cholesterol
without oxidation of cholesterol. The decay of the oxygenated complex
is first order, k = 9.3 x 10 ^sec ^ at 4°C. The rate of autoxidation
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is influenced by pH, ionic strength and the nature of bound sterol.
The activation energy of autoxidation is 75 kJ mole
Investigations into the fate of the electron equivalence as
oxygenated cytochrome P450 -cholesterol complex autoxidises to
s cc
the ferric haemoprotein were initiated and attempts were made to
monitor hydrogen peroxide and superoxide anion generation.
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CHAPTER 6
PARTIAL RECONSTITUTION OF THE MONOXYGENASE ELECTRON TRANSPORT CHAIN
AND THE CATALYTIC TURNOVER OF CYTOCHROME P450n„„
■— — "~o LL
Introduction
Cytochrome ^50^^ ^ the terminal oxidase of the electron
transport chain associated with hydroxylation of camphor to exo-5-
hydroxy-camphor in Pseudomonas putida (Katagiri et al. (1968)).
This cytochrome has been purified and crystallised (Yu et al. (1974))
and a reaction cycle postulated (Gunsalus et al. (1972); Estabrook
et al. (1972)) for the catalytic turnover of the cytochrome to form
a monohydroxylated product.
However the conversion of cholesterol to pregnenolone, catalysed
by cytochrome P450 , appears to be a complex series of reactions
SCO
which may involve stable intermediates. Suggested intermediates are
(20S)-20-hydroxycholesterol (Shimizi et al. (1962)); (22R)-22-
hydroxycholesterol and (20R 22R)-20, 22-dihydroxycholesterol (Burstein
et al. (1975)); cholesterol-(20S)-20-hydroxyperoxide (Van Lierand Smith
(1970)) and 20,22-epoxycholesterol (Kraaipoel et al. (1975)).
This chapter reports the nature of the catalytic turnover cycle
of cytochrome P450gcc; the detection of intermediates in the conversion
of cholesterol to pregnenolone and the integration of those intermediates
into the catalytic cycle.
A variety of monohydroxylated side chain analogues of cholesterol
are metabolised to pregnenolone by adrenal mitochondria (Burstein and
Gut (1971); Mason et al. (1978a)). Similarly sterols retaining the
cholest-5-en-38~ol nucleus but with variable non-polar side chains are
also metabolised to pregnenolone in this system (Arthur et al. (1976)).
In the past cholesterol analogues as substrates for the side chain
cleavage reaction have been confined to variations in the side chain.
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Recently a nuclear di-hydroxylated sterol (7a-hydroxycholesterol)
has been shown to form a high spin complex with cytochrome P450
see
but has not been established as a substrate for the sterol side chain
cleavage reaction (Hume et al. (1979)).
Cytochrome can depleted of endogenous cholesterol
and this allows readdition of cholesterol of known specific radio¬
activity: cytochrome P450gcc+++ + cholesterol cytochrome P450+++ -
cholesterol.
Cytochrome *-s a one electron acceptor and this electron
can be introduced from a non-specific chemical donor: cytochrome P^+50^
cholesterol + le -* cytochrome P450 +-cholesterol.
see
Adrenodoxin is a one electron donor (Estabrook et al. (1973)) and
is required as donor and effector for the second electron introduced
into the oxygenated cytochrome P450scc-cholesterol complex.
Adrenodoxin can be reduced by non-specific chemical donors (Estabrook
et al. (1973)): oxidised adrenodoxin + le -> reduced adrenodoxin.
Hence stoicheiometric amounts of cytochrome P450 -cholesterol
see
complex to adrenodoxin and both artificially reduced with one electron
under anaerobic conditions should on subsequent oxygenation allow one
turnover of the catalytic cycle: reduced adrenodoxin + cytochrome P450
cholesterol + 0^ -*■ ^0 + oxidised adrenodoxin + cytochrome ^^^<->scc+++_
monohydroxylated cholesterol.
RESULTS
Single Cycle Turnover of Cytochrome P^50--c
14
Cholesterol, 74.8 nmoles with 0.1 yCi 4- C cholesterol was
added to 2.2 ml low spin cytochrome P450gcc (containing 17 nmoles
cytochrome P450scc/ml) and allowed to incubate 15 hr at 20°C.
Adrendoxin, 0.23 ml of stock solution 163 nmoles/ml was added so that
the molar ratios of the solution were cholesterol:cytochrome P450gcc:
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adrendoxin:::2:1:1.
The cytochrome P45C>scc-cholesterol complex with adrenodoxin
was reduced anaerobically with sodium dithionite added stoicheiometrically
to reduce the cytochrome and adrenodoxin. The reduction of cytochrome
P450 was observed by the decrease in absorbance at 390 nm and
see
when constant, the solution was oxygenated by bubbling rapidly with
5 ml oxygen. The solution was extracted with organic solvent and
thin layer chromatography performed. A radiochromatogram (Fig. 6.1)
of the thin layer plate showed a product (product A) with an value
0.64 compared to cholesterol 0.76 and that of pregnenolone R^ 0.51
in this solvent system. A minor radioactive product (product B)
was also noted with an R^ value of 0.39.
Mutliple Cycle Turnovers of Cytochrome P450
If the anaerobic stoicheiometric reduction of cytochrome P450-
cholesterol:adrenodoxin complex is repeated for a second time the
pattern of products changes (Fig. 6.2). The cycle can be repeated
many times and (Fig. 6.3) shows an experiment containing 7 cycles.
Expressing the products as a percentage conversion of the total
cholesterol added to the incubation, a pattern emerged suggesting
that the precursor-product relationship was of the type, cholesterol -*■
product A -* product B -> pregnenolone.
Precursor-Product Relationship
Product A was extracted from the silica gel of a thin layer plate
with chloroform:methanol 2:1 by vol and rechromatographed, reextracted
and shown to be a single radioactive species. This sample was added
to low spin, substrate depleted cytochrome P45C>scc reconstituted with
adrenodoxin and a single turnover cycle of reduction/oxygenation performed.
The resultant thin layer radiochromatogram showed conversion of product A
to produce B (Fig. 6.4). Similarly when product B was added to low
o
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Fig. 6.1. A THIN LAYER RADIOCHROMATOGRAM OF PRODUCTS FORMED AFTER A
SINGLE CYCLE OF REDUCTION - OXYGENATION OF (4-14C)-CHOLESTEROL-
CYTOCHROME P450 -ADRENODOXIN COMPLEX
see
Peaks of radioactivity corresponding to cholesterol, product A
and product B are shown. Pregnenolone, R^ 0.51 in this system, had a
mobility between product A and product B. The cytochrome complex
was extracted and chromatography performed as described in Methods.
Origin: 0
Fig. 6.2. A THIN LAYER RADIOCHROMATOGRAM OF PRODUCTS FORMED AFTER
TWO CYCLES OF REDUCTION-QXYGENATION OF (4~14C)-CHOLESTEROL-CYTOCHROME
P450 -ADRENODOXIN COMPLEX
see
Peaks of radioactivity corresponding to cholesterol, product A,
product B and pregnenolone are shown. The cytochrome complex was





Fig. 6.3. THE PATTERN OF PRODUCT FORMATION DURING SINGLE TURNOVER
CYCLES OF ANAEROBIC REDUCTION FOLLOWED BY OXYGENATION OF CYTOCHROME
P450 ;CHOLESTEROL:ADRENODOXIN COMPLEX
s cc
The results are expressed as a percentage conversion of the
14
total (4- C) cholesterol added to the incubation 0 0 cholesterol;
• • 22-hydroxycholesterol; k k 20,22-dihydroxycholesterol
and M 9 pregnenolone.
n
Fig. 6.4. A THIN LAYER RADIOCHROMATOGRAM OF PRODUCTS FORMED AFTER
14
A SINGLE CYCLE OF REDUCTION FOLLOWED BY OXYGENATION OF (4- C)~
PRODUCT A-CYTOCHROME P45Q-ADRENODOXIN COMPLEX
Peaks of radioactivity of Product A and Product B are shown.
represents a radiochromatogram of Product A and a
radiochromatogram after a reduction-oxygenation cycle. The






Fig. 6.5. A THIN LAYER RADIOCHROMATOGRAM OF PRODUCTS FORMED AFTER A
14
SINGLE CYCLE OF REDUCTION FOLLOWED BY OXYGENATION OF A (4- C)-PRODUCT
B-CYTOCHROME P450 -ADRENODOXIN COMPLEX
scc
Peaks of radioactivity corresponding to Product B and pregnenolone
are shown. represents a radiochromatogram of Product B and
a radiochrcmatogram after a reduction-oxygenation cycle. The
cytochrome complex was extracted and chromatography performed as described
in Methods.
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spin substrate depleted cytochrome P45C>scc and a single cycle turn¬
over performed the product was pregnenolone (Fig. 6.5).
Identification of Intermediates in the Conversion of Cholesterol to
Pregnenolone
Thin layer chromatography of products A and B was performed with
known standards in the solvent system di-isopropyl ether:petroleum
ether:acetic acid, 70:30:2 by volume. The value of product A is
similar to the monohydroxylated sterols, (20S)-20-hydroxycholesterol
and (22R)-22-hydroxycholesterol. No differentiation in R^ values
on TLC could be made between these monohydroxylated sterols. The
R^ value of product B was similar to that of 20,22 dihydroxycholesterol
(Table 2).
Gas liquid chromatography of non-derivated sterols on a column of
0.5% SE30 on Gas-Chrom Q support as described in the Methods allows
separation of (22R)-22-hydroxycholesterol retention time 18.5 min
from (20S)-20-hydroxycholesterol, retention time 12.5 min. Product
A has a retention time of 18.5 min. Gas liquid chromatography of
non-derivatised 20,22-dihydroxycholesterol proved unsatisfactory
presumably through dehydration.
The mass spectrum of 22-hydroxycholesterol, (obtained by gas
chromatography-mass spectroscopy of the di(trimethylsilyl) ether)
isolated after turnover of cytochrome P450 was identical to the
see
authentic di(trimethylsilyl) derivative (Fig. 6.6) and agreed in detail
with the mass spectrum previously described by Burstein ^t al^. (1975) .
The ion at m/e 173 comprises the fragment C-22 to C-27, elimination of
trimethylsilanol from this ion results in the ion m/e 83. The
molecular ion was not detected in either standard or isolated material
but ions of low abundance were observed at m/e 295 and 343.
TABLE 6.2 values from thin layer chromatography and retention
times from gas liquid chromatography of reference and
unknown sterols. Thin layer chromatography was
performed in diisopropyl ether:petroleum ether:acetic
acid 70:30:2 by vol. as described in Methods. Gas
liquid chromatography was performed on non-derivatised
sterols as described in Methods.
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Fig. 6.6. MASS SPECTRA OF 22-HYDROXYCHOLESTEROL
The mass spectrum of 22-hydroxycholesterol (obtained by gas
chromatography-mass spectroscopy) of the di(trimethylsilyl)ether)
isolated after catalytic turnover of cytochrome P450 (product A)see
was identical to the authentic di(trimethylsilyl) derivative and
agreed in detail with the mass spectrum previously described by
Burstein et al. (1975).
Upper trace: product A.
Lower trace: authentic 22-hydroxycholesterol.
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The mass spectrum of 20,22-dihydroxycholesterol (obtained by
gas chromatography-mass spectroscopy) of the tri(trimethylsilyl) ether)
isolated after turnover of cytochrome P450 (Fig. 6.7) was identical
see
to the authentic tri(trimethylsilyl) derivative (Fig. 6.7). The
molecular ion was not detected despite scanning the peak to give
skewed spectra favouring high mass ions. The base peak of the
spectrum was m/e 461 (comprising the fragment C-l to C-21) and other
peaks present were m/e 389, 370, 371, 299, 289, 281, 143 and 117.
Efficiency of Single Cycle Turnover of Cytochrome P^50_cc
The efficiency of a single turnover cycle of cytochrome p^^^scc_
cholesterol:adrenodoxin can be calculated. The assumption is made
that formation of a monohydroxylated sterol from cholesterol requires
two electrons; a dihydroxylated product requires four electrons and
pregnenolone, six electrons (Shikita and Hall (1973) .
For a single turnover of the cycle and with two electrons donated
the amount of product formed should be in a 1:1 molar equivalence to
cytochrome P45C>scc. The amount of product formed can be calculated
from the radioactive conversion knowing the specific radioactivity
of added cholesterol and the total amount of cytochrome P450gcc present
or from absolute determinations of 22-hydroxycholesterol quantitated
by gas liquid chromatography. From these calculations the amount of
product formed on a single turnover cycle is 30-33% of the molar
equivalence of cytochrome P450gcc. The efficiency of multiple turnover
cycles is similar to that of a single cycle.
Products of Autoxidation of Oxygenated Cytochrome P450-Cholesterol
14
Cholesterol, pre-equilibrated with 4- C cholesterol, was added
in ten-fold molar excess to a 10 yM solution of low spin cytochrome
in 10 mM potassium phosphate buffer pH 7.4 and made anaerobic in a
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Fig. 6.7. MASS SPECTRA OF 20,22-DIHYDROXYCHOLESTEROL
The mass spectrum of 20,22-dihydroxycholesterol (obtained
by gas chromatography-mass spectroscopy) of the tri(trimethylsilyl)
ether) isolated after catalytic turnover of cytochrome P450gcc
(Product B) was identical to the authentic tri(trimethyl)derivative.
Upper trace: product B.
Lower trace: authentic 20,22-dihydroxycholesterol.
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that 0.1 yCi was added to an incubation of 2.5 ml. The solution was
reduced with stoicheiometric amounts of sodium dithionite, oxygenated,
and the reaction followed by absorbance changes at 418 nm until
autoxidation was complete. The contents of the cuvette were
extracted with organic solvent and thin layer chromatography performed.
The developed chromatogram showed no zones of radioactivity other
than those associated with (4-^C) cholesterol. This was confirmed
by scraping into vials, 1 cm bands of silica gel from the plate,
adding scintillation fluid, and determining radioactive counts. No
zones of radioactivity were detected other than that associated with
t / 14 \(.4- C) cholesterol. The oxygenated cytochrome P450scc~cholesterol
complex autoxidises to the ferric state without oxidation products of
cholesterol being formed.
However, if oxidised adrenodoxin in a molar ratio to cytochrome
P450 , was added to the oxygenated cytochrome P450 -cholesterol
S CC SCO
complex, the product formed was 22-hydroxycholesterol. The efficiency
(electrons consumed) in the formation of 22-hydroxycholesterol
from cholesterol on addition of oxidised adrenodoxin to oxygenated
cytochrome P450 is around 5% and did not increase by increasing
see
the molar ratio of oxidised adrenodoxin added:oxygenated cytochrome
P450 to 8:1.
see
Determination of llg-Hydroxylase Activity of Cytochrome P^5Q-CC
3
Deoxycorticosterone, pre-equilibrated with deoxy la2a(n)~ H
corticosterone, was added to a two-fold molar excess to cytochrome
P450 . Adrenodoxin was added in a molar ratio to cytochrome P450
see see
and the solution reduced anaerobically, then oxygenated. This was
repeated for eight cycles. The reaction mixture was extracted with
organic solvent and thin layer chromatography performed in chloroform:
ethyl acetate, 8:2 by volume. A radiochromatogram of the developed
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thin layer plate showed no zones of radioactivity other than that
associated with deoxycorticosterone. This was confirmed by scraping
into vials, 1 cm bands of silica gel from the plate, adding scintillation
fluid and determining radioactive counts.
The Conversion of 7a-Hydroxycholesterol to 7a-Hydroxypregnenolone
. 14 .
(4- C) 7a-hydroxycholesterol, 160 nmoles with 0.1 yCi, was
added to 1.6 mis low spin substrate depleted cytochrome
(80 nmoles) and incubated 15 hrs at 20°C. Adrenodoxin, 80 nmoles,
was added to the cytochrome P450scc-7a-hydroxycholesterol complex
such that the molar ratio of cytochrome P450 :adrenodoxin:7a-
scc
hydroxycholesterol was 1:1:2. The adrenodoxin and cytochrome
were reduced stoicheiometrically with sodium dithionite under
anaerobic conditions and then oxygenated. This sequence of stoi-
cheiometric anaerobic reduction and oxygenation was repeated for
a further eight cycles. A thin layer radiochromatogram of extracted
sterols, developed in benzene:ethyl acetate::7:13 by volume showed a
single product peak with an 0.3 which corresponded to authentic
7a-hydroxypregnenolone and represented 42% of total radioactivity.
The mass spectrum of 7a-hydroxypregnenolone (obtained by gas chroma-
tography-mass spectroscopy of the di(trimethylsilyl)ether) isolated
after catalytic turnover of cytochrome P450 (Fig. 6.8) was
s cc
indistinguishable from the di(trimethylsilyl) derivatives of authentic
7a-hydroxypregnenolone produced by a photo-oxygenation reaction.
The spectra show one intense ion at m/e 386 presumably arising from
elimination of trimethyl silanol from the C-7 position. The molecular
ion m/e 476 was present in low abundance, 1% of the base ion.
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Fig. 6.8. MASS SPECTRA OF 7a-HYDR0XYPREGNEN0L0NE
The mass spectrum of 7oi-hydroxypregnenolone (obtained by
gas chromatography-mass spectroscopy) of the di(trimethylsilyl)
ether) isolated after catalytic turnover of cytochrome




The detection of intermediates during the side chain cleavage
of cholesterol to pregnenolone has been studied. The method was
based on the fact that cytochrome ^50
^ as prepared is depleted
of substrate cholesterol; this allows readdition of cholesterol of
know specific radioactivity. Cytochrome is a one electron
acceptor and the first electron can be introduced from a non-specific
donor such as sodium dithionite. Adrenodoxin is a one electron
donor (Estabrook et: al_. (1973)) and m^rbe required as an electron
donor or as an effector for the second electron introduced into the
oxygenated cytochrome P450 -cholesterol complex. Adrenodoxin
see
can be reduced with sodium dithionite (Estabrook et: al. (1973)).
Hence stoicheiometric amounts of cytochrome P450 -cholesterol
see
complex to adrenodoxin, artifically reduced with one electron,
under anaerobic conditions, should on subsequent oxygenation allow
one turnover of the cycle.
The evidence presented concerning the reaction sequence of
intermediates in the conversion of cholesterol to pregnenolone
establishes that the initial oxidative attack catalysed by cytochrome
P450 on cholesterol is at C-22 with the formation of 22-hydroxy-
scc
cholesterol followed by oxidative attack at C-20 to form 20,22-
dihydroxycholesterol. This sequence agrees with the kinetic studies
of Burstein and Gut (1971) on the relative rates of utilisation of
(20S)-20-hydroxycholesterol, (22R)-22-hydroxycholesterol and (20R,22R)-
20,22-dihydroxycholesterol in an acetone powder preparation of adrenal
cortex mitochondria. This evidence excludes the possibility of the
initial oxidative attack occurring at C-20 with the formation of 20-
hydroxycholesterol as significant in the conversion of cholesterol to
pregnenolone under the conditions used in this study.
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Cholesterol binding to and subsequent spin state change of
cytochrome P450gcc appears to be the rate limiting step in the
catalytic sequence. The steady state spectrum in intact mitochondria
is the low spin cytochrome (Simpson et al. (1971)). This is compared
to the catalytic sequence of cytochrome P45C>C^ where the second
electron donation is rate limiting and the steady state spectrum is
that of oxygenated cytochrome (Tyson et al. (1972)).
This difference in rate limiting events has a number of consequences.
Determination of the stoicheiometry of cholesterol side chain
cleavage to pregnenolone, in terms of electrons accepted and oxygen
consumed, has involved substantial corrections for reactions not
associated with hydroxylation (Shikita and Hall (1973)). In this
enzyme complex, where substrate binding is rate limiting, low spin
substrate depleted cytochrome ^450^^ could accept electrons with
subsequent partial or non-productive cycle turnover producing
superoxide or peroxide. The study of the stoicheiometry of single
turnover reactions, where the enzyme is primed with substrate, should
theoretically circumvent this problem. However the efficiency of a
single cycle turnover in a partially reconstituted electron transport
chain was low. Adrenodoxin is present in adrenal cortex mitochondria
in a 1:1 molar ratio to cytochrome P450, (Es tab rook ^t al^. (1973))
although binding studies of purified adrenodoxin to partially purified
cytochrome P450 give dissociation constants of 3 yM for a high
see
affinity binding site (Katagiri _e_t_ (1977)). This suggests that
in vitro reconstitutibn of the electron transport chain may require
higher molar ratios of adrenodoxin to cytochrome P450scc for maximal
binding of adrenodoxin to cytochrome P450gcc. The cytochrome P450gcc
used in the single cycle turnover studies is partially purified and
other redox acceptors may be present which reduce the theoretical yield
88.
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of hydroxylated product formed from the electron equivalence donated.
The possibility also exists of distinct cytochrome P450 s involved
in each of the individual steps from cholesterol to pregnenolone.
However, no physical separation of these postulated cytochromes
has been reported and the ability to form pregnenolone from cholesterol
parallels that of pregnenolone formation from (20S)-20-hydroxycholesterol
during purification procedures (Shikita and Hall (1973)); (Horie and
Watanabe (1975)). Similarly the amount of hydroxylated product
formed to electron equivalence donated is similar for single cycles
or multiple cycles. In the possible theoretical case of distinct
cytochrome P450 s catalysing the individual hydroxylation reactions
the efficiency should increase after the first turnover step in the
reaction with cholesterol as substrate.
Ferric cytochrome P450 -cholesterol when reduced stoicheio-
scc
metrically with sodium dithionite under anaerobic conditions and
then bubbled with oxygen to form the oxygenated cytochrome P450 -
see
cholesterol complex, failed to form oxidation products of cholesterol
during the subsequent autoxidation of this complex. However, when
oxidised adrenodoxin was added to this oxygenated cytochrome
cholesterol complex, 22-hydroxycholesterol was formed. The efficiency
of the mixed function oxidase in terms of electrons required to effect
conversion of cholesterol to product under the specified conditions
described, appears to be about five per cent. This is a lower figure
than that obtained in experiments on pre-equilibration and stoicheio-
metric reduction of adrenodoxin and cytochrome P450 -cholesterol
see
prior to oxygenation and raises the question of the importance of the
association kinetics of cytochrome P450 and adrenodoxin and whether
see
this is different with oxidised or reduced adrenodoxin. The role of
adrenodoxin at the stage of electron donation to the oxygenated
89.
cytochrome P450 -cholesterol complex cannot be answered by thes c c
experiments described in this chapter. The possibilities are that
adrenodoxin acts solely as an electron donor or as an effector or
has both functions. In the first case where oxidised adrenodoxin
is added to the oxygenated cytochrome P450 -cholesterol complex,see
one would have to postulate that some of the adrenodoxin be reduced
by reversal of electron flow from a ferrous cytochrome P450gcc
molecule; this reduced adrenodoxin in turn donating an electron
to an oxygenated cytochrome P45C>scc-cholesterol complex. • In
similar experiments when oxidised putidaredoxin was added to oxygenated
cytochrome P450^,^-camphor complex reversal of electron flow through
the iron sulphur protein was postulated (Lipscomb et al. (1976)).
However, one could argue that oxidised adrenodoxin may not be
reduced and that intermolecular transfer of electrons takes place
between cytochrome P450 molecules. The observation that
see
3 6
relatively simple dithiols such as dihydrolipoic acid added in 10 -10
molar excess to oxygenated cytochrome P450^^-camphor will allow
hydroxylation of camphor in the absence of putidaredoxin (Lipscomb
jit al. (1976)), may indicate that iron sulphur proteins may have a
dual role at this stage of the cycle. In essence, we can confirm
the essential requirement of adrenodoxin for the overall reaction of
cholesterol side chain cleavage as observed by Kimura eit al. (1973)
and suggest that the step of electron donation to oxygenated cytochrome
P450 -cholesterol may be the site for this requirement.
SCO
The failure to detect 116~hydroxylation of deoxycorticosterone
under the conditions described or to observe a Type I spectral change
on addition of deoxycorticosterone to cholesterol depleted cytochrome
P450gcc suggests a complete separation of the cytochrome P450 associated
with the side chain cleavage of cholesterol from that associated with
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llg-hydroxylation. The concept of distinct cytochrome P450 s catalysing
side chain cleavage of cholesterol and llg-hydroxylation of deoxycorti¬
costerone has been confirmed by Ramseyer and Harding (1973), Shikita
and Hall (1973) and Katagiri et al. (1975). Corticosterone, a substrate
for the 18-hydroxylation reaction present in adrenal cortex mitochondria,
when added to the cholesterol depleted cytochrome P450gcc preparation
failed to induce a Type I spectral change. The 18-hydroxylase
activity in intact mitochondria is low compared to that of side chain
cleavage of cholesterol or 118-hydroxylation of deoxycorticosterone.
It has been suggested that 18- and llg-hydroxylations are controlled
by the same gene locus and that these activities are supported by a
single enzyme. During the preparation of cytochrome p450gcc no
enzymatic assays of 18-hydroxylase activity were made.
The structural requirements for the sterol side chain cleavage
reaction has been investigated with sterols retaining the cholest-5-en-
3g-ol nucleus but with variable non-polar side chain (Arthur et al. (1976)).
Similarly a variety of monohydroxylated side chain analogues are
metabolised to pregnenolone by adrenal mitochondria (Burstein and Gut
(1971); Mason et al. (1978a)). Cholesterol analogues for the side
chain cleavage reaction have been confined to variations in the side
chain. The evidence presented establishes that a nuclear monohydroxylated
sterol, 7a-hydroxycholesterol, is metabolised to 7a-hydroxypregnenolone.
The 7a-hydroxycholesterol induces a low to high spin state transition
of substrate depleted cytochrome P450gcc, binding more rapidly and to




Addition of equimolar amounts of adrenodoxin to cytochrome
P450 -cholesterol, followed by stoicheiometric reduction under
see
anaerobic conditions and then oxygenation allows single catalytic
turnover cycles of cytochrome P450gcc to be studied. This has
allowed detection of intermediates in the conversion of cholesterol
to pregnenolone and a precursor-product sequence of cholesterol -
22-hydroxycholesterol - 20,22-dihydroxycholesterol-pregnenolone to
be established. <
Addition of oxidised adrenodoxin to oxygenated cytochrome P450gcc
cholesterol results in formation of 22-hydroxycholesterol; in the
absence of added adrenodoxin no oxygenated product of cholesterol is
formed.
Multiple turnover cycles with deoxycorticosterone as substrate
for cholesterol depleted cytochrome P450gcc failed to show deoxy¬
corticosterone to corticosterone.
Multiple turnover cycles with 7a-hydroxycholesterol as substrate
for cholesterol depleted cytochrome P450gcc confirmed that the side






The most commonly postulated pathway for conversion of cholesterol
to pregnenolone entails a consecutive series of reactions - cholesterol-
(20S)-20-hydroxycholesterol-(20R,22R)-20,22-dihydroxycholesterol-
pregnenolone (Shimizi et al. (1961); Constantopoulos and Tchen (1961);
Shimizi et al. (1962)). This scheme was postulated on the basis that
(i) cholesterol is cleaved between carbons 20 and 22 giving rise to
a six carbon fragment (Staple et al. (1956); Constantopoulos et al.
(1962)). (ii) (20S)-20-hydroxycholesterol is formed from(4-^C)
cholesterol by bovine adrenal cortex homogenates in the presence of
trapping agents (Solomon et al. (1956)) and (iii) (20S)-20-hydroxy-
cholesterol and (20R,22R)-20,22-dihydroxycholesterol are more efficiently
transformed to pregnenolone than is cholesterol (Shimizi et al. (1961);
Shimizi et al. (1962)). Constantopoulos et al. (1962) described the
accumulation of (20R,22R)-20,22-dihydroxycholesterol with a bovine
adrenocortical preparation in the presence of pregnenolone. However
Koritz and Hall (1964); Hall and Koritz (1964) and Simpson and Boyd
(1967) were unable to observe the formation of these sterols from
cholesterol and explained this by the suggestion that the cleavage
of the cholesterol side chain is a concerted reaction in which the
intermediates do not appear in the medium and that only the final
product, pregnenolone, is released when the reaction is completed.
The possible involvement of 20-hydroxy, 22-ketocholesterol as an
intermediate has been suggested (Shimizi et al. (1962)), convertible
to pregnenolone but at a slower rate than (20R,22R)-20,22-dihydroxy-
cholesterol. However experiments by Constantopoulos et al. (1962,1966)
have effectively eliminated the formation of a 22-keto group in the
conversion of (20S)-20-hydroxycholesterol to pregnenolone.
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Chaudhuri et al. (1962) showed that (22R)-22-hydroxycholesterol
was effectively converted to pregnenolone. Burstein, Gut and
colleagues (1969,1970) have exploited a kinetic approach to the
study of intermediates in the side chain cleavage of cholesterol
using radioactive sterols in an acetone powder preparation of
adrenal mitochondria. These authors conclude that the slowest step
in the formation of pregnenolone is the conversion of cholesterol
to the monohydroxylated product, that the formation of (20S)-20-
hydroxycholesterol from cholesterol is slower than that of (22R)-22-
hydroxycholesterol and the rate of (22R)-22-hydroxycholesterol
utilisation to pregnenolone is greater than that of (20S)-20-hydroxy-
cholesterol. However most of the pregnenolone formed does not
appear via any of these hydroxylated products and the authors assume
a concerted attack of oxygen to form (20R,22R)-20,22-dihydroxy-
cholesterol which is oxidatively cleaved to pregnenolone. Similar
pathways involving a direct conversion of (20S)-20-hydroxycholesterol
and (22R)-22-hydroxycholesterol to pregnenolone, not mediated via
the dihydroxycholesterol, have also been suggested.
Van Lier and Smith (1970) have shown that cholesterol-(20S)-20-
hydroperoxide is converted to (20R,20R)-20,22-dihydroxycholesterol
by rearrangement of the peroxide, a mechanism not requiring reducing
equivalents or oxygen. If this is a significant mechanism then a
single molecule of oxygen should donate atoms to both positions.
However the evidence of Burstein et al. (1976) shows the distribution
of the oxygen atoms in 20,22-dihydroxycholesterol after incubation
18 16
of cholesterol with and 0^ to be consistent with introduction
from two different oxygen molecules. A subsequent publication by
Van Lier et al. (1976) proposes that the mechanism of side chain
cleavage of cholesterol involves three consecutive iji situ oxidations
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in a manner consistent with those of Burstein et al. (1970).
Kraaipoel et al. (1975) have suggested an alternative mechanism
for side chain cleavage of cholesterol. Cholesterol is dehydrogenated
to form cholesten-5, 20-diene-3f3-ol, subsequent oxygenation forming
20,22-epoxycholesterol which is hydrated to (20R,22R)-20,22-dihydroxy-
cholesterol with an oxygen dependent cleavage of the dihydroxycholesterol
to pregnenolone. The incorporation of (20S)-20-hydroxycholesterol or
(22R)-22-hydroxycholesterol into this pathway is by dehydration at the
C20-22 bond. Another possible route, not suggested by the authors,
to form hydroxylated cholesterol would be through isomerisation of
20,22-epoxycholesterol as is well documented for arene oxides (Jerina
and Daly (1974)).
The formation of an epoxide during a similar dealkylation to the
sterol side chain cleavage reaction has been established in the
conversion of sitosterol to cholesterol in the silkworm with the
intermediate formation of fucosterol 24,28 oxide (Morisaki et al. (1972)
and Awata et al. (1975)). The mammalian liver microsomal cytochrome
P450 dependent systems have been shown, with aromatic compounds as
substrates, to form phenols and diols through intermediate arene oxides
(Jerina and Daly (1974)), although in certain cases direct formation
of a phenol can occur without an intermediate epoxide (Tomaszewski et
al. (1975)).
18
Burstein et al. (1976) have shown that (22R)-(22- 0) 22-hydroxy-
18
cholesterol and (20S)-(20- 0) 20-hydroxycholesterol are converted to
the respective dihydroxycholesterols and that the formed glycols and
18
substrates at the end of incubations have the same 0 abundance as
the starting material. The evidence presented by Burstein et al. (1976)
showing the distribution of oxygen atoms in 20,22-dihydroxycholesterol
18 16
after sequential incubation with 0^ and 0^ is consistent with the
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introduction of two atoms of oxygen into the diol from two different
oxygen molecules. If 20,22-epoxycholesterol were an intermediate
then one of the oxygen atoms in 20,22-dihydroxycholesterol would be
derived from molecular oxygen and the other from water. The four
stereoisomers of 20,22-epoxycholesterol were synthesised chemically
by Morisaki et al. (1976) and incubated with partially purified
cytochrome P450 in the presence of an appropriate electron supply,s cc
None of these derivatives was significantly converted to pregnenolone
although a slight inhibition of side chain cleavage of radioactive
cholesterol by these epoxycholesterols was noted but there occurred
no trapping of the radioactivity by these compounds. However,
Burstein et al. (1976) have shown, using an acetone powder preparation
of adrenal mitochondria, that (20R,22S)-20,22-epoxycholesterol
yielded one fifth the amount of pregnenolone compared to a similar
incubation with cholesterol but (20R,22R)-20,22-epoxycholesterol was
not metabolised. Burstein et al. (1976) and Morisaki et al. (1976)
have shown that no significant (20R,22R)-20,22-dihydroxycholesterol
is formed on incubation of (E)- or (Z)-20(22)-dehydrocholesterol.
Luttrell et al. (1972) and Hochberg et al. (1974) consider that
the hydroxycholesterol compounds to be by-products of the side chain
cleavage of cholesterol and that the true intermediates are short
lived reactive complexes of oxygenated steroidal species and the
metalloenzyme. The authors present evidence that (20R)-20-t-butyl-5-
pregnene-3g,20-diol and (20R)-20-(p-tolyl)-5-pregnene_3B, 20 diol are
converted to pregnenolone by bovine adrenocortical mitochondria and
as position C22 is fully substituted this site is unavailable for
hydroxylation. The authors suggest an ionic or radical reaction for
the basic mechanism of side chain cleavage of cholesterol. However
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Fig. 7.1. PROPOSED CATALYTIC SEQUENCE FOR THE CHOLESTEROL SIDE
CHAIN CLEAVAGE REACTION
A single turnover cycle of cytochrome ^*50 *-s shown with
cholesterol as substrate and the formation of the first stable
intermediate 22-hydroxycholesterol which is retained at the active
site, a further catalytic cycle produces 20,22-dihydroxycholesterol.
The oxygenated complex of cytochrome PASO^^-cholesterol is shown
in only one of the possible resonance forms. ISP: iron sulphur
protein (adrenodoxin) and Fp: NADPH adrenodoxin reductase.
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with partially purified cytochrome P450gcc failed to show significant
conversion to pregnenolone.
The evidence presented concerning the reaction sequence of
intermediates in the conversion of cholesterol to pregnenolone
establishes that the initial oxidative attack catalysed by cytochrome
P450gcc on cholesterol is at C-22 with the formation of 22-hydroxy-
cholesterol followed by oxidative attack at C-20 to form 20,22-
dihydroxycholesterol. This sequence agrees with the kinetic studies
of Burstein and Gut (1971) on the relative rates of utilisation of
(20S)-20-hydroxycholesterol (22R)-22-hydroxycholesterol and (22R,22R)-
20,22-dihydroxycholesterol in an acetone powder preparation of
adrenal cortex mitochondria. This evidence excludes the initial
oxidative attack occurring at C-20 and hence the formation of 20-
hydroxycholesterol is significant in the conversion of cholesterol
to pregnenolone. Similarly if cholesterol (20S)-20-hydroperoxide
were an intermediate (Van Lier and Smith (1970)), rearrangement of
the peroxide might result in 20,22-dihydroxycholesterol as the initial
product isolated. The sequence established excludes 20,22-epoxy-
cholesterol as an intermediate in the catalytic cycle (Kraaipoel
et al. (1975)) as the second product is a glycol 20,22-dihydroxy¬
cholesterol rather than epoxide. The evidence presented cannot
exclude the speculation that the true intermediates in the conversion
of cholesterol to pregnenolone might be a short lived, reactive complex
of oxygenated steroidal species and a metalloenzyme (Hochberg et al.
(1974); Luttrell et al. (1972)). Certainly short lived, unstable
intermediates of this type must exist at the stage of second electron
donation to the oxygenated cytochrome P450gcc-sterol complex whether
this sterol be cholesterol, 22-hydroxycholesterol or 20,22-dihydroxy¬
cholesterol .
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A catalytic sequence for the cholesterol side chain cleavage
reaction is proposed (Fig. 7.1). Cholesterol binds to the ferric
enzyme and induces a spin change to a high spin state; the ferric-
cholesterol complex accepts one electron to form a ferrous-cholesterol
complex which in turn interacts with molecular oxygen to form a ternary
complex termed oxygenated cytochrome ^^5oscc~ cholesterol. The oxygenated
form of cytochrome P450 -cholesterol accepts a second electron to form
s c c
as yet an ill-defined, irreversible intermediate whose decay results in
the formation of 22-hydroxycholesterol. However, instead of product release
and regeneration of the low spin substrate depleted cytochrome P450
Liiul
(Gunsalus et al. (1972)), 22-hydroxycholesterol is retained and a further
catalytic cycle produces 20, 22-dihydroxycholesterol. Similarly, 20, 22-
dihydroxycholesterol is retained at the active site of cytochrome P450
see
and a further cycle results in oxidative cleavage to pregnenolone and
presumably isocaproic aldehyde.
The failure to detect significant conversion of the isomers of
20,22-epoxycholesterol and 20(22)-dehydrocholesterol to pregnenolone
(Burstein et al. (1976); Morisaki et al. (1976) and the evidence presented
in this thesis would seem substantial evidence for sequential oxygenation
of cholesterol at C-22 then C-20 to form 20,22-dihydroxycholesterol rather
than the hydration of the epoxide, 20,22-epoxycholesterol (Kraaipoel et al.
(1975)). This could be further substantiated by experiments not as yet
attempted on the cholesterol side chain cleavage, namely:
a) the demonstration of the absence of an NIH shift during the
formation of 22-hydroxycholesterol, and
b) the demonstration of a significant isotope effect in the
formation of 22-hydroxycholesterol from cholesterol or in the formation
of 20,22-dihydroxycholesterol from cholesterol.
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The migration and retention of substituents that occur during
the monoxygenase catalysed formation of phenols from most aromatic
substrates has been termed the 'NIH shift* (Guroff et al. (1967)).
The occurrence of this shift suggested that the 'aromatic hydroxylations*
are actually epoxidations and that the intermediate arene oxides
undergo a ready isomerisation to phenols with a concomitant migration
and retention of substituents (Jerina and Daly (1974)). The formation
of an arene oxide from a deuterated aromatic substrate should proceed
without a significant isotope effect since carbon-hydrogen bonds are
not broken in the oxidation (Guroff and Daly (1967); Daly and Jerina
(1967)).
When oxidation at a saturated carbon is considered either the
substrate must be activated by loss of hydride, hydrogen atom, or a
proton to form a readily oxidised carbonium ion, radical, or carbanion
(abstraction), or transfer of the equivalent of singlet oxygen to the
substrate must occur. Enzymatic hydroxylation at saturated carbon
often shows a primary isotope effect and invariably proceeds with
a high degree of retention of configuration (Daly (1971)). These
mechanisms are compatible with an insertion mechanism involving transfer
of a single oxygen atom. Abstraction pathways, while generally less
likely for energetic reasons, are equally compatible with primary isotope
effects (Tomaszewski et al. (1975)). In general aromatic hydroxylations
are considered to have arene oxides as intermediates, show no significant
isotope effects but have an NIH shift (Jerina and Daly (1974)).
However, examples of aryl hydroxylation are known with significant
isotope effect (Tanabe et al. (1970); Tomaszewski et al. (1975)).
In general aliphatic hydroxylations show significant isotope effects
(Oesch et al. (1971)) but again exceptions to this generalisation
are known (Ullrich (1968); Tagg et al. (1967)).
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In 1964, Hamilton remarked on the similarity of many of the
monoxygenase catalysed hydroxylations to the carbene and nitrene
reactions and suggested that monoxygenases catalyse their reactions
by an oxygen transfer or oxenoid mechanism. In no case has the
structure of an actual enzyme oxenoid reagent been positively
identified but speculation has been made on the oxenoid reaction as
the mechanism of cytochrome P450 dependent reactions (Hamilton et al.
(1974)). It is generally agreed that the oxidation of substrate
apparently occurs when an electron is transferred to a Fe++ form of
the enzyme that has substrate and oxygen bound to it. Thus, at
least formally, there would appear to be three possibilities for
the oxenoid reagent:
a) an enzyme - Fe+ - molecular oxygen complex,
b) an enzyme - Fe+++ - peroxide compound, and
\ -r-i +++++
c) an enzyme - Fe - oxygen atom complex.
The Fe+ enzyme would presumably be a resonance hybrid of Fe+-porphyrin,
Fe -reduced porphyrin (by one electron), and Fe+++-reduced porphyrin
(by two electrons). Similarly, the formal Fe+++++ intermediate would
1 • • i • ++++ , __ +++ . .
have resonance contributions involving Fe and Fe , with
oxidised porphyrin structures (Hamilton (1969)). The first possibility
appears unlikely as the oxygen would have an excess of electrons rather
than being electron deficient, a condition necessary for model compound
reactions (Hamilton (1974)). The second alternative has been
discounted on the basis that Fe+++-peroxide complexes do not react
readily with alkanes or aromatic compounds (Hamilton (1974)). The
third alternative is regarded as a possible structure for the oxenoid
reagent (Hamilton (1974); van Lier and Rousseau (1976)). Van Lier
and Rousseau (1976) have proposed a reaction mechanism (Fig. 7.2)
for the cholesterol side chain cleavage reaction with a ferryl ion
complex, Fe++-oxygen atom as the reactive species not only for the
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sequential hydroxylations at C^ and C^q but also for the oxidative
cleavage of the ^20~^22 ^onc^"
The reaction involving the cleavage of the ^20~^22 car^on
bond of 20,22-dihydroxycholesterol to pregnenolone and a six carbon
fragment has a number of unusual features. This reaction appears
to require molecular oxygen and a source of reducing equivalents
in the form of NADPH (Fiet et al. (1971)). The cleavage of 20,22-
dihydroxycholesterol to pregnenolone is inhibited by carbon monoxide
and the photochemical action spectrum on reversal of this carbon
monoxide inhibition has a peak at 451 nm suggesting that cytochrome
P450 is involved in the reaction (Hall et al. (1975)). The
stoicheiometry of conversion of 20,22-dihydroxycholesterol to
pregnenolone has been investigated by Shikita and Hall (1974) and
the authors conclude the reaction has a ratio of pregnenolone
produced:NADPH consumed:oxygen consumed of 1:1:1. However these
measurements did involve substantial corrections for undefined
background reactions not, according to the authors, involved in the
production of pregnenolone.
The nature of the six carbon fragment formed during cholesterol
side chain cleavage to pregnenolone was initially considered to be
isocaproic acid (Lynn et al. (1954); Staple et al. (1956)). The
six carbon fragment was shown to be formed in a 1:1 molar ratio to
pregnenolone (Constantopoulos and Tchen (1961))but the authors
considered that the initial product formed was isocaproic aldehyde
and not isocaproic acid. Burstein and Gut (1971) observing the
formation of isocaproic aldehyde, isohexyl alcohol and isocaproic
acid during the cholesterol side chain cleavage reaction in human,
chicken and bovine adrenal material made a number of observations.
The authors observed that in individual adrenal preparations from
the same species isocaproic aldehyde was the major product formed
although the ratio to isocaproic acid and isohexyl alcohol varied.
Comparison of species showed that chicken and human adrenal produced
isohexyl alcohol as the major product. Incubation of isocaproic
aldehyde with bovine adrenals led to the formation of isohexyl
alcohol and isocaproic acid while a similar incubation with human
tissue led to the formation of isohexyl alcohol. The authors
conclude that isocaproic aldehyde is the primary product of the
cholesterol side chain cleavage reaction and that it is followed by
reduction to isohexyl alcohol and oxidation to isocaproic acid.
Takemoto et al. (1968) have presented evidence to show that in
18
the presence of O2 no oxygen is incorporated into either pregnenolone
or isocaproic aldehyde on incubation of 20,22-dihydroxycholesterol
with a bovine adrenal preparation. No evidence can be presented
for the fate of the oxygen molecule, apparently required in
stoicheiometric amounts to the substrate. If the molecular oxygen
is incorporated into water then two moles of water would be formed
per mole of pregnenolone formed. A conclusion of this nature
would not be consistent with this reaction being termed a mixed
function oxidation according to the definition of Mason (1957).
A reaction mechanism for the cholesterol side chain cleavage
reaction has been proposed by Van Lier and Rousseau (1976) based
on the ferryl ion-oxygen complex catalysing three in situ
oxidations at the C22~H, ^20~H anc^ ^20~22 ^on<^s to 8^ve pregnenolone
and isocaproic aldehyde as the final products (Fig. 7.2a). The
authors postulate formation of the ferryl-oxygen atom complex by
protonation of a ferrous-superoxide form with the intermediate formation
of the hydroperoxy state, elimination of the hydroxyl ion results in




















Fig. 7.2. REACTION MECHANISM FOR CHOLESTEROL SIDE CHAIN CLEAVAGE
PROPOSED BY VAN LIER AND ROUSSEAU (1976).
The authors postulate formation of the ferryl-oxygen atom
complex by protonation of a ferrous-superoxide form with the
intermediate formation of the hydroperoxy state, elimination of
the hydroxyl ion results in cleavage of the 0-0 bond (Fig. 7.2a).
The cleavage of the ^2(^22 ^on<^ 20,22-dihydroxycholesterol is
envisaged as a two electron abstraction by the ferryl ion complex





















Fig. 7.3. PROPOSED MECHANISM FOR THE CLEAVAGE OF THE BOND
OF 20,22-DIHYDROXYCHOLESTEROL
In this model both atcms of a molecule of oxygen are incorporated
into 20,22-dihydroxycholesterol forming a peroxy bridge across the
^20~22 k°nc^ and facilitating cleavage of the bond to yield isocaproic
alcohol and 3B,20,20-trihydroxypregnene-5-ene. Elimination of a
molecule of water from each of these products would yield isocaproic
aldehyde and pregnenolone.
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cholesterol and 20,22-dihydroxycholesterol by either an initial
abstraction of hydrogen or a direct insertion of oxygen over the C-H
bond would be consistent with the evidence presented in this thesis
and the evidence of Burstein and Gut (1971); Morisaki et al. (1976).
Van Lier and Rousseau (1976) envisage the cleavage of the C20~^22
bond of 20,22-dihydroxycholesterol by a two electron abstraction by
the ferryl ion complex resulting in the formation of pregnenolone
and isocaproic aldehyde (Fig. 7.2b). This final stage in the
cholesterol side chain cleavage reaction envisages cytochrome
P450 as an oxidase with no oxygenase function and with thesee
elimination of two moles of water per mole of product formed.
In considering potential mechanisms for the cleavage of the
C"20~^22 bond of 20,22-dihydroxycholesterol, Van Lier and Rousseau
(1976) have speculated on an oxidase function for cytochrome ^450
a major divergence from the traditional view of cytochrome ^50
^
as a monoxygenase. In a similar speculative vein one could propose
that cytochrome might act as a dioxygenase at the stage of
cleavage of the ^20~^22 ^on<^ 20,22-dihydroxycholesterol. This
would involve incorporation of both atoms of a molecule of oxygen
into 20,22-dihydroxycholesterol forming a peroxy bridge across the
C2Q-C22 bond and facilitating 36,20,22-trihydroxypregnene-5-ene formation
(Fig. 7.3). Elimination of a molecule of water from each of
these products would yield isocaproic aldehyde and pregnenolone.
The oxygen atom eliminated in water from each of the initial products
would have to be derived from that oxygen incorporated to form
the peroxy bridge across the ^20~^22 t0 sat-i-sfy the lack of
incorporation of oxygen during the cleavage of 20,22-dihydroxycIiolesterol.
Mechanisms similar to this reaction scheme have been proposed for
103,
C-C bond cleavage by dioxygenase systems such as 3,4^dihydroxyphenyl-
acetate dioxygenase and for cathecol 1,2 - and 2,3 - dioxygenase
(Dorn and Knackmuss (1978)).
In conclusion elucidation of the nature of the ^20~^22 k°n<*
cleavage of 20,22-dihydroxycholesterol may reveal a reaction mechanism
singular to cytochrome P450 dependent reactions.
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